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1. Summary
Tenascin-R (TN-R) is a glycosylated brain extracellular matrix protein
(BECM; Zamze et al., 1999) restricted to the central nervous system (Pesheva et al.,
1989; Rathjen et al., 1991; Weber et al., 1999). A special feature of TN-R, and some
of its known ligands, is their accumulation around certain sub-populations of
neurones, forming perineuronal nets of extracellular matrix (PNEMs; Wintergerst et
al., 1996; Matsui et al., 1998; Hagihara et al., 1999; Haunso et al., 1999).
In these studies, bacterial expression of the C-terminal domain of TN-R, the
FG-knob, led to the formation of inclusion bodies concurring those of previous studies
(Norenberg et al., 1995; Elefteriou et al., 1999). Heterologous expression of the
FG-knob, as a secreted protein, in the yeast P. pastoris gave rise to different
glycosylated proteins. The majority of these expressed proteins remained within the
yeast cells, with only extremely low amounts being secreted. Expression of
recombinant FG-knob, as a secreted protein, in a mammalian cell line (Cos-1/M6)
produced two different glycosylated forms with a size difference of 40 kDa. However,
these forms were not detected in conditioned medium as the FG-knob precipitated
around the host cells upon secretion leading to the formation of large cell aggregates.
Despite the general insolubility of the FG-knob, an affinity column was generated and
potential ligands purified from pig cortex. These ligands contained neither sites to
common matrix components such as elastin, collagen type II and IV or hyaluronic
acid nor did they contain the carbohydrate N-acetyl-D-galactosamine (GalNAc), a
common constituent of proteoglycans such as chondroitin sulphates and keratan
sulphates, found extensively in extracellular matrices (Lodish et al., 1995).
PNEMs are lattice-like accumulations of BECM components, consisting
mainly of chondroitin sulphate proteoglycans (CSPGs; Margolis and Margolis, 1993;
Ruoslahti, 1996), around GABAergic interneurones expressing the calcium binding
protein parvalbumin (PV). Here, it is shown that phosphacan, a specific member of
the CSPG family (Matsui et al., 1998; Hagihara et al., 1999), preferentially associates
with both cortical and non-cortical PNEMs. In this study, the identification of
phosphacan in PNEMs in vivo provides functional and biological importance to
previously described interactions with other defined PNEM components in vitro
(Milev et al., 1997, 1998; Xiao et al., 1997). Recently, it has been shown in vitro that
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all lecticans, a family of CSPGs which form large aggregates with hyaluronic acid,
interact with TN-R (Aspberg et al., 1997). Examination of PV and TN-R single and
double knockout (KO) mice revealed that PNEMs appear normal in mice lacking PV
whereas TN-R deficient mice show morphological alterations in these entities. These
alterations have been shown to occur because defined lecticans such as phosphacan
and neurocan were no longer present in PNEMs. Neither the membrane-related
cytoskeleton in PV-expressing GABAergic interneurones, nor the density or
distribution of cortical GABAergic interneurones were altered in any of the examined
KO mice. Thus, the principal role for TN-R in PNEMs may be to attract and/or retain
other matrix components. TN-R is however not envisaged to be involved in
determining which neurones form PNEMs or the GABAergic properties of these
neurones. The intimate involvement of TN-R in the formation of the lattice-like
structure of PNEMs is probably effectuated via the multimerisation of TN-R
molecules leading to the formation of a scaffold onto which other PNEM components
assemble.
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2. Résumé
La tenascine-R (TN-R) est une glycoprotéine de la matrice extracellulaire du
cerveau (Zamze et al., 1999) dont la distribution est restreinte au système nerveux
central. (Pesheva et al., 1989; Rathjen et al., 1991; Weber et al., 1999) Une des
caractéristiques de la TN-R et de quelques-uns de ses ligands connus, est son
accumulation autour de certaines sous-population de neurones, formant ainsi les
réseaux périneuraux de la matrice extracellulaire (PNEMs; Hagihara et al., 1999;
Haunso et al., 1999; Matsui et al., 1998; Wintergerst et al., 1996).
Dans ces études, l'expression bactérienne du domaine COOH-terminal de la
TN-R, le bouton Fibrinogène (FG), conduit à la formation de corps d'inclusion en
accord avec la littérature. (Norenberg et al., 1995; Elefteriou et al., 1999).
L'expression hétérologue du bouton FG sous forme de protéine sécrétée par la souche
de levure P. Pastoris, a donné différentes protéines glycosylées. La majorité de ces
protéines recombinantes se trouvent à l'intérieure des levures et seule une infime
quantité est sécrétée. L'expression du bouton FG dans une lignée de cellules de
mammifère (Cos-1/M6) sous forme de protéine sécrétée a produit deux formes de
protéines glycosylées avec une différence de 40 kDa entre elles. Cependant ces deux
formes n'ont pas pu être détectées dans le milieu conditionné car le polypeptide
recombinant précipitait autour des cellules hôtes lors de la sécrétion conduisant à la
formation de larges agrégats cellulaires. Malgré l'insolubilité générale du bouton FG,
une colonne d'affinité a été faite pour tenter de purifier des ligands à partir du cortex
cérébral de cerveaux de porcs. Ces ligands ne contiennent pas de sites communs aux
composants de la matrice extracellulaire tels que l'élastine, le collagène type II et IV
ou l'acide hyaluronique. Ils ne contiennent pas non plus d'hydrates de carbone tel que
du N-acétyl-D-galactosamine (GalNAc), un constituant commun aux protéoglycans
comme la chodroïtine sulfate et les kératanes sulfate que l'on trouve en grande
quantité dans les matrices extracellulaires. (Lodish et al., 1995).
Les PNEMs sont des accumulations en forme de treillis de composants de la
matrice extracellulaire du cerveau. Ils sont constitués principalement de
protéoglycans-chondroïtine sulfate (CSPGs; Margolis et Margolis et al., 1993;
Ruoslahti, 1996). Ils sont localisés autour des interneurones GABAergiques exprimant
une protéine liant le calcium: la parvalbumine. Dans ce travail, nous montrons que le
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phosphacan, un membre spécifique de la famille des CSPG (Hagihara et al., 1999;
Matsui et al., 1998), s'associe de préférence avec les PNEMs corticaux et non-
corticaux. Par l'identification des phosphacans dans les PNEMs in vivo, nous
montrons qu'ils ont une importance fonctionnelle et biologique dans les interactions
précédemment décrite in vitro avec d'autres composants du PNEM (Milev et al., 1997;
Xiao et al., 1997). Il a été récemment montré in vitro que tous les lecticans, une
famille de CSPGs formant de larges agrégats avec l'acide hyaluronique, agissent avec
la TN-R. L'étude des souris déficientes pour les gènes de la PV et/ou de la TN-R a
révélé que les PNEMs apparaissaient normaux dans le cerveau des souris déficientes
pour le gène de la PV alors que dans le cerveau de celles dont le gène de la TN-R
avait été supprimé, les PNEMs montraient des altérations morphologiques. Ces
désordres des PNEMs survenaient parce que certains lecticans tels que le phosphacan
et le neurocan n'étaient plus présents dans les PNEMs. Ni le cytosquelette lié à la
membrane cellulaire des interneurones GABAergiques exprimant la parvalbumine ni
la densité ou la distribution corticale de ces cellules n'étaient altérées dans les
cerveaux des souris déficientes pour les gènes suscités.
Ainsi le rôle principal de la TN-R dans les PNEMs pourrait être d'attirer et/ou
de retenir d'autres composants de la matrice. Cependant, la TN-R ne semble pas être
impliquée dans la détermination du type de neurones susceptible de former des
PNEMs ou d'avoir des propriétés GABAergiques. L'implication intime de la TN-R
dans la formation d'une structure en forme de treillis des PNEMs est probablement
possible via une multimérisation des molécules de TN-R. Cette dernière conduit à la
formation d'un échafaudage sur lequel viennent s'assembler les composants du
PNEM..
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3. General introduction
3.1 Extracellular matrices
3.1.1 Extracellular matrix
The extracellular matrix (ECM) is a macromolecular ground substance of
connective material secreted by fibroblasts and other connective tissue cells into the
surrounding medium. The ECM comprises the non-cellular portions of animal tissues
and consists of proteins, polysaccharides and proteoglycans (Lawrence, 1995).
Recently, the ECM has been shown to be intimately involved in regulating the
behaviour of the cells it surround (Blackshaw et al., 1995).
3.1.2 Brain extracellular matrix
Until recently, the amount and even the existence of a brain extracellular
matrix (BECM) has been much disputed (for a historic overview and original
references see Celio, 1999). With the introduction of improved tissue preparation
techniques for electron microscopy the existence of a substantial matrix-filled
interstitial space, comprising up to 20% of the brain volume, has recently been
established (Carlson and Hockfield, 1996). Yet, in contrast to extracellular matrices
(ECMs) in other organs the BECM shows a relative low content of fibrous matrix
components such as collagens, fibronectin and vitronectin (Rucklidge et al., 1989;
Gladson and Cheresh, 1991). The BECM is however composed of a complex network
of glycosaminoglycans, proteoglycans and glycoproteins (for review see Celio and
Blümcke, 1994; Ruoslahti, 1996; Celio, 1999). Using less specific staining methods
such as the colloidal-iron or the periodic-acid Schiff methods (for review see Celio
and Blümcke, 1994), it has been shown that all neurones throughout the central
nervous system (CNS) are surrounded by a ‘glycocalyx’ or ECM. This matrix has
been shown to be involved in cell migration, maturation (Rutka et al., 1988) and
tumour cell invasion (Ruoslahti and Giancotti, 1989). Moreover, it is also involved in
regulation of cell adhesion, neurite outgrowth and can serve both as co-factors and as
regulators of growth factors (Ruoslahti and Yamaguchi, 1991). Through this
multitude of effects, the BECM is intimately involved in the normal development and
maintenance of nervous system functions (Schachner, 1994).
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3.2 Perineuronal nets of extracellular matrix
3.2.1 Historic perspectives
Perineuronal nets of extracellular matrix (PNEMs; reviewed in Celio and
Blümcke, 1994) were first described by Camillo Golgi at the end of the 19th century
(for a historic overview and original references see Celio et al., 1998). Golgi observed
“a delicate covering, mainly reticular in structure, but also in the form of tiny tiled
scales or an interrupted envelope which surrounds the cell body of all nerve cells and
continues along their protoplasmic extensions....”a in the grey matter of the CNS.
These nets were further characterised by Donaggioa who showed that the nets were
continuous with both the intracellular neurofibrillar network and the extracellular
environment. He also proposed that the observed holes in the lattice-like structure
were places where axon terminals interacted with the surface of nerve cells. In 1931,
while examining animals belonging to the Phylum Chordata, Rondinini showed that
PNEMs also existed in the CNS of such diverse classes as amphibians, reptiles and
birds.
3.2.2 Composition of PNEMs and their distribution
It is generally believed that PNEMs are pericellular condensations of ECM
components forming a fine meshwork within the local neuropil (Celio, 1999). With
the introduction of immunohistochemical, biochemical and molecular biological
methods, it has become possible to further characterise PNEMs and identify their
individual constituents. PNEMs are composed of classical BECM molecules, which
are present in higher concentration within these PNEMs (Celio and Blümcke, 1994).
At the ultrastructural level, it has been confirmed that PNEM components are found
between synaptic boutons impinging upon the cell body and major dendritic
arborisations (Bruckner et al., 1993; Celio and Blümcke, 1994).
PNEMs are exclusively detected during postnatal (P) development with the first
nets observed around P7 and fully developed nets around P28 (Schweizer et al.,
1993). PNEMs have been described in a variety of locations such as spinal cord, deep
cerebellar nuclei, hippocampus and cerebral cortex (Brauer et al., 1982, 1984;
                                                                
a From Celio et al. 1998
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Hockfield and McKay, 1983; Lafarga et al., 1984; Naegele et al., 1988) and are
mainly found surrounding nerve cells, which have a considerable proportion of their
cell bodies devoted to synaptic contacts (Celio and Blümcke, 1994). In spite of a
complex pattern of distribution in the cerebral cortex and hippocampal formation, nets
are mainly observed surrounding a subpopulation of non-pyramidal GABAergic
neurones (Celio, 1986, 1993) expressing the calcium-binding protein parvalbumin
(PV; Kosaka and Heizmann, 1989; Kosaka et al., 1989, 1990, 1992; Naegele and
Barnstable, 1989).
Using immunohistochemistry, several distinct molecules belonging to
different classes of BECM components have been identified in PNEMs. Chondroitin
sulphate proteoglycans (CSPGs) are the main constituents of PNEMs (Margolis and
Margolis, 1993; Ruoslahti, 1996) with individual members such as brevican
(Hagihara et al., 1999), neurocan (Matsui et al., 1998; Haunso et al., 2000) and
phosphacan (Lodish et al., 1995; Haunso et al., 1999, 2000) have been identified in
PNEMs. Certain glycoproteins such as tenascin-C (Celio and Chiquet-Ehrismann,
1993) and –R (Celio and Rathjen, 1993; Wintergerst et al., 1996) are also present in
high amounts in PNEMs. Moreover, hyaluronic acid has also been shown to be
accumulated in PNEMs (Delpech et al., 1982; Bignami et al., 1992). This
heterogeneity in composition is reflected by the fact that PNEM components are not
secreted by the neurones surrounded by the nets, but by neighbouring neurone and
glia populations (Maleski and Hockfield, 1997; Lander et al., 1998). A biologically
significant role for the presence of these components in PNEMs in vivo has been
further validated as several of them also interact in vitro (Aspberg et al., 1995, 1997;
Xiao et al., 1997).
3.2.3 Putative functions for PNEMs
The exact functions of PNEMs have yet to be elucidated, but many have been
proposed. A direct function of these matrix components could be to prevent the
occlusion of the extracellular space (Celio and Blümcke, 1994). PNEMs may also
function in synapse stabilisation (Bertolotto et al., 1990; Zaremba et al., 1990) or as a
barrier for the formation of new synaptic contacts (Celio and Blümcke, 1994) and
influencing the maintenance of cellular relationships in adult CNS (Hockfield and
McKay, 1983). Other putative functions could be the generation of an ion-buffering
microenvironment or the attraction and concentration of growth factors, proteases and
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protease-inhibitors in the vicinity of the neurones, thereby modulating their
microenvironment (Celio and Blümcke, 1994). An overall role in neuroprotection has
also been suggested (Okamoto et al., 1994). Härtig et al. (1999) hypothesised that
physico-chemical properties of PNEMs provide the basis for neurones to sustain fast-
spiking activity. Finally, a membrane related cytoskeleton (MRC), partly composed of
ankyrinR, has been identified in parvalbumin expressing cortical interneurones with a
proposal that the PNEMs may be interacting with this intracellular scaffold via
transmembrane receptors (Celio and Rathjen, 1993; Celio and Blümcke, 1994;
Wintergerst et al., 1996) thus influencing the morphology of the neurone and its
intracellular signalling.
3.2.4 PNEMs and pathology
PNEMs were first described at the end of the 19th century and although their
existence at that time was much disputed, the first description of morphological
changes in pathological conditions occurred already in 1911. Here, Bethe b observed
that PNEMs remained intact although neurones and the converging synapses were
severely affected by lesions. It was observed that modifications of PNEMs occurred
independently of those observed in neurones. In recent years it has been reported that
alterations and destruction of PNEMs occurs in a number of diseases such as patients
infected with human immunodeficiency virus (HIV; Belichenko et al., 1997b),
suffering from Rett syndrome (Belichenko et al., 1997a) and transmissible spongiform
encephalopathies (TSEs) including Creutzfeldt-Jacob disease (CJD; Guentchev et al.,
1998; Belichenko et al., 1999). Loss of ECM components may therefore be involved
in the observed decline of cognitive, motor and behavioural functions in some patients
belonging to these groups. Furthermore, PNEMs have been thought to be effected in
Alzheimer’s disease (AD; Kobayashi et al., 1989) but this notion still remains
controversial (Celio et al., 1998). However, recent observations have shown that
PNEM components are not directly involved in the pathogenic processes in AD but
lowers the neurones susceptibility to neurofibrillary changes (Bruckner et al., 1999).
                                                                
b For original references see Celio et al., 1998.
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3.3 The tenascin multi-gene family
Glycoproteins are major constituents of extracellular matrices in organs of
higher order animals (Johansson, 1996). One such group of matrix molecules is the
tenascin multi-gene family (tenascins) comprising members of structurally related
modular glycoproteins (Chiquet-Ehrismann, 1995). These members are believed to be
important in regulating numerous developmental processes such as organogenesis and
morphogenetic cell migration (Chiquet-Ehrismann et al., 1994). In the literature, five
individual tenascins, including tenascin-C, -R, -X, -Y and -W, have been described in
diverse species such as zebrafish (Weber et al., 1998), chicken (Jones et al., 1988;
Norenberg et al., 1992; Hagios et al., 1999), rodents (Saga et al., 1991; Fuss et al.,
1993) and man (Gulcher et al., 1989; Matsumoto et al., 1992; Bristow et al., 1993;
Carnemolla et al., 1996). All members of the tenascin family are modular
glycoproteins with repeating sequence motifs folding into small globular domains
(Bork and Koonin, 1996). Each member is very homologous to tenascins in other
species and show relatively high similarity to other family members (Chiquet-
Ehrismann et al., 1994). Tenascins share four distinctive domains (Erickson, 1993)
and vary in calculated molecular size from 132 kDa for TN-W to >400 kDa for TN-X
(Johansson, 1996). The amino-terminal of the tenascins contains a cysteine-rich
segment that is unique to members of this family (Norenberg et al., 1995). This
segment contains oligomerisation sites involved in the assembly of monomers into
dimers, trimers or hexamers (Pesheva et al., 1989; Spring et al., 1989; Erickson, 1993;
Pesheva et al., 1993; Norenberg et al., 1995). The cysteine-rich segment is followed
by a variable number (3.5 to 18.5) of epidermal growth factor (EGF) like repeats
(Erickson, 1993) and a series of fibronectin (FN) type III like domains (5 to 33)
depending upon the species and type of tenascin molecule (Chiquet-Ehrismann et al.,
1994). The carboxyl-terminal segment of the tenascins is similar to the carboxyl-
terminal domain of b- and g-fibrinogen (FG; Erickson, 1993; Chiquet-Ehrismann et
al., 1994).
3.3.1 Tenascin-C
Tenascin-C (TN-C) was the first discovered, and remains by far the most
extensively studied member of the tenascin family (tenascins; for review see Erickson
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and Bourdon, 1989; Weber et al., 1999). TN-C, formerly termed J1-200/220 (Kruse et
al., 1985; Faissner and Kruse, 1990; Lochter et al., 1991 Bartsch et al., 1992),
hexabrachion (Erickson and Inglesias, 1984) or cytotactin (Grumet et al., 1985; Jones
et al., 1988, 1989) has been found in both the central (Grumet et al., 1985; Kruse et
al., 1985; Prieto et al., 1990) and peripheral nervous system (Daniloff et al., 1989;
Martini et al., 1990) and in various non-neuronal structures (Erickson and Inglesias,
1984; Chiquet-Ehrismann et al., 1986). In the CNS, TN-C has been implicated in a
range of different morphogenetic processes during development such as promotion of
neurite outgrowth, neuronal migration, repulsion of neuronal cell bodies and growth
cones, polarisation of neuronal morphology and inhibition of axonal regeneration in
adults (Husmann et al., 1992; Prieto et al., 1992; Lochter and Schachner, 1993; Taylor
et al., 1993)
Surprisingly, mice deficient for TN-C (Saga et al., 1992) develop normally
and show no major neurological alterations or gross changes in behaviour, indicating
that the TN-C either has no essential function that the loss can be compensated for by
other proteins (Chiquet-Ehrismann et al., 1994).
3.3.2 Tenascin-X, -Y and –W
The three tenascins, TN-X, TN-Y and TN-W, have yet to be well characterised
with a function only proposed for TN-X. The mRNA of TN-X has been detected in
foetal muscle, testis, adrenal gland, kidney and lung and it has been suggested that
TN-X may exert a role in connective-tissue structure and function (Bristow et al.,
1993; Johansson, 1996). More recently, an association between TN-X deficiencies
and a group of connective tissue disorders, the Ehlers-Danlos syndrome, has been
proposed (Burch et al., 1997).
TN-Y has been identified in chicken and is highly expressed in developing
lung, kidney, skin (Hagios et al., 1999), and in the connective tissue of adult skeletal
muscle of this species (Hagios et al., 1996) but has also been detected in the avian
nervous system (Tucker et al., 1999).
TN-W has been identified in zebrafish, with a distribution partly overlapping
that of TN-C, and has been proposed to be involved in the migration of neural crest
and sclerotome cells (Weber et al., 1998).
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3.4 Tenascin-R
3.4.1 Structure of tenascin-R
Tenascin-R (TN-R; for review see Schachner et al., 1994), formerly termed
janusin (Fawcett et al., 1992; Bartsch et al., 1993; Wintergerst et al., 1993), restrictin
(Rathjen et al., 1991; Norenberg et al., 1992) and J1-160/180 (Fuss et al., 1993), is an
extracellular matrix glycoprotein (Zamze et al., 1999) detected in the CNS (Pesheva et
al., 1989; Rathjen et al., 1991; Weber et al., 1999). The gene for TN-R gives rise to
two alternative splice variants with molecular sizes of either 160 or 180 kDa and has
recently been mapped to the region q23-q24 on chromosome 1 in humans
(Carnemolla et al., 1996). Both TN-R splice variants are composed of a cysteine-rich
amino-terminal, which is followed by 4.5 EGF-like repeats, eight or nine FN type III
like domains (depending upon the isoform) and a FG-knob at the carboxyl-terminal
(Norenberg et al., 1992; Fuss et al., 1993; Johansson, 1996; see figure 3.4.1). TN-R,
as the other tenascins, is a glycoprotein and carbohydrates comprise 10 – 20% (w/w)
of the observed molecular size (Zamze et al., 1999). Electron microscopic
investigations of the multimerisation of TN-R have revealed that the 180 kDa isoform
assemble into dimeric or trimeric structures whereas the 160 kDa isoform mainly
exists as a monomer (Pesheva et al., 1989; Norenberg et al., 1992).
3.4.2 Expression pattern of tenascin-R
Expression of TN-R mainly occurs late during development (Pesheva et al.,
1989), with the larger isoform predominating in humans (Carnemolla et al., 1996).
TN-R is mainly synthesised by oligodendrocytes during the onset and early phase of
myelination (Bartsch et al., 1993; Wintergerst et al., 1993) but TN-R has also been
detected in vitro in type-2 astrocytes (Ffrench-Constant and Raff, 1986; Wintergerst et
al., 1993). TN-R is also expressed in vivo in subsets of neurones such as stellate cells
Cysteine-rich region EGF-like repeats FN type III like domains FG-knob
Tenascin-R
Figure 3.4.1 Human tenascin-R
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and basket cells in the cerebellar cortex, motor neurones in the spinal cord and
neurones in the hippocampus and olfactory bulb (Fuss et al., 1993; Wintergerst et al.,
1993). In the CNS, the protein appears mainly to be associated with the surface of
oligodendrocytes, myelinated axons in the white matter (Norenberg et al., 1992;
Bartsch et al., 1993), and with PNEMs around certain groups of interneurones and
motor neurones throughout the nervous system (Celio and Rathjen, 1993; Wintergerst
et al., 1996). During postnatal development the expression of TN-R by
oligodendrocytes decreases significantly whereas labelling intensity of neurones
remains constant (Bartsch et al., 1993; Wintergerst et al., 1993). This pattern of
expression suggests a role in the process of myelination, stabilisation and maintenance
of nerve fibre tracts and axosomatic synaptic contacts in the CNS.
3.4.3 Properties of tenascin-R domains
Tenascin-R has been shown to be involved in promotion of neurite outgrowth
and morphological polarisation of different neurones when presented as a uniform
substrate in vitro (Lochter and Schachner, 1993; Lochter et al., 1994). TN-R is also a
repellent for growth cone advance when presented as a sharp substrate boundary
(Pesheva et al., 1993; Taylor et al., 1993), promotes adhesion and differentiation of
oligodendrocytes and astrocytes (Pesheva et al., 1989, 1997; Morganti et al., 1990)
and has also been suggested as a modulator of fasciculation (Xiao et al., 1998).
Different properties accounting for various functions observed for TN-R have been
localised to different structural domains of the protein core in vitro (Xiao et al., 1996;
see table 3.4.1). Nonetheless, additional functions may be observed for native TN-R
as the type of attached carbohydrates may also play a role.
Table 3.4.1 Properties of Rat
TN-R domains
Cys &
EGF
FN 1-3 FN 3-5 FN 6-8 FG-knob Native TN-R
Short term neuronal adhesion ± + ± ++ ++ ++
Repulsion of neuronal cell bodies ± + + + ++ ++
Repulsion of growth cones ++ + + + ++ ++
Polarisation of neuronal morphology - - - - ++ ++
Compiled from Xiao et al., 1996. Abbreviations: Cys & EGF; cysteine rich and EGF-like domains, FN; fibronectin type III-
like repeats, FG; fibrinogen like. Arbitrary scale of activity ranging from no observed activity, - to high activity, ++.
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Therefore, the cellular responses to TN-R are complex and probably mediated
by several neuronal receptors interacting with distinct domains of the TN-R molecule
(Xiao et al., 1996; Weber et al., 1999).
As was observed for mice deficient for TN-C, mice lacking TN-R also develop
normally and show no major neurological alterations or gross changes in behaviour,
indicating that the functions of individual tenascins can be compensated for by other
members of the family (Weber et al., 1999).
3.4.4 Receptors for tenascin-R
TN-R, like most other ECM molecules, is a modular protein containing many
potential sites for interaction with other ligands (Xiao et al., 1996). As TN-R is a
secreted extracellular matrix glycoprotein, these ligands are either cell receptors or
other ECM molecules. So far three receptors, F3/F11/contactin (Pesheva et al., 1993)
and myelin-associated glycoprotein (MAG; Yang et al., 1999), both belonging to the
immunoglobulin (Ig) superfamily, and chicken acidic leucine-rich EGF-like domain
containing brain protein (CALEB) have been shown to interact with TN-R in vitro
(Schumacher et al., 1997).
F3/F11/contactin is a 135 kDa glycosyl-phosphatidyl-inositol (GPI)-anchored
cell surface glycoprotein, predominantly expressed by neurones and presumably
involved in promoting axon outgrowth (Brummendorf et al., 1989; Gennarini et al.,
1989) and neurone-glial interactions (Revest et al., 1999). Interaction between
F3/F11/contactin and TN-R has been shown to occur through the Ig-like domains on
F3/F11/contactin (Brummendorf et al., 1993; Norenberg et al., 1995; Xiao et al.,
1996, 1998) and the FN repeats of TN-R (Xiao et al., 1996, 1999). This interaction
mediates the antagonistic TN-R–elicited effects on neurites and growth cones and
axonal defasciculation, when presented as uniform or sharp substrate boundaries (as
described above; Pesheva et al., 1993; Xiao et al., 1996, 1998). In addition, because of
a high sequence homology between F3/F11/contactin and the b2-subunit of the
voltage-gated sodium channel (Isom et al., 1995), TN-R was thought to function as a
regulator of sodium channel localisation and play a role at nodes of Ranvier. This
notion has now been substantiated by the recently shown interaction between TN-R
and the b2-subunit of the voltage-gated sodium channel (Srinivasan et al., 1998; Xiao
et al., 1999).
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The second receptor, so far shown to bind to TN-R, is myelin-associated
glycoprotein (MAG) now also designated siglec-4 (for review see Schachner and
Bartsch, 2000). MAG is a minor constituent of myelin and is implicated in formation
and maintenance of myelin and in interactions between nerve cells and myelin-
forming glial cells (Poltorak et al., 1987). Two isoforms of MAG are expressed (67 or
72 kDa) with the larger isoform being functionally important in the CNS and the
smaller in the PNS (Inuzuka et al., 1991). Expression of MAG and TN-R has been
shown to overlap both in time and space (Yang et al., 1999). Both molecules
accumulate at nodes of Ranvier (Weber et al., 1999) indicating their involvement in
regulating voltage dependent Na+ channel properties (Srinivasan et al., 1998; Xiao et
al., 1999). Furthermore, it has been shown that MAG is involved in the signalling
pathway of TN-R repulsion and that this action is mediated via its interaction with
both the amino-terminal region and the FG-knob of TN-R (Yang et al., 1999).
CALEB, the third receptor for TN-R identified so far, is also the least
described. It is a transmembrane glycoprotein, restricted to the developing and adult
chick nervous system and associated with neuronal and glial surfaces (Schumacher et
al., 1997). It has been immunohistochemically shown to overlap with TN-R in the
retina and implicated in neurite formation in vitro (Schumacher et al., 1997).
3.4.5 ECM ligands for tenascin-R
TN-R has also been shown in vitro to interact with several ECM components
such as a group of chondroitin sulphate proteoglycans (CSPGs) comprising aggrecan,
brevican, neurocan, versican (Aspberg et al., 1995, 1997) and phosphacan (Xiao et al.,
1997; Milev et al., 1998). These interactions are mediated either by carbohydrate-
protein (Aspberg et al., 1995) or by protein-protein interactions (Aspberg et al., 1997).
Using immunohistochemistry, co-localisation between TN-R and different CSPGs has
been shown in many areas of the CNS (Aspberg et al., 1995; Xiao et al., 1997; Matsui
et al., 1998; Hagihara et al., 1999; Haunso et al., 1999), indicating that their
interactions observed in vitro also plays a biologically significant role in vivo. It has
been proposed that these interactions between ECM molecules may influence the
properties of the intercellular space (Weber et al., 1999) or may be involved in
attracting different ECM components to their correct location in the CNS, leading to
the correct assembly of matrix components between and around cell bodies. This
notion is supported by the observation that PNEMs have an altered appearance in
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TN-R deficient mice, resulting from an impaired attraction of certain CSPGs when
TN-R is lacking (Weber et al., 1999; Haunso et al., 2000). Finally, these ligands not
only interact with TN-R but also with each other, different receptors and ECM
molecules, all depending upon the developmental stage and region of the CNS, further
increasing the complexity of these interactions and their functions.
3.4.6 Tenascin-R and pathological conditions
The involvement of TN-R in human pathological conditions has yet to be
extensively studied. As TN-R is a major component of PNEMs (Celio and Rathjen,
1993; Wintergerst et al., 1996) and it can be envisaged that the alteration or
destruction of PNEMs in diseases such as HIV, Rett syndrome and CJD also
influences the distribution of TN-R in these entities. Recently, a loss of TN-C and -R
in acute plaques in multiple sclerosis (MS) has been reported (Gutowski et al., 1999).
This remodelling of ECM components increase during development of MS, indicating
an increase in enzyme-mediated breakdown of ECM components. This was followed
by an increase in TN-C and -R production by astrocytes resulting in glial scar
formation hindering re-myelination and axonal repair in MS lesions (Gutowski et al.,
1999).
3.5 Aims
In these studies, the aim was to further identify and characterise the role of
TN-R in PNEMs and its involvement with the membrane-related cytoskeleton found
in GABAergic PV-expressing cortical interneurones. For this purpose a number of
biochemical and molecular biological techniques were applied to identify
ligands/receptors for TN-R e.g. expression of recombinant proteins in bacteria, yeast
and mammalian cell lines, generation of TN-R affinity column and analysis of TN-R
associating proteins. As the FG fragment is the most conserved domain in the
tenascins (Erickson, 1993) the research focused mainly on this C-terminal fragment.
Furthermore, using combined immunofluorescence and confocal microscopic
techniques, immunohistochemical characterisation of PNEMs and the membrane-
related cytoskeleton was performed to help elucidate the role of TN-R in these
entities.
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4. Bacterial expression of recombinant proteins
4.1 Introduction
From a comparison between the protein sequences of different tenascins it has
become evident that the FG domain is the most conserved module in the tenascins
(Erickson, 1993). The FG-knob of rat TN-R strongly mediates short-term neuronal
adhesion, repulsion of neuronal cell bodies, repulsion of growth cones and
polarisation of neuronal morphology (Xiao et al., 1996). Although the FG region is
relatively conserved between TN-C and -R, similar effects are not observed for
FG-knob of TN-C (Xiao et al., 1996). This, together with the fact that ligands mainly
binding to the amino-terminal region or the FN repeats of TN-R have been
discovered, lead us to postulate that putative receptors/ligands existed for the FG
region of TN-R.
Recently, by affinity chromatography using a recombinant fragment of rat
TN-R comprising the amino-terminal cysteine-rich stretch and all EGF repeats, Xiao
et al. isolated a phosphacan-related molecule from mouse brain (Xiao et al., 1997).
Interactions between recombinant produced chimera of members of the CSPG family
and native full length rat TN-R or recombinant rat TN-R fragments have also been
shown in vitro, with these interactions being mediated by the protein core and not by
carbohydrate-protein interactions (Aspberg et al., 1997). Despite the fact that the
obtained recombinant material does not contain carbohydrates and is potentially
incorrectly folded, these two reports indicate that recombinant technology is a
powerful tool that may be used to identify natural ligands interacting in a non-
carbohydrate mediated manner with TN-R.
28
4.2 Materials and methods
4.2.1 Recombinant DNA technology
4.2.1.1 Polymerase chain reaction
To amplify tenascin-R cDNA fragments
required for construction of expression vectors,
polymerase chain reaction (PCR; Saiki et al., 1988)
was performed on plasmids containing human
tenascin-R cDNA fragments (kindly provided by Dr.
Zardi; Carnemolla et al., 1996). All primers were
produced by Microsynth (Switzerland) and used at a
concentration of 0.4 pmol/mL. To run the PCR, 1 unit
of Pfu DNA polymerase (Promega), forward and
reverse primers, 200 ng of template plasmid and 0.2
nmol/mL of dNTPs (GibcoBRL) were mixed in 1 x
Pfu-buffer (Promega). The PCR was performed as
shown in figure 4.2.1 with a schematic overview of
the PCR process shown in figure 4.2.2.
All PCRs were run using a
Peltier Thermal Cycler PTC-200
DNA engine (MJ Research). The
produced R1 cDNAs spanned bases
2831-4158, whereas the FG cDNAs
spanned bases 3561-4158 of human
tenascin-R.
The amplification products
were separated on 1% agarose gels in
0.5 x TBE, cast using a Mini-Gel
electrophoresis unit (Cosmo Bio Co)
and purified from there using the
QIAEX II gel extraction kit,
according to the protocol supplied by
the manufacturer (Qiagen).
94°C for 2 min.
10 cycles at:
94°C for 30 sec.
55°C for 15 sec.
DT=0.1°C/sec. until 45°C
72°C for 3 min.
30 cycles at:
94°C for 30 sec.
50°C for 15 sec.
DT=0.5°C/sec. until 72°C
72°C for 3 min.
72°C for 5 min.
Figure 4.2.1 PCR program
Figure 4.2.2 PCR procedure
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The sequences for the primers for cloning R1 into pRSET-B were:
hTNR-F-R1 : 5'GGGATCCG GAA TTC ACC ATC ACC AGA C3'
R-R1-pRSET : 5' TCTAGA TCA GAA CTG TAA GGA CTG3'
The sequences for the primers for cloning R1 into pGEX-1 were:
hTNR-F-R1 : 5'GGGATCCC GAA TTC ACC ATC ACC AGA C3'
R-R1-pGEX : 5' GGATCC TCA GAA CTG TAA GGA CTG C3'
The sequences for the primers for cloning FG into both pRSET-B and pGEX-1 were:
hTNR-F-FG : 5'GGGATCCC GAG CTG AGC CAG AAA TTA C3'
R-PRIMER : 5' GAAT TCA GAA CTG TAA GGA CTG C3'
The position of the restriction sites for the endonucleases, included in the
primer sequences, are underlined above. The primers hTNR-F-R1, hTNR-F-FG and
R-R1-pGEX contained restriction sites for BamH1, R-PRIMER for EcoR1 and R-R1-
pRSET for BglII. The first and stop codon in the tenascin-R fragments are indicated in
bold above.
4.2.1.2 cDNA cloning and construction of expression vectors
Expression of cDNAs, cloned into the pRSET-B vector (Invitrogen) resulted
in the production of recombinant proteins with nine additional residues
(RGSHHHHHH, subsequently termed the hexahistidine tag) at the amino-terminus.
Expression of cDNA cloned into the pGEX-1 (Pharmacia biotech) vector resulted in
proteins fused with glutathione-S-transferase (GST) at the amino-terminus.
4.2.1.3 Enzymatic digestion, ligation and transformation into E. coli
Purified R1 cDNA for ligation into pGEX-1 was digested with BamH1
(GibcoBRL), whereas R1 cDNA for ligation into pRSET-B was digested with BamH1
and BglII (Boeringer Mannheim). FG cDNAs for ligation into pGEX-1 and pRSET-B
were digested with BamH1 and EcoR1 (Boeringer Mannheim). The appropriate
vectors (pBluescript II KS +/-, pRSET-B and pGEX-1) were digested using the same
enzymes. All digestions were performed for 1 hr at 37°C in the optimal buffers. All
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digested vectors and cDNAs were purified from 1% agarose gels using the QIAEX II
gel extraction kit.
Unless otherwise stated, all the following centrifugations were performed for 1
min. at 13,000 rpm in a Micro Centaur table centrifuge and all media contained 50
mM ampicillin (Sigma). Approximately 50 ng of the appropriately digested cDNA
and 20 ng of pBluescript II KS +/- vector, together with 2 units T4 DNA ligase
(Fermentas) in 1 x T4 DNA ligase buffer (GibcoBRL) were incubated at room temp.
for 3 hrs. Subsequently, tubes were placed for 5 min. at 56°C, transferred on ice, 100
mL chemical competent XL-1 Blue bacteria (Promega, for production of chemical
competent bacteria see the appendix) were added and the mixture placed on ice for 20
min. The mixtures were then heated to 42°C for 45 sec. in a Techne Dri-block DB-20
heating block (Witec AG) and placed on ice for 5 min. One mL Lennox L broth base
(LB-medium GibcoBRL), without ampicillin, was added and the solutions were
placed for 1 hr at 37°C, followed by centrifugation. Centrifuged pellets were
re-suspended in 50 mL LB-medium and plated on LB-agar (GibcoBRL) plates
together with 10 mL 0.1 M IPTG (Saxon Biochemicals GMBA) and 80 mL 20 mg/mL
X-Gal (Axonlab AG) per 9 cm petri-dish (Milan). This makes it possible to
distinguish clones containing inserts as white and clones without insert as blue. Plates
were subsequently placed overnight in an incubator (Köttermann) at 37°C. The
following day ten white clones were randomly chosen, placed individually in 14 mL
polystyrene tubes containing 3 mL LB-medium and left to grow overnight at 37°C in
an orbital shaking incubator (Gallenkamp). Plasmids were extracted from the
transfected bacteria by centrifuging 1 mL of the cultures, grown overnight, in 1.5 mL
Eppendorf tubes. Supernatants were removed and mini-preparations carried out
according to a procedure described by Feliciello and Chinali (1993). Supernatants
were centrifuged and 200 mL of solution I was added after which the pellets were
re-suspended by vortexing. Subsequently, 200 mL of solution II was added to each of
the tubes, the contents were mixed by inverting the tubes 5-6 times and then 200 mL
of solution III was added, and the contents mixed by inverting (see the appendix for
solutions I, II & III used in the mini-preparation of plasmid cDNAs from bacteria).
All tubes were subsequently centrifuged, supernatant transferred to new tubes, 600 mL
of absolute ethanol added and briefly mixed by vortexing. The contents of the tubes
were centrifuged for 10 min. at 13,000 rpm followed by aspiration of the supernatant
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after which 500 mL of 70% ethanol was added and the pellets partly re-suspended by
vortexing. The tubes were centrifuged for 5 min. at 13,000 rpm, the supernatant
removed and pellets left to dry in a table excicator (Kartell). Pellets were then
re-suspended in 10 mM Tris-HCl, (pH8.0) and stored at -20°C.
Mini-preparations of the plasmids were checked by digesting the plasmids
with restriction enzymes, as described previously, and the results were evaluated on
1% agarose gels. Plasmids containing inserts of the appropriate sizes were sequenced
as described in section 5.2.2. Plasmids containing the appropriate inserts were
digested as described above and the inserts purified from the agarose gels using the
QIAEX II kit and ligated
into their appropriately
digested expression vectors
(pRSET-B or pGEX-1). The
ligation products were
introduced into BL21(DE3)
pLysS bacteria (Promega) as
previously described. After
1 hr at 37°C in LB-medium,
without ampicillin, tubes
were spun, pellets re-
suspended in 50 mL LB-
medium, plated on LB-agar
plates and placed at 37°C
overnight. Clones were then
picked for expression of
recombinant material (for a
schematic overview of the
ligation of FG or R1 into
pRSET-B or pGEX-1 see
Fig. 4.2.3).
Figure 4.2.3 Ligation of cDNA for R1 and the FG-
knob into pGEX1 and pRSET-B
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4.2.2 Expression and purification of recombinant materialc
4.2.2.1 Pilot expression of recombinant material
For bacteria transformed with pRSET-B-R1, pRSET-B-FG or pGEX-1-FG,
five clones were picked from the LB-agar plates and transferred to 14 mL polystyrene
tubes containing 3 mL LB-medium with ampicillin. Ten clones were chosen from
bacteria transformed with pGEX-1-R1 and placed in 14 mL tubes with 3 mL
LB-medium containing ampicillin. Tubes were agitated for 1 hr at 37°C in an orbital
shaking incubator and the content subsequently divided into two. Expression of
recombinant proteins were achieved by adding IPTG to a final concentration of 0.5
mM to one half of the tubes whereas the other half were left un-induced. Tubes were
then agitated for 3 hrs at 37°C after which 1 mL bacteria containing LB-medium was
removed and centrifuged for 1 min. at 13,000 rpm. Pellets were subsequently
re-suspended in 1 x Laemmli loading buffer, sonicated for 2 times 20 sec. using a
Micro Ultrasonic Cell Disrupter (Kontes) and heated for 2 min. at 94°C on a heating
block before applying onto small SDS-PAGE gels to evaluate the expression.
4.2.3 Gel electrophoresisd
4.2.3.1 Preparation, staining and drying of small SDS-PAGE gels
Small (8 x 6.5 cm) discontinuous SDS-containing (Sigma) polyacrylamide gel
electrophoresis slab gels (subsequently termed small SDS-PAGE gels) were prepared
using a Mighty Small SE245 Dual Gel Caster System (Hoefer). The concentration of
acrylamide varied in the separation gels depending upon the experiment (6 - 12%)
whereas stacking gels contained 5% acrylamide. Samples were prepared by dissolving
in Laemmli loading buffer and heated to 94°C on a heating block for 2 min. then
applied to wells made in the stacking gels. The small SDS-PAGE gels were
subsequently run at 20 mA per gel in a Mighty Small II SE250/260 running chamber
(Hoefer) until the tracking dye was 5 mm from the bottom of the gel. Subsequently,
gels were placed in Coomassie Brilliant Blue R-250 solution (Serva) and left to stain
for 3 hrs under agitation. The staining solution was removed and destaining solution
                                                                
c See Guan and Dixon, 1991
d See Laemmli, 1970 and Hames and Rickwood, 1990
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added to the gels, which were then left to destain overnight. The following day, the
gels were placed for 1 hr in drying solution (10% ethanol, 4% glycerol) and
subsequently placed on wet 3M chromatography paper (Whatman) in a GD 5040 gel
dryer (Witec AG) and dried at 60°C for 1 hr under vacuum.
4.2.3.2 Preparation of large SDS-PAGE gels
Large polyacrylamide gels were prepared using a large gel caster (Hoefer).
Separation gels were prepared from acrylamide solutions of two different
concentrations (4% and 16%), which were mixed together using a Hoefer SG50 linear
gradient mixer, and poured in between electrophoretic glass plates (15 x 13 cm),
sealed by spacers and electrophoretic vaseline. Acrylamide solutions were immersed
with water, saturated with butanol, and allowed to polymerise for approximately 1 hr
at room temperature. Subsequently, the water was removed and a 3% stacking gel
comprising of acrylamide was poured in between the electrophoretic glass plates.
Wells were made by placing a comb into the acrylamide solution, which was left to
polymerise for 1 hr. Samples were prepared as described above. Electrophoresis of the
large SDS-PAGE gels were performed at 40 mA per gel in a vertical gel
electrophoresis system (Life Technologies Inc) until the tracking dye was 5 mm from
the bottom of the gels. Following the electrophoresis, the polyacrylamide gels were
removed from the glass plates and either stained by the silver staining method or by
Coomassie Brilliant Blue R-250 where after they were placed overnight in drying
solution. Gels were then placed between two (22 x 22 cm) cellophane sheets wetted in
drying solution, placed on wet 3M paper and dried at 60°C for 4 hrs in a gel dryer
under vacuum.
4.2.3.3 2D electrophoresis, first dimension
Two-dimensional gel electrophoresis was used in order to analyse homogenate
and eluates from the tenascin-R FG affinity column. Proteins were first separated by
isoelectric focusing on 18 cm long Immobiline Drystrips (Pharmacia) with
immobilised linear pH gradient ranging from pH3 to 10. The next step comprised the
separation on linear gradient of 4% to 16% polyacrylamide gels (see section 4.2.3.4).
To perform the first dimension of the isoelectric focusing, Immobiline
DryStrip gels (IPG) were re-hydrated in re-hydration buffer (8 M urea, 2% (w/v)
34
CHAPS, 10 mM DTE, 2% (v/v) resolyte 3.5-10, 0.02 (w/v) bromphenol blue)
overnight at room temperature. After re-hydration, strips were briefly washed with
de-ionised water and transferred to adjacent grooves of the aligner in the Immobiline
DryStrip tray. Strips were placed with the angular end (acidic) at the top of the tray
near the red electrode (anode). The moistened electrode strips were placed across the
cathode and anode ends of the aligned IPG. Both electrodes were aligned over an
electrode strip and pressed down to contact the electrode strips. Sample cups were
placed on the sample cup bars, high enough to avoid touching the gel surface. The
sample cup bars were positioned and pushed towards the electrodes until the spacers
(on the side of sample cup bars) touched the electrodes. The sample cups were pressed
against the IPG strips to ensure good contact with each IPG strip and 230 ml of
silicone oil was poured to completely cover the IPG strips. Samples were applied to
the sample cups by pipetting under the surface of the silicone oil. Samples for 2D
electrophoresis (100 mL) were lyophilised in a speed vak (SC1000, Savant) and
subsequently dissolved in 100 ml of sample buffer (7 M urea, 2 M thiourea, 4% (w/v)
CHAPS, 1% (w/v) DTE, 20 mM Tris, 0.02 (w/v) bromphenol blue, 1 mM EDTA, 1
mini EDTA-free protease inhibitor cocktail tablet (Boehringer & Mannheim)) per 10
ml of sample buffer just prior to use. After placing the safety lid and setting the cooler
to 14°C, the Multiphor unit was connected to the power supply. For the first 15-20
minutes, voltage was set at 250 V where after the voltage was increased to 500 V for
1-2 hrs. Finally, the voltage was increased by 250 V each 15 minutes up to 3500 V. In
total the samples were exposed to approximately 100 kV-hrs of isoelectric focusing
(1.5 day).
4.2.3.4 2D electrophoresis, second dimension
Polyacrylamide gels were prepared from acrylamide solutions of two different
concentrations (4% and 16%; see the appendix), which were mixed together using a
gradient maker and poured in between electrophoretic glass plates (20 x 20 cm) sealed
by spacers and electrophoretic vaseline. Acrylamide solution in between the
electrophoretic glasses was immersed by water, saturated with butanol, and allowed to
polymerise for approximately 1 hr at room temperature. After isoelectric focusing,
strips were picked from strip tray and placed individually in labelled 9 cm petri-dishes
with the plastic side from the strip touching the wall of the petri dish. Strips were first
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pre-incubated for 15 min. at room temp. in equilibrium buffer (0.05 M Tris-HCl
(pH6.8), 6 M urea, 30% (v/v) glycerol, 2% (w/v) SDS, 0.02 (w/v) bromphenol blue)
containing 1% (w/v) DTE. The strips were further incubated for 15 min. at room
temp. in equilibrium buffer containing 2.5 % (w/v) of iodoacetamide. After incubation
with equilibrium buffers, the anode and cathode ends of the strips were removed and
the strips placed on top of the polymerised polyacrylamide gels. Strips were fixed to
the top of the gels by adding melted agarose sealing solution (0.5 % (w/v) agarose and
0.02 % (w/v) bromphenol blue in running buffer) with the aid of a Pasteur pipette, and
allowed to solidify. After filling the electrophoretic chamber with running buffer,
electrophoresis was performed at constant current in two steps. During the initial
migration, a current of approximately 15 mA per gel was used then increased to 30
mA per gel after 30 min. and electrophoresis continued until the front of the tracking
dye was approximately 5 mm from the bottom. After electrophoresis, gels were
placed in a plastic tray and proteins were fixed and stained either by the silver staining
method or by Coomassie Brilliant Blue R-250. The gels were dried as described in
section 4.2.3.
4.2.3.5 Rapid silver staining method
Polyacrylamide gels were silver stained according to the procedure described
in “Short Protocols in Molecular Biology” (Ausubel et al., 1995). The gels were fixed
for 20 min. in 150 mL formaldehyde fixing solution (40% methanol, 0.5 mL/L 37%
formaldehyde), after which they were washed twice for 10 min. with double distilled
water (ddH2O). Subsequently gels were soaked in 150 mL 0.2g/L sodium thiosulfate
(Na2S2O3, Fluka) for 2 min., washed 3 times for 1 min. with ddH2O and placed in
0.1% AgNO3 in ddH2O for 10 min. After incubating in silver-containing solution, gels
were briefly rinsed in ddH2O followed by thiosulfate developing solution (TDS)
comprised of 3% Na2CO3, 0.0004% Na2S2O3, 0.5 mL/L 37% formaldehyde, and
placed in TDS until adequate spot intensities were achieved (between 1 to 10 min.).
Silver precipitation was stopped by adding 5 mL 2.3 M citric acid per 100 mL TDS
and gels left to agitate for 20 min. Subsequently, the gels were washed for 20 min. in
ddH2O and placed overnight in drying solution. The following day, the gels were
placed on wet 3M chromatography paper and dried at 60°C for 4 to 5 hrs in a gel
dryer under vacuum (GD 5040, Witec AG).
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4.2.4 Production and affinity purification of recombinant materiale
4.2.4.1 Large-scale production of recombinant material
Three litres of ampicillin containing LB-medium in Erlenmeyer flasks was
inoculated with 3 mL overnight culture of the appropriately transfected BL21
bacteria. The medium was agitated at 37ºC in an orbital shaking incubator until an
OD600 of 0.2 was reached, where after the expression of recombinant protein was
induced by adding IPTG to a final concentration of 0.5 mM. After 5 hrs of incubation
at 30ºC, the bacteria were pelleted by centrifugation at 5,000 rpm for 15 min. in a
Sorval RCSC centrifuge (GSA rotor). For recombinant material expressed from the
pGEX-1 vector, pellets were re-suspended in 10 mL GST-lysis buffer containing 1
mini EDTA-free protease inhibitor cocktail tablet (Boehringer and Mannheim).
Recombinant material produced from the pRSET-B vector was either re-suspended
under native (50 mM Tris-HCl, 500 mM NaCl, 1 mini EDTA-free protease inhibitor
cocktail tablet, pH7.8) or denaturing conditions (50 mM Tris-HCl, 500 mM NaCl, 8
M urea, pH7.8). Re-suspended pellets were subsequently frozen in liquid N2, then
thawed at 37ºC in a heating block and sonicated on ice for 3 times 30 sec. with 30 sec.
pauses. This procedure was performed twice for each pellets and homogenates were
cleared by centrifugation at 10,000 rpm for 10 min. in a Sorval centrifuge (SS-34
rotor). The supernatant was subsequently loaded on appropriate pre-calibrated affinity
columns (see below).
4.2.4.2 Purification of hexahistidine-fusion proteins
Purification of hexahistidine containing fusion proteins (his-tag) was
performed under both native and denaturing conditions. Buffers for the native and
denaturing affinity-purification were similar except, for denaturing conditions the
solutions in addition contained 6 M urea. All the following manipulations of the
column were performed with the aid of a peristaltic pump (Perplex). In 5” P.P.
chromatography columns (Evergreen Scientific; dimensions, l:d:VT  ; 11 cm:1 cm: 7
mL) was packed 1.5 mL of Ni-NTA (nickel-nitrotriacetic acid) agarose (Qiagen) gel,
re-suspended in either 10 mL native or denaturing buffer. Subsequently 10 mL native
                                                                
e See Pharmacia, 1993 and Scopes, 1994
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or denatured protein lysate was applied to the column and left to run through. After
either washing with 2 x 10 mL native or denaturing His washing solution (nHis or
dHis), 5 mL of nHis or dHis elution buffer was applied and 1 mL fractions were
collected. Ni-NTA agarose columns were regenerated by extensive washes with either
nHis or dHis washing buffer, and stored at 4ºC in either nHis or dHis washing buffer
(native buffer containing 0.02% sodium azide (Merck)). Analysis of eluted material
was performed by SDS-PAGE, using a 1:1 mixture of eluted fraction with 2 x
Laemmli loading buffer (samples containing urea were not heated before being
applied to the SDS-PAGE gel). The gels were stained with Coomassie Brilliant Blue
R-250 and dried in a gel dryer (as previously described).
4.2.4.3 Purification of GST-fused recombinant proteins
All the following manipulations of the column were performed with the aid of
a peristaltic pump. In a 5” P.P. chromatography column was packed 1.5 mL of
glutathione sepharose 4B gel (Pharmacia Biotech), re-suspended in 10 mL GST-
washing buffer. Subsequently, the 10 mL protein lysate was applied to the column and
left to run through. After washing with 2 times 10 mL GST-washing solution, 5 mL of
GST-elution buffer was applied and 1 mL fractions collected. Glutathione sepharose
columns were regenerated by extensive washing with GST-washing buffer, and stored
at 4ºC in GST-washing buffer containing 0.02 % sodium azide. Elution fractions were
diluted 1:1 by 2 x Laemmli loading buffer and analysed by SDS-PAGE as previously
described.
4.2.5 Generation of an affinity column and analysis of eluting proteinsf
4.2.5.1 Generation of human tenascin-R column
Recombinant hexahistidine FG protein (hFG, Vtotal = 20 mL), purified under
denaturing conditions as described above, was dialysed 3 times against 1 litre 3 M
sodium thiocyanate (NaSCN, Aldrich) in 0.1 M NaHCO3, pH8.3. Subsequently, the
solution was centrifuged at 10,000 rpm for 10 min. in a Sorval centrifuge (rotor
SS-34). 0.45g of cyanogen bromide (CNBr) activated sepharose 4 fast flow gel
(Pharmacia Biotech) was placed in a 15 mL centrifuge tube (Milan) and washed 8
                                                                
f See Pharmacia, 1993 and Scopes, 1994
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times in 10 mL ice-cold 1 mM HCl, pH3.0. Dialysed recombinant hFG was added to
the washed sepharose gel and the tube was rotated in a multi-purpose rotor (Bender-
Hobein) for 17 hrs at 4ºC. Subsequently, the sepharose gel was pelleted by
centrifugation for 3 min. at 2,000 rpm in a Rotina 46R table centrifuge (Hettich) and
washed for 5 min. in 14 mL 2 M NaSCN. This was followed by 5 min. washes in 1 M
NaSCN and 0.5 M NaSCN (all in 0.1 M NaHCO3, 0.25 M NaCl, 2.5% glycerol,
pH8.3). Finally, the sepharose gel was washed in coupling buffer (0.1 M NaHCO3, 0.5
M NaCl, pH8.3). All centrifugations were performed at 2,000 rpm for 3 min.
Thereafter, remaining active CNBr groups were blocked by incubating the sepharose
gel with 0.2 M glycine (pH8.0) for 2 hrs at room temperature. Subsequently, the
sepharose gel was washed 3 times with coupling buffer followed by acetate buffer
(0.1 M sodium acetate, 0.5 M NaCl, pH4.0). Finally, the tenascin-R-coupled
sepharose gel was packed in a 5” P.P. chromatography column and stored at 4ºC.
4.2.5.2 Preparation of pig cortex homogenate
Whole pig brains were obtained from the slaughterhouse and placed on ice for
the duration of the transportation (approximately 20 min.). The cortex was separated
from the white matter by dissection under a light microscope (Zeiss), aliquoted into 2
g portions, frozen in liquid nitrogen and stored at -80ºC until used. Approximately 2 g
of pig cortex was placed in 10 mL ice-cold homogenisation buffer A containing 1
mini EDTA-free protease inhibitor cocktail tablet and homogenised using a hand-
operated 15 mL glass homogeniser (Braun Melsungen) on ice for 10 min. The
homogenate was transferred to a 14 mL polystyrene tube and rotated overnight at 4ºC
in a multi-purpose rotor. The following day the solution was centrifuged at 100,000 g
in a Sorval Ultra 80 ultracentrifuge (37,000 rpm, rotor T-865-1), and the pellet
re-suspended in 2 mL homogenisation buffer B and further rotated overnight at 4ºC.
Thereafter, the solution was cleared by centrifugation at 100,000 g, the supernatant
diluted 1:10 in homogenisation buffer C and loaded on the prepared human
tenascin-R FG affinity column. The column was washed 10 times with 1 mL washing
buffer (10 mM Tris-HCl, 1 mM EDTA, 1 mM EGTA, 0.02% sodium azide, pH7.0)
containing stepwise increasing NaCl concentrations (0.0 M to 1.0 M NaCl, Dc=0.1 M)
and 10 mL homogenisation buffer D was applied. Proteins still binding to the column
were eluted with 3 mL homogenisation buffer E, collected in 0.5 mL fractions into
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Eppendorf tubes containing 0.2 mL 1 M Tris-HCl, pH6.8. Before dialysing the eluates
against a carbonate buffer (0.1 M NaHCO3, 0.15 M NaCl, 0.1% Tween-20, pH8.8)
and storage at -20ºC, 100 mL eluate was removed from each Eppendorf tube and
analysed either by SDS-PAGE (large gel) or 2D electrophoresis as described in the
respective sections. The column was washed in 1 M Tris-HCl (pH6.8) followed by
extensive washing with homogenisation buffer A in which it was also stored at 4°C.
4.2.5.3 Enzymatic digestion of eluates
All the following digestions of material eluted from the recombinant FG
column were performed for 1 hr at 37ºC with a concentration of enzyme of
approximately 0.02 U. Collagenase type II (Koch-Light Laboratories) digestions were
carried out at pH7.5 whereas digestions for elastase (Koch-Light Laboratories),
hyaluronidase (Sigma) and chondroitinase ABC (Sigma; Yamagata et al., 1968) all
were performed at pH8.0. Additionally, digestion of collagenase type II was
performed in the presence of 3 mM CaCl2. Eluate (100 mL) was mixed together with
50 mL 1 M sodium phosphate buffer of the appropriate pH, 0.02 U enzyme and
ddH2O up to a total volume of 200 mL. After 1 hr of digestion at 37ºC, 33 mL 6 x
Laemmli loading buffer together with 2 mL 0.1 M DTT were added, the samples
heated to 95ºC for 5 min. and subsequently loaded on a large 4 to 16% linear gradient
SDS-PAGE gel. Proteins were detected by the silver staining method.
4.2.5.4 FITC-labelling and fluorometric detection of ligand - hexahistidine FG
interactions
To 1.2 mL dialysed eluate was added 6 mL FITC (in absolute ethanol), the
tube was wrapped in silver paper, placed in a multi-purpose rotor and mixed by
rotation for 40 min. at room temperature. Subsequently, 100 mL saturated glycine in
ddH2O was added, to block the remaining free FITC molecules, and the tube was
incubated for an additional 15 min. at room temperature. The solution was applied to
a spin column, already pre-packed with P-6 Bio-Gel (BioRad, bead sizes = 90-180
mm) re-hydrated in homogenisation buffer C, and then centrifuged for 3 min. at 3,000
rpm. To four of eight wells in a Ni-NTA HisSorb Strip was added 100 mL purified
recombinant hFG (in 50 mM Tris-HCl, 150 mM NaCl, 4 M urea; pH7.8) which was
subsequently incubated overnight at 4°C. Then, the content of all eight wells was
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washed three times in homogenisation buffer C and 100 mL FITC-labelled eluate was
added to seven of the eight wells. To the last remaining well 100 mL homogenisation
buffer C was added and the strip
subsequently incubated overnight at 4°C.
Three consecutive washes in
homogenisation buffer C and incubation
for 1 min. in 100 mL homogenisation buffer
E, to release any proteins binding to the
hFG-fragment, preceded mixing with 100
mL 1 M Tris-HCl (pH6.8) and collection in
micro-cuvettes (for a schematic overview
of the solution added to the NTA-coated
wells see Fig. 4.2.4). Solutions were
excited at 494 nm and emissions were
measured at 520 nm using a luminescence
spectrometer (Perkin Elmer LS50B). OD
values for wells incubated both with
recombinant hFG and FITC-labelled eluate were compared with values obtained from
the wells incubated only with FITC-labelled eluate or only with recombinant hFG.
Figure 4.2.4 Solutions added to
NTA-coated wells
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4.3 Results
4.3.1 Expression of recombinant material from pGEX-1 vectors
Expression of recombinant material, from cDNA ligated into the pGEX-1
vector, resulted in production of proteins fused at the N-terminal to GST. Production
of recombinant GST-R1 and GST-FG in BL21(DE3) pLysS bacteria was confirmed
by Coomassie Blue staining of bacterial pellets loaded on SDS-PAGE gels. Notably,
the production of recombinant material was only observed in bacteria after induction
with IPTG (Figs 4.3.1 A & B). From SDS-PAGE gels, the molecular size of GST-R1
was estimated to be 70 kDa (Fig. 4.3.1 A, lanes 2, 4, 6 & 8) and the size of GST-FG
          A        B
Figure 4.3.1  Coomassie Blue stained SDS-PAGE gels of bacterial pellets .
Expression of recombinant GST-R1 (A) and GST-FG (B) in BL21 bacteria. Lane M (A & B), 10
kDa molecular marker (Pharmacia Biotech). Lanes 1, 3, 5 and 7 represent pellets from non-
induced bacteria and lanes 2, 4, 6 and 8 pellets from IPTG induced bacteria. Arrows in A & B
indicate the expression of recombinant material of 70 and 45 kDa respectively. The lack of
material in lane 4 (B) occurred due to a problem during the loading of the material.
        A B
Figure 4.3.2  Coomassie Blue stained SDS-PAGE gels of eluates from the glutathione gel.
Detection of recombinant GST-R1 (A) and GST-FG (B). Lane M (A & B), 10 kDa molecular
marker. Lane P, pellet from induced bacteria. The numbered lanes represent: 1; the solution
loaded onto column, 2; the run-through from column, 3; GST washing buffer and 4 to 7; eluates
from the glutathione gel. Arrows in A & B give an example of the expression of recombinant
material. Arrowheads in A indicate elution of proteins associating with the glutathione gel.
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to be 45 kDa (Fig. 4.3.1 B, lanes 2, 6 & 8) both fitting with the calculated sizes.
Evaluation on Coomassie Blue stained SDS-PAGE gels of the solubility of GST-R1
and GST-FG in GST-lysis buffer showed that although GST-R1 and GST-FG were
present in the pellets, they were not detected in the material loaded onto the column
(Fig 4.3.2 A & B, lanes P & 1). As GST-R1 and GST-FG were not soluble in
GST-lysis buffer, nothing bound to - and eluted from - the glutathione gel, and
subsequently it was impossible to purify the recombinant GST proteins from bacteria
transfected with pGEX-1 vector.
4.3.2 Expression of recombinant material from pRSET-B vectors
Expression of recombinant material from the pRSET-B vector resulted in the
production of proteins fused with hexahistidine tags at their N-terminal. The
production of recombinant hexahistidine R1 and FG (hR1 and hFG) in BL21(DE3)
pLysS bacteria was detected by Coomassie Blue staining of bacterial pellets loaded on
SDS-PAGE gels. From here, the molecular size of recombinant hR1 was estimated to
be 52 kDa and that of hFG to be 27 kDa (Figs 4.3.3 A & B, lanes 2, 4 & 6).
4.3.3 Native conditions
When induced bacteria, expressing either recombinant hR1 or hFG, were
treated under native conditions, it was not possible to purify the recombinant proteins
from a Ni-NTA agarose gel (Fig. 4.3.4 A & B, lanes 4 to 7). Recombinant hR1 was
only detected in pellets from induced bacteria (Fig, 4.3.4 A, lanes P) and not in the
    A     B
Figure 4.3.3  Coomassie Blue stained SDS-PAGE gels of bacterial pellets .
Expression of recombinant hexahistidine R1 (A) and FG (B) in BL21 bacteria. Lane M (A & B), 10
kDa molecular marker. Lanes 1, 3 and 5 represent pellets from non-induced and 2, 4 and 6 from
induced bacteria. Arrows in A & B give an example of the production of recombinant material with
molecular sizes of 52 and 27 kDa respectively.
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native homogenate as it remained
in inclusion bodies under native
lysis-conditions. In contrast,
recombinant hFG was detected in
the native homogenate (Fig. 4.3.4
B, arrows) but the majority
remained as inclusion bodies.
However, the soluble part of
recombinant hFG was still unable
to bind to the Ni-NTA gel (Fig.
4.3.4 B, lanes 4 to 7). In addition,
binding of hFG to the Ni-NTA gel
was absent when pellets were
processed under denaturing
conditions, dialysed against native
buffer to renature the protein and subsequently incubated with the Ni-NTA gel (Fig
4.3.5, lanes 7 & 8). When using an NTA agarose gel where Ni2+ ions had been
exchanged for Cu2+ ions, enabling stronger interaction between the histidine amino
        A       B
Figure 4.3.4  Coomassie Blue stained SDS-PAGE gels of eluates from the Ni-NTA gel under
native conditions . Recombinant hexahistidine R1 (A) and FG (B). Lane M, 10 kDa molecular
marker. Lane P, pellet from induced bacteria. The numbered lanes represent: 1; solution loaded onto
column, 2; run-through from column, 3; native His-washing buffer and 4 to 7; eluates from the Ni-
NTA gel. White arrow in A shows expression of recombinant material with a molecular size of 52
kDa. White arrows in B show recombinant FG in both the solutions loaded onto the column and the
flow-through. Arrowheads in A & B indicate elution of proteins associating with the Ni-NTA gel. In
both A and B it can be observed that certain bacterial proteins associate with the gel and are present
in the eluates (arrowheads).
Figure 4.3.5  Coomassie Blue stained SDS-PAGE gel
of bacterial pellets lysed under denaturing conditions
and dialysed against native buffer.
Lane M, 10 kDa molecular marker. Lane P, pellet from
induced bacteria. The numbered lanes represent: 1;
solution loaded onto column, 2; run-through from
column, 3; native His-washing buffer and 4 to 8; eluates
from the Ni-NTA gel. Arrowhead shows the expression
of recombinant material in the bacterial pellet. Arrow
indicates the presence of recombinant hexahistidine FG
in the flow-through. No proteins were detected in the
eluates.
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acids and the NTA agarose gel, it was not possible to purify recombinant hFG (data
not shown).
4.3.4 Denaturing conditions
Purification of both recombinants, hR1 and hFG, was only possible under
denaturing conditions (Fig. 4.3.6 A, lanes 5 & 6 and Fig. 4.3.6 B, lanes 5 to 8). Both
hR1 and hFG bound strongly to the Ni-NTA gel and eluted mainly with concentration
of imidazole higher than 100 mM. Purification of recombinant hFG resulted in an
almost completely pure protein (Fig. 4.3.6 B, lanes 7 & 8) whereas some
contaminating proteins were present after purification of hR1 (Fig. 4.3.6 A). Dialysis
of purified recombinant hFG against 3 M sodium thiocyanate in coupling buffer
resulted in some protein precipitation. Consequently, a maximum of 1 to 2 mg
recombinant material could be coupled to CNBr-activated agarose, as determined by
Coomassie Blue staining of SDS-PAGE gels (data not shown).
4.3.5 Elution of material from affinity column
The amount of material eluted from the recombinant hFG affinity column,
after the homogenate of pig cortex had been applied, was very low and proteins could
only be detected by silver staining. On large SDS-PAGE gels, the homogenate
showed proteins ranging from less than 20 kDa to more than 500 kDa, with the
majority being between 30 and 200 kDa (Fig 4.3.7, part A - lane 3). Evaluation of the
A    B
Figure 4.3.6  Coomassie Blue stained SDS-PAGE gels of eluates from the Ni-NTA gel under
denaturing conditions . Detection of recombinant hexahistidine R1 (A) and FG (B). Lane M (A &
B), 10 kDa molecular marker. Lane P , pellet from induced bacteria. The following lanes represent:
1; solution loaded onto column, 2; run-through from column, 3; denaturing His-washing buffer, 4  to
8; eluates from the Ni-NTA gel. Arrow in A shows expression of recombinant R1 in the bacterial
pellet. Arrowheads in A & B indicate the elution of recombinant material from the Ni-NTA gel.
Asterisks in A show then presence of contaminating proteins in the eluates.
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washes showed the disappearance of lower weight proteins with increasing salt
concentration (Fig. 4.3.7, lanes 5 to 10). Proteins interacting with the recombinant
hFG column were eluted by high pH. Three predominant bands, with molecular sizes
of 70 kDa, 300 kDa and > 600 kDa, appeared repeatedly throughout independent
experiments (Fig. 4.3.7, part B - lanes 10 to 12). After two additional steps of affinity
purification, no protein appeared to predominate when evaluated on large SDS-PAGE
gels and improvement in specific tenascin-binding activity was also not observed
(data not shown).
The high molecular weight proteins detected on large silver stained SDS-
PAGE gels were not present when eluates were analysed by 2D-elecrophoresis.
Nevertheless, three groups of proteins were detected on the acidic part of the silver
Figure 4.3.7  Large gradient SDS-PAGE gel of homogenated pig cortex, washes and eluates
from FG column. Coomassie Blue staining of the part of the gel containing pig cortex
homogenates (A). Silver staining of the part of the gel containing washes and eluates (B). Lane M,
10 kDa molecular marker. Lane M* , heavy protein marker (CibcoBRL). The numbered lanes
represent: 1; homogenate of pig cortex, 2; semisolid liquid present below homogenate of pig
cortex after centrifugation, 3; pellet after centrifugation, 4 to 9; washes with increasing salt
concentrations and 10 to 12; elutions from column by high pH. Arrows (B ) indicate three
predominant bands with sizes of 70, 300 and >600 kDa in eluates. Proteins with lower molecular
sizes disappear as concentrations of NaCl increases in the washing buffer.
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stained 2D gel. The protein with the highest molecular weight gave rise to three
equidistant spots, with the more basic being the predominant one (Fig. 4.3.8). The
smallest of the three proteins gave rise to two spots (curved arrow) whereas the last
protein only gave rise to one spot (Fig. 4.3.8). On the basic part of the 2D gel, proteins
with more complex elution patterns could be observed (Fig. 4.3.8).
4.3.6 Enzymatic digestions and fluorometric measurements
Digestion of eluates from the recombinant hFG column, with either elastaseg,
collagenase type II, hyaluronidase or chondroitinase ABC, caused no change in the
                                                                
g The enzyme elastase digests both elastin and collagen type IV repeats (Lawrence,
1995).
Figure 4.3.8  Silver staining of eluates from FG column separated by 2D electrophoresis .
The straight arrow indicates a phosphorylated protein comprised of three spots with the
distance of one charge unit between them. The curved arrow shows a phosphorylated protein
comprised of two spots that are separated by one charge unit. The asterisk displays the staining
pattern for a protein without a complex phosphorylation pattern. The arrowheads point to a
protein with complex elution pattern different from the one observed for the phosphorylated
proteins. The distance between these spots and the constant molecular size of the protein
indicates a protein containing multi-charged groups such as SO4
2-.
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migration pattern or size of bands when they were evaluated on silver stained SDS-
PAGE gels (data not shown).
Monitoring the tenascin-R-binding activity of eluted samples was performed
by measuring the emission of solutions from Ni-NTA HisSorb wells that were
incubated with either homogenisation buffer C, FITC labelled eluate or recombinant
hFG combined with FITC labelled eluate (Table 4.3.1).
Table 4.3.1 Fluorometric measurements Excitation Emission Slit-width Av-I1 SD2 Numbers
Recombinant hFG-eluate 494 nm 520 nm 10 nm 16.74 4.25 9
Eluate 494 nm 520 nm 10 nm 11.84 3.10 8
Hom. buffer C 494 nm 520 nm 10 nm 1.18 0.50 7
1Av-I; average intensities, 2SD; standard deviation
Evaluation of the measured intensity between FITC labelled eluate and
combined recombinant hFG - FITC labelled eluate revealed no statistical significant
difference (Fig. 4.3.9). In addition, it was not possible to detect any eluted fraction
with a higher biological activity using this method.
Fig. 4.3.9 Graphic representation of measured
intensities shown as absolute measured values. Bars =
standard deviations.
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5. Expression of recombinant protein in yeast cells
5.1 Introduction
As it was not possible to produce large amounts of soluble recombinant human
TN-R FG using a bacterial expression system, a system more likely to yield correctly
folded recombinant material was chosen. One reason that the FG fragment of human
TN-R aggregated and formed inclusion bodies when it was expressed by a bacterial
host could be the lack of carbohydrates that may be needed for proteins to fold into
their correct three-dimensional structures (Creighton, 1993). Based on the primary
structureh of a protein, a full prediction of where and what kinds of carbohydrates are
attached during processing in the endoplasmatic reticulum (ER) and Golgi apparatus
is still impossible. The most predictable type of glycosylation is the attachment of N-
linked carbohydrates, which mainly occurs on aspartate amino acids in the sequence
Asn-Xxx-Ser/Thr/Cys (Creighton, 1993). The exact sites responsible for attachment
of O-linked carbohydrates are less well described and most likely not predictable from
the protein sequence at all. Nonetheless, it is known that O-linked carbohydrates are
attached to serine or threonine amino acids. An investigation of the sequence of
FG-knob from human TN-R showed that it contains one potential site for N-linked
glycosylation (Asn-Gly-Ser) and 25 serine and 28 threonine amino acids. Although
Zamze and colleagues did not show where the different carbohydrates were attached
to mouse TN-R, they did show that the most abundant carbohydrates on TN-R are
neutral N-linked oligosaccharides and O-linked sialylated structures (Zamze et al.,
1999).
Therefore the yeast Pichia pastoris was chosen as an alternative expression
system (Invitrogen, 1997a). The heterologous expression and subsequent secretion of
proteins by P. pastoris has the advantage that P. pastoris secretes very low levels of
native protein (Invitrogen, 1997a). P. pastoris has also been shown to perform
N-linked glycosylation on similar sites as in higher eucaryotic cells (Asn-X-Ser/Thr)
and not to hyperglycosylate proteins as has been observed in S. cerevisiae (Invitrogen,
1997a).
                                                                
h The ‘primary structure’ is a synonym for the amino acid sequence
49
5.2 Materials and methods
5.2.1 Recombinant DNA technology
5.2.1.1 Polymerase chain reaction i
To amplify the human tenascin-R FG fragment,
PCR was performed with a plasmid containing the
human tenascin-R R1 cDNA fragment as template
(kindly provided by Dr. Zardi, Geneva; see Carnemolla
et al., 1996). Primers were purchased from Microsynth
and used at a final concentration of 0.4 pmol/mL. The
PCR was performed in a Peltier Thermal Cycler DNA
Engine (PTC-200) as illustrated in figure 5.2.1. One unit
of Pfu DNA polymerase (Promega), primers, 200 ng of
template plasmid and 0.2 nmol/mL of dNTPs were mixed
in 1 x Pfu-buffer (Promega). Following the PCR, the
sample was loaded on a 1% agarose gel and purified
using a QIAEX II gel extraction kit (Qiagen).
The sequences for the primers were:
FG-F-EcoR1 : 5'TGAATTC GAG CTG AGC CAG AAA TTA C3'
FG-R-Xba1 : 5'TTCTAGA AA CTG TAA GGA CTG CCG T3'
The FG-F-EcoR1 was used as the forward primer and FG-R-Xba1 as the
reverse primer. The position of the restriction sites for the endonucleases EcoR1 and
Xba1, included in the primer sequence, are underlined. The first and last codons in
tenascin-R are indicated in bold.
                                                                
i See Saiki et al., 1988
94°C for 2 min.
10 cycles at:
94°C for 30 sec.
56°C for 45 sec.
72°C for 3 min.
30 cycles at:
94°C for 30 sec.
54°C for 45 sec.
72°C for 3 min.
72°C for 5 min.
Figure 5.2.1 PCR program
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5.2.1.2 cDNA cloning and construction of expression vectors
The purified PCR product and the plasmids pBluescript II KS +/- and
pPICZaA (Invitrogen) were digested for 1 hr at 37°C with the restriction
endonucleases EcoR1 (Boeringer Mannheim) and Xba1 (Amersham) in buffer H
(Boeringer Mannheim). All digested products were purified from 1% agarose gels
using the QIAEX II kit. Unless otherwise stated all media contained low salt (5 g/L)
and all centrifugations were performed at 13,000 rpm in a Micro Centaur table
centrifuge. Approximately 20 ng digested pBluescript II and 50 ng tenascin-R FG
cDNA together with 2 units T4 DNA ligase (Fermentas) in 1 x T4 DNA ligase buffer
(GibcoBRL) were placed for 3 hrs at room temperature. Subsequently, tubes were
placed for 5 min. at 56°C, transferred on ice, 100 mL chemical competent XL-1 Blue
bacteria (Promega) were added and the mixture was placed on ice for 20 min. The
bacteria were given a heat shock at 42°C for 45 sec. and returned on ice for 5 min.,
after which 1 mL LB-medium (without antibiotics) was added and the tube placed at
37°C for 1 hr. The solution was centrifuged and the pellet re-suspended in 50 mL
LB-medium, after which 10 mL 0.1 M IPTG and 80 mL 20 mg/mL X-GAL were
added and the tubes content plated on LB-agar plates containing 50 mM ampicillin
(Sigma). This makes it possible to distinguish clones containing insert as white and
clones without as blue. Plates were then incubated overnight at 37°C. The following
day ten white clones were picked with a sterile toothpick and placed individually in
separate 14 mL polystyrene tubes along with 3 mL low salt LB-medium containing 25
Figure 5.2.2 Ligation of cDNA for the FG-knob into pBluescript and pPICZ
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mg/mL Zeocin (Invitrogen). The tubes were then placed in an orbital shaking
incubator overnight at 37°C. Plasmids were extracted from the bacteria as described
by (Feliciello and Chinali, 1993) and in section 4.2.1.3 and digested with EcoR1 and
Xba1 to retrieve the inserted FG cDNAs, which were subsequently ligated into
pPICZaA vector as described above (for a schematic overview of the vectors see Fig
5.2.2). XL-1 blue bacteria were transformed with the ligation mixture and plated on
LB-agar plates containing 100 mg/mL Zeocin from where clones were chosen and
plasmid DNA extracted as outlined previously.
5.2.2 DNA sequencing
All enzymes and solutions (except plasmid, primer, ddH2O, NaOH, NaOAc
and absolute ethanol) were provided in the T7 Sequenase v. 2.0 DNA sequencing kit
(Amersham) and the sequencing reactions were performed according to the protocol
supplied by the manufacturer.
To 8 mL extracted pPICZaA yeast expression vector containing the human
tenascin-R FG fragment (pPICZaA-FG) was added 2 mL 2 M NaOH and the mixture
incubated at room temp. for 10 min., after which it was heated to 37°C for 5 min.
FG-F-EcoR1 primer (1 mL) was added together with 2 mL 3 M NaOAc, 7 mL ddH2O
and 50 mL absolute ethanol and placed at -70°C for 5 min. and subsequently
centrifuged for 10 min. at 13,000 rpm. The pellet was re-suspended in 10 mL 1 x
sequencing buffer. Two solutions, the first comprising of 7 mL sequence dilution
buffer, 0.5 mL pyrophosphatase and 1 mL T7 Sequenase v2.0 DNA polymerase
(enzyme mixture) and the second composed of 2 mL dGTP label mix. with 8 mL
ddH2O (label mixture) were prepared. Dithiothreitol (1 mL, DTT) together with 0.5
mL 35S-dATP (Hartmann), 2 mL of the enzyme mixture and 2 mL of the label mixture
were combined and added to the 1.5 mL Eppendorf tube containing the re-suspended
vector. From this tube, 3.5 mL solution was removed and added at an interval of 30
sec. to each of four individual tubes, marked G, A, T & C, already containing 2.5 mL
of the appropriate dNTP solution (G, A, T & C respectively). These marked tubes
were placed for 3 min. at room temp. before being moved to 37°C for 5 min. The
reaction was stopped by adding 4 mL stop-solution and the samples were stored at
-20°C.
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5.2.2.1 DNA sequencing gel
Two large glass plates, first cleaned in absolute ethanol, were treated with
dimethyldichlorosilane solution (Repel-Silan, LKB-produkter AB), cleaned with 70%
ethanol and assembled in a SA-32 casting boot (LIFE Technologies). To an
acrylamide solution (40% acrylamide 19:1, 1 x TBE, 7 M urea), APS (Fluka) and
TEMED (Fluka) were added. The solution was degassed, poured into already
assembled glass plates, a comb placed into the sequencing gel to introduce small wells
and the solution left to polymerise for 1 hr. Subsequently, the gel was pre-run in 0.6 x
TBE for 15 min. at 2,000 V & 60 W in a model SA adjustable sequencing gel
electrophoresis system (BRL Life Sciences). During the pre-run, the frozen samples
were heated at 75°C for 5 min. To each well 2 mL of sample was applied and the gel
was left to run for 2 to 3 hrs at 70 W. After the run, the electrophoresis solution was
discarded into appropriate radioactive material containers, glass plates were separated
and the gel fixed in distilled water containing 10% acetic acid and 10% ethanol. The
gel was placed on wet 3M paper and dried for 3 hrs in a gel dryer under vacuum. In a
dark room, the dried gel was placed in a holding cassette, an X-Omat AR film
(Kodak) was placed on top of it and exposed overnight. The following day the
autoradiogram was developed in ILFORD PQ universal developer and fixed in
ILFORD Hypam fixator.
5.2.3 Transformation of Pichia pastoris with pPICZaA
Solutions I, II & III for the production of easy-competence Pichia pastoris
yeast stains were supplied by Invitrogen. Pichia pastoris yeast strain KM71 and
GS115 were grown overnight in 10 mL YPD-medium (yeast extract peptone dextrose)
and placed in 150 mL YPD-medium and rotated at 30°C until an OD600 of 0.8 was
reached (all performed in Erlenmeyer flasks). The medium was centrifuged for 5 min.
at 500 g, pellets re-suspending in 10 mL solution I, centrifuged and pellets re-
suspended in 1 mL solution I, from where 60 mL aliquots were prepared and stored at
-70°C.
A total of 5 mg pPICZaA vector, containing the human FG fragment of
tenascin-R, was linearised by digestion with the endonuclease SacI (Fermentas) in
buffer H. Agarose gel electrophoresis was performed on the digested product and the
linearised plasmid was purified from the agarose gel using the QIAEX II kit. To two
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tubes containing a mixture of 5 mg of purified vector and 50 mL competent Pichia
pastoris (KM71 or GS115), were incubated for 10 min. at 30°C and 1 mL solution II
was added. The tubes were incubated at 30°C for 1 hr and intermittently vortexed
every 15 min., where after they were placed at 42°C for 10 min. The content of each
tube was divided into two separate tubes and placed together with 1 mL of YPD
medium for 1 hr at 30°C to allow expression of Zeocin resistance. Solutions were
centrifuged for 5 min. at 3,000 g, supernatant discarded and each pellet re-suspended
in 500 mL solution III. The appropriate KM71 or GS115 mixtures were pooled and
centrifuged for 5 min. The resulting two pellets were each solubilised in 100 mL
solution III, plated on YPDS plates containing 100 mg/mL Zeocin and incubated for 3
days at 30°C.
5.2.3.1 Determination of Mut phenotype (Mut+/MutS)
One hundred Zeocin-resistant Pichia pastoris GS115 transformants were
independently picked using sterile toothpicks and streaked first on MMH (minimal
methanol with histidine) and subsequently on MDH (minimal dextrose with histidine)
plates. On these plates were also placed positive and negative controls supplied by
Invitrogen (GS115/MutS albumin and GS115/pPICZ/lacZ(mut+) respectively). The
plates were incubated at 30°C for 2 days after which clones growing better on MDH
than on MHH plates were streaked onto MDH plates to obtain single colonies.
5.2.4 Expression of recombinant material, affinity purification and Western blot
5.2.4.1 Small-scale protein expression and affinity purification j
Overnight cultures of two KM71 and GS115 clones, containing the
pPICZaA-FG vector and of the correct Mut phenotype, together with positive and
negative controls, were prepared in buffered minimal glycerol medium containing
histidine (BGMH). Expression of recombinant material was induced by mixing 5 mL
overnight culture with 20 mL buffered minimal methanol medium with histidine
(BMMH) and adding methanol to a final concentration of 0.5%. Methanol was
supplemented every 24 hrs of incubation. To test the expression efficiency, 1 mL of
                                                                
j See Pharmacia, 1993 and Scopes, 1994
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expression cultures were removed at different time points (0, 4.5, 14, 24, 36, 48, 57,
72 and 96 hrs after initial induction) and kept in 1.5 mL Eppendorf tubes. Cultures
were centrifuged and pellets and supernatants separated. These pellets were
re-suspended in 50 mL 1 x Laemmli loading buffer, sonicated for three times 30 sec.
and stored until loaded on small 12% SDS-PAGE gels. The pH of the supernatants
was controlled (between 7.0 to 8.1), 100 mL washed Ni-NTA (nickel-nitrotriacetic
acid) agarose gel (Qiagen) was added, and the mixtures incubated under rotation for
1.5 hr at room temp. Before being centrifuged for 10 min. at 10,000 rpm and
re-suspended in 100 mL dHis washing solution, the Ni-NTA gel was washed twice in
dHis washing buffer. Subsequently, the content of the tubes were incubated 5 min. in
dHis elution buffer, centrifuged and the supernatants mixed with 6 x Laemmli loading
buffer. All samples were heated for 2 min. at 94°C before loading on small SDS-
PAGE gels, prepared as previously described, and stained with Coomassie Brilliant
Blue R-250 solution.
5.2.4.2 Small-scale protein expression and Western blottingk
Transformed GS115 and KM71 clones, together with controls, were induced
with methanol to express recombinant protein as described in section 5.2.4. After
centrifugation pellets were prepared for SDS-PAGE whereas supernatants were
precipitated by adding 100% trichloroacetic acid (TCA, Fluka) to a final
concentration of 10% (v/v). This mixture was placed on ice for 30 min. and
subsequently centrifuged for 10 min. at 13,000 rpm. Pellets were re-suspended in 50
mL 1 x Laemmli loading buffer and liquid ammonia (25%) was added until the
solution became basic (turned blue). The samples (pellets and precipitated
supernatants) were applied to small 12% SDS-PAGE gels and run as previously
described. The gels were either stained with Coomassie Brilliant Blue R-250 or
assembled together with a Hydrobond-ECL nitrocellulose membrane (Amersham) and
transferred (1 hr at 80 W in blotting buffer) using a Mini Protean II blotting chamber
(Hoefer Pharmacia). Following the protein transfer, nitrocellulose membranes were
briefly washed in ddH2O and placed overnight at 4°C in 1 x Tris-buffered saline
solution containing 0.1 % triton-X 100 (TBS-T) with 1% skimmed milk (Rapilait,
Migros). The following day, blots were incubated for 2 hrs in 10 mL TBS-T together
                                                                
k See Pierce, 1998
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with a mouse monoclonal antibody raised against the Myc-epitope (Invitrogen,
1:5,000). Subsequently, blots were washed three times in 10 mL TBS-T and placed
for 2 hrs in 10 mL TBS-T containing biotinylated goat anti-mouse antibody (Vector,
1:10,000). Blots were then washed as previously described and incubated using the
avidin-biotin peroxidase method for 30 min. in 10 mL TBS-T containing (pk-4000
ABC kit, Vectastain). After extensive washes, the blots were placed, in a dark room,
in 10 mL enhanced chemiluminescence (ECL) SuperSignal substrate (Pierce) for 2
min. Subsequently, the blots were placed in a cassette, a sheet of Saran wrap placed
on top, excessive liquid removed, everything covered by a Hyperfilm-ECL film
(Amersham) and exposed for time intervals ranging from 5 sec. to 5 min. The films
were developed in ILFORD PQ universal developer and fixed in ILFORD Hypam
fixator.
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5.3. Results
5.3.1 Analysis of control expression
The GS115 yeast strain transfected with a control vector (GS115/MutS-
albumin) supplied by Invitrogen, showed secretion of a protein with a molecular size
similar to the one expected for albumin (67 kDa). Albumin was first detected after 14
hrs of incubation with the amount increasing over time (Fig. 5.3.1). After 48 hrs,
proteins of lower molecular sizes, probably constituting degradation products, were
also observed (Fig. 5.3.1).
5.3.2 Expression in KM71 yeast cells
Analysis of pellets from the low expressing yeast strain KM71 transfected
with pPICZaA-FG, on Coomassie stained SDS-PAGE gels, revealed a protein with a
relative molecular size of 27 kDa. These results fits well with the expected size of
24.5 kDa for recombinant FG fused with the Myc-epitope (Fig. 5.3.2 A). The amount
of protein increased in a time-dependent manner, reaching maximum after 96 hrs of
induction with methanol (Fig. 5.3.2 A, lane 9). It was impossible to detect any
Figure 5.3.1  Coomassie stained SDS-PAGE gel of Ni-NTA
purified proteins from medium of GS115/MutS-albumin
transfected GS115 yeast cells.  All numbered lanes, except
lane 1, represent induced growth. Lane M, 10 kDa molecular
marker. Lane 1, eluate from medium before induction with
methanol. The following lanes represent elutions after : 2; 4.5
hrs, 3; 14 hrs, 4; 24 hrs, 5; 36 hrs, 6; 48 hrs, 7; 57 hrs, 8; 72
hrs and 9; 96 hours of induction. Arrow shows the presence of
albumin (67 kDa) in the eluate from the medium. It can be
observed that the amount of purified protein increases in a
time-dependent manner. Arrowhead indicates the appearance
of degradation products from albumin.
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secreted protein in eluates from Ni-NTA agarose gel incubated with medium from
transfected KM71 yeast cells (Fig. 5.3.2 B, lanes 2 to 9). However, on Western blots,
eluates from KM71 yeast cells transfected with pPICZaA-FG revealed secreted
proteins containing the Myc-epitope (Fig. 5.3.3). After 24 and 36 hrs of induction,
proteins of 27 kDa were
detected on Western blots
(Fig. 5.3.3). After 48 hrs of
induction, the size of the
band had shifted to 35 kDa
(Fig. 5.3.3). Secreted Myc-
containing proteins could
not be detected in non-
induced material or at any
other time points of
induction.
A    B
Figure 5.3.2 Coomassie blue stained SDS-PAGE gel of pPICZaA-FG transfected KM71
yeast cells. Coomassie stained gel of pellets (A) and eluates from the Ni-NTA gel (B) of
transfected KM71 yeast cells at different time intervals. All numbered lanes, except lane 1,
represent material induced with methanol. Lane M (A & B), 10 kDa molecular marker. Lane 1,
before induction with methanol. The following lanes represent material after: 2; 4.5 hrs, 3; 14 hrs,
4; 24 hrs, 5; 36 hrs, 6; 48 hrs, 7; 57 hrs, 8; 72 hrs and 9; 96 hours of induction. Arrow in A shows
the presence of a protein with a relative molecular size of 27 kDa. Expected size of recombinant
FG fused to the Myc-epitope is 24.5 kDa. No significant amount of purified secreted protein can
be detected in B.
Figure 5.3.3  Western blot of Ni-NTA purified proteins
secreted by pPICZaA-FG transfected KM71 yeast cells.
Lanes 1, 7, 8 and 9 represent eluates from non-induced
material. The remaining lanes (2 - 6) represent material
induced with methanol. Lane M, 10 kDa molecular marker.
Lane 1, eluate from medium before induction with
methanol. The following lanes represent eluates after 2; 4.5
hrs, 3; 14 hrs, 4; 24 hrs, 5; 36 hrs, 6 & 7; 48 hrs, 8; 57 hrs,
and 9; 72 hours of growth. Arrow indicates the detection of
a secreted protein containing the Myc-epitope with a size of
27 kDa. Arrowhead shows secreted protein of a slightly
larger size at t48 after induction. No protein was detected
from non-induced yeast cells. Asterisks indicate proteins
precipitated at the border between stacking and separation
gel resulting in cross-reaction with the applied antibodies.
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5.3.3 Expression in GS115 yeast cells
Investigation of pellets from the high expressing yeast strain GS115,
transfected with pPICZaA-FG showed a higher background expression of proteins
than KM71 yeast cells. Between
14 and 96 hrs of induction with
methanol, two proteins of roughly
10 and 27 kDa could be
distinguished on Coomassie
stained SDS-PAGE gels (Fig.
5.3.4 A). In eluates from medium
incubated with Ni-NTA agarose
gel, the smaller protein appeared
after 14 hrs of induction and could
be detected, in constant amounts,
until 96 hrs (Fig. 5.3.4 B). The
smaller sized protein was detected
between 14 and 57 hrs after
induction but later disappeared
although the total amount of
proteins increased. On Coomassie
stained SDS-PAGE gels, the larger protein was not detected in the medium at any of
A B
Figure 5.3.4 Coomassie Blue stained SDS-PAGE gel of pPICZaA-FG transfected GS115 yeast
cells. Coomassie stained gels of pellets (A) and eluates from the Ni-NTA gel (B) of transfected
GS115 yeast cells at different time intervals. All numbered lanes, except lane 1, represent material
from induced material. Lane M (A & B), 10 kDa molecular marker. Lane 1, material before induction
with methanol. The following lanes represent material after 2; 4.5 hrs, 3; 14 hrs, 4; 24 hrs, 5; 36 hrs,
6; 48 hrs, 7; 57 hrs, 8; 72 hrs and 9; 96 hours of induction. Arrow in A shows the presence of a
protein with a relative molecular size of 27 kDa in pellets between t14 and t96 hrs of induction.
Arrowhead in A indicates the presence of a protein with a size of approximately 10 kDa. The latter
protein is also observed in eluates in B (arrow) at induction intervals ranging from t14 to t72.
Figure 5.3.5  Western blot of Ni-NTA purified
proteins secreted by pPICZaA-FG transfected GS115
yeast cells.  Lanes 1, 3 and 8 represent eluates from non-
induced yeast. The remaining lanes (2, 4 - 7 & 9)
represent material induced with methanol. Lane M, 10
kDa molecular marker. Lane 1, eluate from medium
before induction with methanol. The following lanes
represent eluates from the Ni-NTA gel incubated with
medium grown for 2 & 3; 4.5 hrs, 4; 14 hrs, 5; 24 hrs, 6;
36 hrs, 7; 48 hrs and 8 & 9; 57 hours. Arrow indicates
the purification of a secreted protein containing the Myc-
epitope with a molecular size of 40 kDa.
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the examined time points. Secreted proteins containing the Myc-epitope were detected
on Western blots of medium from transfected GS115 yeast cells (Fig. 5.3.5). Eluates,
from medium incubated with Ni-NTA agarose gel, revealed bands corresponding to
proteins with a molecular size of 40 kDa. Proteins were detected, in variable amounts,
between 4.5 and 57 hrs after initial induction with methanol. On Western blots, the
highest band intensity was observed 36 hrs after induction where after the intensity
decreased (Fig. 5.3.5, lane 6).
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6. Expression of recombinant proteins in mammalian cells
6.1 Introduction
As purification of soluble recombinant human TN-R protein using either
bacterial or yeast expression systems were not accomplished, another approach was
chosen focusing on the expression of the FG-knob in a transformed mammalian cell
line. Cos-1/M6 cells, which are SV40 transformed Simian fibroblasts from green
monkeys, were chosen for two reasons. Firstly, they do not express the CNS restricted
extracellular matrix molecule TN-R or potential biological ligands for TN-R and
secondly they respond well to Zeocin treatment. The pSecTag2 vector (Invitrogen)
promised to be a suitable expression vector since it contained a signal peptide
enabling secretion of produced material. Moreover, using primate cell lines, proteins
with more ‘natural’ post-translational modifications than are produced in yeast may be
expected. Native mouse TN-R contains a complex pattern of carbohydrates (Zamze et
al., 1999) whereas Pichia pastoris mainly adds mannose residues (Invitrogen, 1997a).
Although cDNA fragments ligated into the pSecTag2 vector give rise to proteins
fused at the C-terminal with a hexahistidine tag, the method of choice was to express
the recombinant FG fragment as a chimeric protein together with GST. The
motivation for this was that the addition of GST (known to easily fold into a soluble
protein) could result in a soluble GST-FG protein.
61
6.2 Material and methods
6.2.1 Recombinant DNA technology
6.2.1.1 Polymerase chain reaction l
To amplify the cDNA for cloning into the
pSecTag2 C vector (Invitrogen), PCR was performed
using the pGEX-1 plasmid, containing human tenascin-R
FG fragment, as template. The primers were purchased
from Microsynth, Switzerland and used at a final
concentration of 0.4 pmol/mL. The PCR was performed
in a Peltier Thermal Cycler DNA Engine (PTC-200).
One unit of Pfu DNA polymerase (Promega), primers,
200 ng of template plasmid and 0.2 nmol/mL of dNTPs
were mixed in 1 x Pfu-buffer (Promega) and the PCR
was performed as described in figure 6.2.1. The PCR
resulted in the production of cDNA where GST was
fused to the 5’ end of tenascin-R FG (GST-FG).
Following the PCR, the sample was loaded on a 1% agarose gel and purified by the
aid of the QIAEX II gel extraction kit (Qiagen).
The primer sequences were:
pSec-Hind-F : 5'TACGAAGCT TTG TCC CCT ATA CTA GGT TAT TG3'
pSec-Eco-R : 5'GG AAT TCT CAG AAC TGT AAG GAC TGC C3'
The position of the restriction sites for the endonucleases Hind III and EcoR1
included in the primer sequences are underlined. The first codon in GST and the stop
codon in tenascin-R FG are indicated in bold.
6.2.1.2 cDNA cloning and construction of expression vectors
Both the purified PCR product and the plasmids pBluescript II KS +/- and
pSecTag2 C (Invitrogen) were digested for 1 hr at 37°C with the restriction
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94°C for 2 min.
10 cycles at:
94°C for 30 sec.
60°C for 45 sec.
DT=0.1°C/cycle
72°C for 3 min.
30 cycles at:
94°C for 30 sec.
58°C for 45 sec.
DT=0.1°C/cycle
72°C for 3 min.
72°C for 5 min.
Figure 6.2.1 PCR program
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endonucleases EcoR1 and Hind III in buffer B (all Boeringer Mannheim). Digested
products were purified from 1% agarose gels using the QIAEX II kit. Unless
otherwise stated, all media contained 50 mM ampicillin and all centrifugations were
performed at 13,000 rpm in a Micro Centaur table centrifuge. Approximately 20 ng
digested pBluescript II and 50 ng GST-FG cDNA together with 2 units of T4 DNA
ligase (Fermentas) in 1 x T4 DNA ligase buffer (GibcoBRL) were kept for 3 hrs at
room temp. Subsequently, tubes were placed for 5 min. at 56°C, transferred on ice,
100 mL chemical competent XL-1 Blue bacteria (Promega) were added and the
mixture was placed on ice for 20 min. The mixture was heated at 42°C for 45 sec.,
returned on ice for 5 min. before adding 1 mL LB-medium without antibiotics, and
incubating at 37°C for another hr. Subsequently, the solution was centrifuged and the
pellet re-suspended in 50 mL LB-medium, after which 10 mL 0.1 M IPTG and 80 mL
20 mg/mL X-GAL were added and the tubes content plated on LB-agar plates
containing 50 mM ampicillin (Sigma), which were kept at 37°C overnight. The
presence of IPTG and X-GAL makes it possible to distinguish clones with insert as
white and clones without as blue. The following day, using sterile toothpicks, 10
white colonies were picked, placed in 14 mL polystyrene tubes containing 3 mL
LB-medium and incubated overnight at 37°C in an orbital shaking incubator (200
rpm). As described by (Feliciello and Chinali, 1993) and in section 4.2.1.3, plasmids
were extracted from the bacteria and four plasmid mini-preparations were chosen for
DNA sequencing performed as previously described. One of the sequenced plasmids,
shown to contain the appropriate insert, was digested with the endonucleases EcoR1
and Hind III to retrieve the GST-FG cDNAs. The insert was purified from agarose gel
Figure 6.2.2 Ligation of the cDNA for GST-FG into pSecTag2A
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and subsequently ligated into a previously digested pSecTag2 C vector (for a
schematic overview of the vectors see Fig. 6.2.2). XL-1 blue bacteria were
transformed with the pSecTag2 C/GST-FG ligation and plated on low salt LB-agar
plates containing 25 mL/mL Zeocin (Invitrogen). Several clones were chosen and
mini-preparations of plasmid DNA were performed. Digestion of the mini-
preparations with Hind III and EcoR1 were evaluated on 1% agarose gels. A maxi-
preparation of one pSecTag2 C/GST-FG plasmid, containing the appropriate GST-FG
cDNA, was performed according to the protocol supplied by the manufacturer
(Nucleobond, AX500).
6.2.2 General cell culture techniquesm
Cos-1/M6 p25 cells (kindly provided by Dr. Bonaiti, Geneva) were propagated
as a monolayer at 37°C in an automatic CO2 incubator (Forma Scientific) in 50 mL
culture flasks (Milan) or 35 mm microtiter wells (Nalgene Nunc Int.). Dulbecco’s
Modified Eagle’s Medium (DMEM, GibcoBRL) with or without 10% foetal calf
serum (FCS, GibcoBRL) and containing 2 mM glutamine, penicillin and streptomycin
(10,000 U, 10,000 mg/ml) was used. The cells were trypsinised by first removing the
growth medium followed by a brief wash in excess of sterile PBS containing 0.25%
trypsin and 0.02% EDTA. The cells were left for 1 min. at room temp., excess
solution aspirated, and subsequently placed at 37°C until the cells began to detach
from the plastic and started to round up. The cells were re-suspended in 5 mL DMEM
containing 10% FCS and split in a ratio of 1:10 in a 50 mL culture flask or into
microtiter wells.
Cells for storage were, after trypsination, re-suspended in DMEM containing
10% FCS at a concentration of 5 x 106 cells per mL, centrifuged and re-suspended at 2
x 106 cells per mL in freezing medium (90% FCS, 10% glycerol (v/v)). The
suspension of cells was dispensed in 1 mL aliquots, cooled to –80°C for 24 hrs in
polystyrene containers and transferred to liquid nitrogen.
6.2.2.1 Transfection of the Cos-1/M6 cell line
Before obtaining stable transfected Cos-1/M6 cells, their susceptibility to
Zeocin was determined. Cells were plated at 8 x 104 cell/well in 35 mm wells, grown
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until 50% confluency before different concentrations of Zeocin diluted in DMEM
were applied (0.0, 0.1, 0.2, 0.3, 0.5 and 1.0 mg/mL). Viability of the cells was
checked under an ID 02 light microscope (Zeiss). After nine days at 37°C, with the
medium being changed every third day, the remaining cells were trypsinised and the
concentration was estimated using a hemocytometer.
A positive control vector (pSecTag2/PSA) secreting the prostate-specific
antigen (PSA) fused C-terminally with the Myc-epitope was supplied by Invitrogen.
Cos-1/M6 cells plated one day prior to the transfection experiment and having
reached 50% confluency in 35 mm wells were used. Into a sterile 1.5 mL Eppendorf
tube 97 mL DMEM without FCS and 3 mL FuGENE 6 (Boehringer Mannheim) per 35
mm well were added. This mixture was incubated for 5 min. at room temp. then added
dropwise either 2 mg pSecTag2 C, pSecTag2/PSA or pSecTag2 C/GST-FG vectors in
separate Eppendorf tubes. These tubes were incubated for 15 min. at room temp. and
the transfection mixture added dropwise to the Cos-1/M6 cells. After two days at
37°C, the medium was changed into DMEM containing 10% FCS and cells were
incubated for another 2 days. Cells were then trypsinised and split into Zeocin
containing DMEM (10% FCS, 0.5 mg/mL Zeocin) and changed every second day for
the following 10 days. Stable transfected clones were plated into 96 wells using
limited dilution to obtain single colonies and were propagated in DMEM containing
10% FCS and 0.25 mg/mL Zeocin. Medium was changed every third day. Aliquots of
all non-transfected and stable transfected Cos-1/M6 cells were prepared and stored in
liquid nitrogen as described in section 6.2.2.
6.2.3 Protein expression, purification and Western blottingn
Cos-1/M6 cells, stable transfected with either pSecTag2/PSA or pSecTag2
C/GST-FG, were incubated in 9 cm petri dishes together with 2 mL DMEM without
FCS. The following day, 1 mL conditioned serum-free DMEM was removed and 60
mL were mixed with 2 x Laemmli loading buffer. The remaining medium was
precipitated with a final concentration of 10% TCA and prepared for SDS-PAGE as
described in section 4.2.3. The remaining cells were re-suspended in 200 mL 1 x
Laemmli loading buffer. Electrophoresis of SDS-PAGE gels and subsequent Western
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blotting was performed as previously described. Processing of Western blots was
performed as described below.
Cos-1/M6 cells, stable transfected with either pSecTag2/PSA or pSecTag2
C/GST-FG, were incubated in 35 mm wells together with 300 mL DMEM without
FCS. The following day the 300 mL serum-free DMEM was removed and the cells
were re-suspended in 50 mL 1 x Laemmli loading buffer. From the serum-free
medium 30 mL was removed and mixed with 2 x Laemmli loading buffer. To the
remaining 270 mL serum-free DMEM from the pSecTag2 C/GST-FG transfected cells
was added 200 mL 1 x PBS containing 5 mM EDTA and 0.2% Triton-X 100 (Sigma),
pH³7.0, together with 200 mL washed glutathione sepharose 4B gel which was left
under rotation at room temp. for 1 hr. Subsequently, the sepharose gel was rinsed 2
times in 10 min. in GST-washing buffer and eluted in 100 mL GST-elution buffer.
Part of the elutions (15 mL) were mixed 1:1 in 2 x Laemmli loading buffer and the
remaining sepharose gel was re-suspended in 50 mL 1 x Laemmli loading buffer. All
samples were loaded on small SDS-PAGE gels, the proteins electrophoretically
separated and transferred onto nitrocellulose membranes as previously described.
After the protein transfer, nitrocellulose membranes were blocked overnight in
TBS-T containing 1% skimmed milk. The next day, membranes were incubated in 10
mL TBS-T containing either goat antibody against GST (Pharmacia, 1:10,000) or
mouse monoclonal antibody against the Myc-epitope (Invitrogen; Evan et al., 1985;
1:5,000) for 2 hrs at room temp. Extensive washes preceded the 2 hrs incubation in 10
mL TBS-T containing either biotinylated horse anti-goat antibody (Vector; 1:10,000)
or biotinylated anti-mouse antibody (Vector; 1:10,000) respectively. Subsequently,
membranes were washed and the immunoreaction visualised using the avidin-biotin
peroxidase method (pk-4000 ABC kit; Vectastain) and the ECL method as described
in section 5.2.4.2.
6.2.4 Immunohistochemical staining of PFA-fixed stable transfected Cos-1/M6 cells.
Unless otherwise stated all washes were performed twice for 15 min. in PBS
and incubations in PBS containing 10% bovine serum. Sterilised round coverslips
with a diameter of 15 mm were placed in 35 mm wells, covered with DMEM
containing 10% FCS and trypsinised Cos-1/M6 cells (transfected with pSecTag2
C/GST-FG or non-transfected) were added. The following day, the medium was
66
aspirated and the cells fixed for 4 min. with 4% paraformaldehyde in PBS and
subsequently washed. The coverslips were incubated with the antibody against the
Myc-epitope (1:1,000 in PBS containing 10% bovine serum and 0.05% Triton-X 100)
overnight at 4°C. Cells were washed prior to incubation for 2 hrs with the biotinylated
anti-mouse antibody (Vector; 1:200) at room temp. After extensive washes, they were
incubated for an additional 2 hrs in PBS containing Texas Red conjugated
streptavidine (1:200; Molecular Probes), washed, air dried for 2 hrs at room temp., re-
hydrated in distilled water and dried for an additional 30 min. at room temp. The
coverslips were then mounted in SlowFade (Molecular Probes) onto 76 x 26 mm
slides (Menzel) and sealed using clear varnish. Slides were visualised under an
Axiophot fluorescence microscope (Zeiss) and photographed using a Spot cameraä
(Diagnostic Instruments).
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6.3 Results
6.3.1 Detection of material using antibodies against GST
The amount of recombinant GST-FG expressed from stable transfected
Cos-1/M6 cells was low, and no protein was observed to predominate on either
Coomassie Brilliant Blue R-250 or silver stained SDS-PAGE gels (data not shown).
When proteins were transferred onto nitrocelluose membranes, and subsequently
incubated with an antibody against GST, expression of two GST-containing proteins
were detected in the cell-lysate
from pSecTag2 C/GST-FG
transfec-ted Cos-1/M6 cells
(Fig. 6.3.1, lane 5). The
proteins had a relative
molecular mass of
approximately 60 and 100 kDa.
It was however not possible to
detect any secreted recom-
binant material in conditioned
medium from these cells (Fig.
6.3.1, lanes 4 & 5). Expression
of recombinant material could
not be detected in cell-lysate or
conditioned medium from Cos-
1/M6 cells transfected with the
control vector pSecTag2/PSA,
supplied by Invitrogen (Fig.
6.3.1, lane 2).
Figure 6.3.1  Detection of GST-containing proteins by
Western blotting .  The numbered lanes represent: 1; cell-
lysate of BL21 bacteria expressing GST-FG, 2; TCA
precipitate of serum–free medium from pSecTag2/PSA
transfected cells, 3; cell-lysate of pSecTag2/PSA
transfected cells, 4; serum-free medium of pSecTag2/PSA
transfected cells, 5; TCA precipitated serum-free medium
of pSecTag2 C/GST-FG, 6; cell-lysate of pSecTag2
C/GST-FG transfected cells and 7; serum-free medium of
pSecTag2 C/GST-FG transfected cells. Arrows indicate
GST-containing proteins with a molecular size of
approximately 60 kDa and 100 kDa in the cell-lysate of
pSecTag2 C/GST-FG transfected cells, possibly
representing glycosylated versions of GST-FG. Arrowhead
shows band corresponding to GST-FG expressed in BL21
bacteria. Remaining immunoreactivity in lane 1 represents
cross-reaction between the anti-GST antibody and
bacterial proteins.
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6.3.2 Detection of material using antibodies against the Myc-epitope
A Western blot incubated with an antibody against the Myc-epitope revealed
two proteins containing the Myc-epitope in the cell-lysate of pSecTag2 C/GST-FG
transfected Cos-1/M6 cells (Fig. 6.3.2, lane 6). These proteins were of a similar
molecular size as those
identified on Western blots
incubated with the antibody
against GST (Fig. 6.3.1 &
6.3.2). No secreted proteins
were found in the conditioned
medium of pSecTag2 C/GST-
FG transfected cells when
detecting the Myc-epitope
(Fig. 6.3.2, lane 5). However,
cells transfected with the
control vector SecTag2/PSA
secreted a protein with a size
of approximately 55 kDa as
can be seen on Western blots
incubated with the antibody
against the Myc-epitope (Fig.
6.3.2, lane 2). Although the
calculated size for PSA is 25
kDa, a 55 kDa glycosylated
protein was observed when
PSA was expressed in a breast carcinoma cell line (Invitrogen, 1997c). Recombinant
material was not detected in the cell-lysate of control-transfected cells.
6.3.3 Affinity purification and anti-GST detection
On Western blots of eluates from glutathione sepharose 4B gel incubated with
medium from pSecTag2 C/GST-FG transfected Cos-1/M6 cells, it was not possible to
detect any secreted proteins fused to GST. Nevertheless, bands corresponding to
proteins with sizes of either 60 and or 100 kDa were detected in the cell-lysate (Fig.
6.3.3, lane 6).
Figure 6.3.2  Detection of Myc-containing proteins by
Western blotting. The numbered lanes represent: 1; cell-
lysate of BL21 bacteria expressing GST-FG, 2; TCA
precipitate of serum–free medium from pSecTag2/PSA
transfected cells, 3; cell-lysate of pSecTag2/PSA transfected
cells, 4; serum-free medium of pSecTag2/PSA transfected
cells, 5; TCA precipitated serum-free medium of pSecTag2
C/GST-FG, 6; cell-lysate of pSecTag2 C/GST-FG
transfected cells and 7; serum-free medium of pSecTag2
C/GST-FG transfected cells. Arrows indicate proteins
containing the Myc-epitope in the cell-lysate of pSecTag2
C/GST-FG transfected cells. Arrowhead shows a band
corresponding to secreted PSA by pSecTag2/PSA
transfected cells. The difference between the calculated
molecular size of PSA (25 kDa) and the observed size (55
kDa) may arise because of glycosylation.
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6.3.4 Immunohistochemistry
Immunohistochemistry
performed on 4% PFA fixed
Cos-1/M6 cells (either mock
transfected or transfected with
pSecTag2 C/GST-FG) showed
marked morphological differen-
ces when incubated with an
antibody binding to the Myc-
epitope. Mock-transfected Cos-
1/M6 cells could not be distin-
guished from un-transfected cells
Figure 6.3.3  Detection of GST-containing proteins by Western
blotting. The numbered lanes represent: 1; cell-lysate of BL21
bacteria expressing GST-FG, 2; elution from the glutathione
sepharose 4B gel, 3; serum-free medium after the addition of the
glutathione sepharose 4B gel, 4; serum-free medium before
addition of the glutathione sepharose 4B gel, 5; the glutathione
sepharose 4B gel after elution, 6; cell-lysate of Cos-1/M6 cells
transfected pSecTag2 C/GST-FG and 7; non-transfected Cos-
1/M6 cells. Arrows indicate proteins of approximately 60 and 100
kDa in the cell-lysate of pSecTag2 C/GST-FG transfected cells,
recognised by the antibody against GST. Arrowhead shows a
band corresponding to GST-FG expressed in BL21 bacteria.
Remaining immunoreactivity in lane 1 represents cross-reaction
between the anti-GST antibody and bacterial proteins. Asterisks
indicate bands arising from proteins aggregating at the border
between stacking and separation gel leading to a cross-reaction
with the applied antibodies.
Figure 6.3.4  Immunofluorescence image of finely
spread mock-transfected Cos-1/M6 cells . Cells show
normal morphology with dispersed point-like
immunoreactivity in the cytosol (arrowheads) and an
overall staining of the nucleus (arrows). Scale bar = 50
mm.
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when examined under a light
microscope (not shown); nor did
they show any difference in proli-
feration rates. Mock-transfected
cells (see figure 6.3.4) showed
weak point-like immunoreactivity
in the cytosol and a general staining
of the nucleus. Overall, strong
immunoreactivity could not be
observed in these cells. In Cos-
1/M6 cells, stable transfected with
pSecTag2 C/GST-FG, normal cell
structures - such as nucleus and
cytoplasm - were no longer
detectable. Individual cells could no longer be identified as transfected cells clumped
together forming large fibrous aggregates (Fig. 6.3.5). The anti-Myc
immunoreactivity was seen covering these aggregates indicating the presence of the
Myc-epitope in association with these structures (Fig. 6.3.5).
Figure 6.3.5 . Immunofluorescence image of
pSecTag2 C/GST-FG transfected Cos-1/M6 cells .
Cos-1/M6 cells transfected with pSecTag2 C/GST-
FG clump together forming large aggregates, leading
to a disappearance of normal cell structures and an
altered morphology. Arrow marks large fibrous
aggregate. Scale bar = 50 mm.
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Discussion for section 4 to 6
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7. Discussion
In these studies, TN-R has been further characterised in view of its role in the
function of PNEMs found around GABAergic parvalbumin expressing interneurones.
A number of techniques were applied to discover novel ligands for TN-R e.g. cDNA
cloning, heterologous protein expression in various host cells such as bacteria, yeast
and mammalian cell lines and the generation of a TN-R affinity column. The FG
fragment is the most conserved domain in the tenascins (Erickson, 1993) and has been
suggested to be the functionally dominant region (Elefteriou et al., 1999). This lead to
the hypothesis that the FG domain might play an important role in mediating many of
the effects observed for the native full length TN-R (Xiao et al., 1996), with the
research focusing on this C-terminal fragment. However, problems arising from this
work involved the general insolubility and precipitation of the FG-knob. The different
techniques and methods employed to resolve this problem are further elucidated and
discussed below.
7.1 Bacterial expression of recombinant material
Although the expression of different sized C-terminal TN-R fragments
containing various affinity tags were induced under several temperature conditions,
the recombinant proteins remained insoluble in native buffers. Furthermore,
unsuccessful attempts were also made to obtain soluble chimeric proteins fused to
calbindin by expressing the R1 and FG fragments in a pCal vector. Purification of
bacterially expressed hFG was not possible under native conditions as none of the tags
used were capable of inducing soluble folding of recombinant C-terminal TN-R
fragments, although the tags themselves are generally believed to fold spontaneously
into soluble forms (Scopes, 1994), concurring the insolubility of the FG-knob
observed in both tenascin-R and tenascin-X (Norenberg et al., 1995; Elefteriou et al.,
1999). All other previously studied tenascin domains have been shown to
spontaneously fold into soluble forms (Norenberg et al., 1995; Elefteriou et al., 1999),
indicating that the FG-knob needs additional factors such as other tenascin domains or
carbohydrates to induce correct folding. Indeed, carbohydrates can play an essential
role in determining the overall tertiary and quaternary structure of a protein
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(Creighton, 1993). Analysis of the primary structure of the FG-knob from human
TN-R showed that it contained one potential site for N-linked glycosylation (Asn-Gly-
Ser) and 53 potential sites for O-linked glycosylation (serine or threonine; see also
section 5.1). Native mouse TN-R contains both N- and O-linked glycosylations
(Zamze et al., 1999), but whether the FG-knob is glycosylated in vivo has yet to be
determined. The observed insolubility of the FG knob may reflect some particular
property of this part of TN-R in comparison to other TN-R domains, with this domain
shown to be the most conserved in the tenascins (Erickson, 1993).
Under denaturing conditions o, non-covalent bonds holding together the
secondary, tertiary and quaternary structure of a protein are disrupted leaving the
protein backbone in an unfolded state (Lawrence, 1995). Associations between
hexahistidine tags and the Ni-NTA gel are nonetheless still feasible as interactions do
not depend upon an overall structure, but upon interactions between individual
histidine amino acids and the Ni-NTA gel (Scopes, 1994). Buffers containing
primary, secondary or tertiary amino groupsp cannot be used when coupling proteins
to activated CNBr groups, as such amino groups react with them thereby blocking all
active sites and leaving none for the proteins to couple to (Pharmacia, 1993). Purified
recombinant hFG was only soluble in buffers containing 4 M or higher concentrations
of urea, and precipitated when dialysed against a variety of native buffers. Analysis of
the amino acid sequence of the FG-knob showed that it contains many charged amino
acids (more than 20%) and precipitation could occur because of hydrophilic
interactions between FG-domains. To overcome the precipitation in non-urea
containing buffers, purified hFG was dialysed against buffers containing high
concentration of chaotropic salts. High salt concentrations are believed to disrupt all
non-hydrophobic interactions between proteins but also to increase the hydrophobic
forces between them (Scopes, 1994). To avoid the latter, the chaotropic q salt sodium
thioscyanater (NaSCN) was chosen, as it has low ‘salting out’s abilities according to
the Hofmeister series (Scopes, 1994). This, combined with the fact that it does not
                                                                
o Such as buffers containing urea
p Urea contains two primary amino groups
q Salts interacting directly with proteins thereby counteracting the ‘salting out’ properties
r Also termed sodium thiocyanide, sodium sulfocyanate and thiorhodanid
s ‘Salting out’, a decrease in solubility of proteins due to increased hydrophobic interactions as a result
of high salt concentrations  (Scopes, 1994).
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contain any amino groups, is highly soluble, relatively non-toxic t and has no major
buffering effect, made it an ideal salt for “solubilising” the FG fragment.
Examination of silver stained SDS-PAGE gels of proteins eluted from the TN-R
affinity column revealed eluates composed predominantly of three different sized
proteins. The large apparent size of the largest of the three affinity-purified proteins (>
600 kDa), together with recent reports of interactions between TN-R and CSPGs
(Aspberg et al., 1995, 1997; Xiao et al., 1997; Milev et al., 1998) indicated a
proteoglycan, whereas nothing could be extrapolated from the sizes of the other two
proteins. Additional affinity purification of eluted proteins did not result in further
predominance of any of the three proteins, which would otherwise have indicated a
potential difference in binding affinities to the FG-knob. These three proteins could
therefore not be distinguished using this method, either because the smaller proteins
represented degradation fragments of the larger protein, or because they were
independent proteins with binding affinities in the same range.
Investigation of eluates on 2D-PAGE gels showed that they contained both
acidic and basic proteins, with sizes less than 100 kDa. The polyacrylamide pore size
in the IPG strip excludes extremely large proteins (Pharmacia, 1994) and may be the
reason that the high molecular weight proteins were not observed on the 2D-PAGE
gels. On the acidic side of the 2D-PAGE gel, the proteins consisted of a dominating
spot closely trailed by one or more less predominant ones indicating the proteins to be
phosphorylated (Hames, 1990; Celis et al, 1995). These proteins were possibly
comprised of cytosolic domains as phosphorylation has been shown to primarily occur
intracellularly (Creighton, 1993). As most cytosolic proteins were removed during the
preparation of the pig cortex homogenate, it is conceivable that these proteins
consisted of degradation fragments of transmembrane proteins. The basic side of the
gel revealed several spots separated by a relative large distance demonstrating that the
proteins here contained multi-charged groups (Hames, 1990; Celis et al, 1995).
Attachment of multi-charged groups such as SO42- may occur on tyrosine residues in
proteins passing through the Golgi apparatus (Creighton, 1993). Furthermore, these
multi-charged groups are an integrated part of the carbohydrate N-acetyl-D-
galactosamine (GalNAc; Alberts et al., 1994), a common constituent of proteoglycans
such as chondroitin sulphates and keratan sulphates (Alberts et al., 1994), found
                                                                
t Danger class Xn; R 20/21/22-32 and S 13; see Lenga, 1985 and the searchable database KIROS at
http://www.kemi.aau.dk/kiros/kiros.html
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extensively in ECMs (Lodish et al., 1995). The protein on the basic side of the 2D-
PAGE gel may therefore represent a degradation product of either a transmembrane or
a secreted protein. The general insolubility of the FG-knob, even in buffers containing
chaotropic salts, and the consequent low capacity of the affinity column may have
been the reason for the low amount of purified proteins. Eluted proteins could only be
visualised by silver staining of SDS-PAGE and 2D-PAGE gels thereby excluding the
possibility of microsequencing the proteins (Celis et al., 1995).
PNEMs are rich in hyaluronic acid, chondroitin-bearing proteoglycans such as
CSPGs and glycoproteins (Delpech et al., 1982; Bignami et al., 1992; Bruckner et al.,
1994), with collagenous molecules also shown to associate with these entities
(Murakami et al., 1999). Enzymatic digestion directed against elastin, collagen type II
and IV repeats, hyaluronic acid and GalNAc carbohydrates, all constituents known to
exist in many ECMs, revealed that no major change in protein migration pattern had
occurred. This would indicate that the eluted proteins did not contain any sites
recognised by the applied enzymes. Considering the many recent reports of
interactions between TN-R and CSPGs (Aspberg et al., 1995, 1997; Xiao et al., 1997;
Milev et al., 1998), a major family of proteoglycans in the BECM (Margolis and
Margolis, 1993; Ruoslahti, 1996) characterised by containing GalNAc epitopes
(Maeda et al., 1995), it was surprising that none of the eluated proteins belonged to
this family. A reason could be that the eluted proteins comprised degradation
fragments from larger proteins, which normally contain these sites. Nevertheless,
many types of BECM proteins without these sites exist (Alberts et al., 1994; Weber et
al., 1998), and the eluted proteins may therefore still represent matrix molecules.
The biological interaction between recombinant TN-R and eluted proteins was
estimated by fluorometric measurements using FITC labelled eluates. A slight
increase in intensities was observed when FITC labelled eluates were incubated
together with the purified FG-knob in comparison to FITC labelled eluates alone.
Nevertheless, a statistically significant difference was not found and it was not
possible to validate whether the eluted proteins truly were comprised of TN-R binding
proteins or just contaminating proteins associating non-specifically with the affinity
column. Therefore, focus was placed on producing larger amounts of recombinant FG
using other expression systems to overcome the general insolubility problem of the
FG-fragment.
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7.2 Expression of recombinant material in P. pastoris
Expression of recombinant FG-knob in KM71 and GS115 yeast cells resulted
in the production of several proteins of different sizes. Analysis of pellets from
transfected KM71 yeast cells revealed the expression of a protein with a size of 27
kDa, whereas two proteins of roughly 10 and 27 kDa predominated in pellets from
transfected GS115 yeast cells. The calculated size of recombinant FG fused to the
Myc-epitope was 24.5 kDa indicating that the recombinant proteins with sizes of
approximately 27 kDa represented non-secreted full length chimera within the yeast
cells. The 10 kDa protein detected in transfected GS115 yeast cells may either be due
to degraded fragments of recombinant FG or to contaminating proteins associating
with the Ni-NTA gel (see discussion below). Evaluation by Coomassie Blue staining
of proteins eluted from Ni-NTA gel incubated with conditioned medium from both
KM71 and GS115 yeast cells showed that secreted proteins were only detected in
eluates from GS115 yeast cells. The fact that only the smaller recombinant protein (10
kDa) associated with the Ni-NTA gel indicated that the full length recombinant FG
(27 kDa), observed in pellets from both KM71 and GS115 yeast cells, was either not
secreted, present in non-detectable amounts or did not associate with the Ni-NTA gel.
Nonetheless, by Western blotting, detection of Ni-NTA purified proteins present in
conditioned medium were observed in both transfected KM71 and GS115 yeast cells.
Proteins of either 27 or 35 kDa, containing the Myc-epitope, were detected in
conditioned medium from transfected KM71 yeast cells, whereas GS115 yeast cells
secreted a protein with a size of 40 kDa. The shift in size of proteins secreted from
transfected KM71 yeast cells occurred after 48 hrs of induction, suggesting that a
change in glycosylation pattern had occurred. It can be envisaged that the size
difference may represent glycosylated (35 kDa) and non-glycosylated proteins (27
kDa), and that such a shift only occurs after a certain time of induction in KM71 yeast
cells. The difference in size between recombinant FG detected in pellets (27 kDa) or
in conditioned medium (40 kDa) in GS115 yeast cells, may also occur because of an
addition of carbohydrates. Comparison of the different sizes of proteins secreted from
transfected KM71 and GS115 (27/35 or 40 kDa) yeast cells indicated that the two
yeast strains do not perform the same type of glycosylation. Whether the intracellular
non-glycosylated recombinant FG with a size of 27 kDa, detected in both transfected
KM71 and GS115 yeast cells, represents material yet to be post-translationally
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modified (in ER or Golgi apparatus) or aggregated proteins, is still unclear. The 10
kDa secreted protein that was detected in conditioned medium from transfected
GS115 yeast cells was not observed by Western blotting. These findings contradict
each other because the protein associated with the Ni-NTA gel, suggesting that it
contained the hexahistidine stretch. As recombinant proteins expressed using the
pPICaA vector are fused C-terminally to the Myc-epitope followed by the
hexahistidine tag (Invitogen, 1997a), it is unlikely that the 10 kDa protein could
contain the hexahistidine stretch (840 Da) and not the Myc-epitope (2.5 kDa). It is
therefore more likely that the observed 10 kDa protein represents a contaminating
protein that is expressed by the GS115 and not KM71 yeast strain and associate with
the Ni-NTA gel because of a high histidine content. Such proteins have frequently
been observed in bacteria (Invitrogen, 1997b) and presumably exist in eukaryotic cells
as well.
7.3 Mammalian protein expression
Two recombinant proteins were detected in cell-lysates of pSecTag2 C/GST-
FG transfected Cos-1/M6 cells using antibodies against both GST and the Myc-
epitope. The expected molecular size of recombinant GST-FG fused C-terminally to
the Myc-epitope (without carbohydrates) is 50 kDa. As the antibodies did not
recognise any of the proteins endogenously expressed in the Cos-1/M6 cells, the
bands observed in material from transfected cells may represent recombinant proteins
containing both the GST and the Myc-epitope suggesting them to be GST-FG. Several
potential glycosylation sites exist in the FG-knobu, and the size difference between the
two forms of GST-FG (60 and 100 kDa) may have been due to differences in the
glycosylation pattern. Variation in molecular size of TN-R arising from differences in
glycosylation patterns has never previously been suggested in the literature, but two
alternatively spliced isoforms have been described (of 160 and 180 kDa; Pesheva at
al., 1989). The difference in size may therefore occur because the FG fragment is
expressed in a cell line that is quite different from the neurone and glia populations
known normally to express TN-R (Bartsch et al., 1993; Wintergerst et al., 1993).
Unfortunately, no recombinant GST-FG was detected after affinity purification of
                                                                
u See also sections 5.1 and 7.1.
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conditioned medium from transfected cells, which may have been due to a lack of
sensitivity of the method used, or because the proteins were not secreted in a soluble
form. However, as recombinant PSA was easily detected on Western blots, it seems
unlikely that affinity purification of GST-tagged fusion proteins followed by Western
blotting should not be sensitive enough to detect the recombinant protein (see
discussion below).
Mock- and non-transfected Cos-1/M6 cells showed normal morphologies and
cell structures. On the contrary, Cos-1/M6 cells transfected with the pSecTag2
C/GST-FG vector clumped together leading to the formation of large aggregates and
the loss of normal cell structures. In transfected cells, the immunoreactivity around
aggregated Cos-1/M6 cells indicated that secreted GST-FG associated with these
structures. It is noteworthy, that although it cannot be excluded that such aggregation
could occur because GST-FG molecules interacted with ECM proteins or receptors
expressed de novo by the Cos-1/M6 cells, it seems more likely that the formation of
these aggregates occurred because recombinant GST-FG molecules stuck together
when secreted. This homophilic association then resulted in a pericellular aggregation
of GST-FG at the surface of the Cos-1/M6 cells thereby knitting them together
leading to the formation of large cell aggregates. Assembly of native TN-R monomers
into dimers and trimers via the cysteine-rich N-terminal of the molecule has
previously been reported (Pesheva et al., 1989; Norenberg et al., 1992). However, as
interaction between FG domains in native TN-R has never been reported in the
literature, it may be assumed that the aggregates observed here are simply due to a
precipitation/aggregation of non-soluble GST-FG and not a biologically functional
interaction.
7.4 Summary
The prokaryotic expression of recombinant proteins spanning the C-terminal
part of TN-R resulted in the production of inclusion bodies rendering the proteins
insoluble in native buffers. Renaturing of purified proteins was impossible in native
buffers and only minor amounts of purified protein remained soluble in solutions
containing high concentrations of chaotropic salts. This indicated that factors beyond
the primary structure, such as glycosylation, are needed for the correct folding of the
FG-knob. The overall insolubility of the FG-knob makes it very distinct in
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comparison to other TN-R domains and this may reflect some still unidentified
intrinsic function of this domain. Fragments of phosphorylated or differently modified
proteins were purified from pig cortex using a TN-R affinity column. These proteins
did not contain sites similar to common matrix components such as elastin, collagen
type II or IV repeats and hyaluronic acid. It was also intriguing that these fragments
did not belong to the CSPG family, suggesting that they may be transmembrane
proteins or secreted glycoproteins.
When expressing recombinant FG in P. pastoris yeast cells it was clearly shown
that recombinant FG could be generated and purified in a soluble form. The molecular
size of the proteins indicated that they were glycosylated, but the quantity of soluble
material was extremely low. Obtaining large amounts of recombinant FG from these
yeast cells seemed not to be possible.
The expression of recombinant GST-FG in a Simian fibroblast cell line gave
rise to two differently glycosylated proteins. These proteins, when secreted, stuck
together leading to the formation of large cell/protein aggregates. Affinity purification
of recombinant GST-FG was therefore not feasible using this method.
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8.1 Abstract
A special feature of the extracellular matrix in adult brains of various species is
the concentration of certain components around different sub-populations of neurones
giving rise to net-like structures termed perineuronal nets. Recently, some of these
components have been identified but the function of these nets has yet to be resolved.
Using immunofluorescence microscopy we report here that phosphacan, a chondroitin
sulphate proteoglycan, is an additional component of Wisteria floribunda labelled
perineuronal nets surrounding parvalbumin-expressing neurones in rat cerebral cortex.
Glycoproteins such as tenascin-C and R have been identified in perineuronal nets and
the present detection of phosphacan immunoreactivity in the same entity is of
potential physiological importance because of their previously described interactions.
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8.2 Introduction
It is generally recognised that brain extracellular matrix (B-ECM) plays an
important role in the development and maintenance of the central nervous system.
B-ECM, which mainly consists of hyaluronan, glycoproteins and proteoglycans can
influence the nervous system by binding growth factors and cell receptors, and by
modulating cell adhesion and signalling (for review see Ruoslahti, 1996). A large part
of potential signalling molecules in the B-ECM belongs to the chondroitin sulphate
proteoglycan family (CSPGs) whose members tend to have distinct distribution
patterns in the brain (Rauch et al., 1991; Lander et al., 1998). Phosphacan (reviewed
in Margolis and Margolis, 1997), comprising the extracellular region of the receptor
protein tyrosine phosphatase z/b  (RPTP z/b), belongs to this family of CSPGs.
Phosphacan is synthesised by astrocytes (Milev et al., 1994) and its localisation,
carbohydrate and sulphate compositions are developmentally regulated in the nervous
tissue (Meyer-Puttlitz et al., 1996). In embryonic and early postnatal rat brain,
phosphacan immunoreactivity is distributed in the neuropil of the cerebral cortex and
in the adult rat brain is localised mainly around multipolar non-pyramidal neurones
(Maeda et al., 1995). CSPGs have been shown to be present in the perineuronal net
(Celio and Blümcke, 1994) surrounding GABAergic interneurones expressing the
calcium-binding protein parvalbumin (PV; Hartig et al., 1994; for an overview of PV
distribution in the brain see Celio, 1990). In this report we show that phosphacan
immunoreactivity is present in the perineuronal net surrounding PV-positive
GABAergic interneurones in the adult rat cerebral cortex.
8.3 Material and Methods
Eight adult Wistar rats of either sex weighing ~ 300g were euthanised with
carbon dioxide and perfused via the left ventricle with 150 ml of 4% (w/v)
paraformaldehyde in PBS (0.147 M NaCl, 2.68 mM KCl, 1.76 mM KH2PO4 and
10.14 mM Na2HPO4; pH7.4). Brains were removed and placed for a further 1 hr in
4% paraformaldehyde, then transferred for an additional 1 hr in PBS and subsequently
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incubated overnight at 4 °C in 18% (w/v) sucrose in PBS. Brains were frozen and cut,
using a cryostat, into 40 mm thick horizontal sections. Prior to applying the primary
antibodies the sections were washed in PBS for five minutes, post fixed for one
minute in 4% (w/v) paraformaldehyde and subsequently washed again in PBS for two
minutes. Double-immunolabellings were performed by incubating the sections with a
rabbit polyclonal anti-phosphacan antibody (Milev et al., 1994; dilution 1:1,000) and
either with the biotinylated lectin Wisteria floribunda agglutinin (WFA, Sigma) at a
concentration of 20 µg/ml or with a mouse monoclonal anti-PV antibody (PV235;
Swant) diluted 1:1,000. Free floating sections were incubated overnight at 4 °C in
PBS containing 10% (v/v) bovine serum. Sections were rinsed three times ten minutes
in PBS. All the following incubations were carried out at room temp in PBS
containing 10% (v/v) bovine serum and all washes for three times ten minutes in PBS.
Sections incubated with the anti-PV antibody were revealed with an anti-mouse
Cy3™-conjugated antibody (Jackson Laboratories). Sections incubated with
biotinylated WFA were revealed by a Cy2™-conjugated streptavidin (Jackson
Laboratories). The anti-phosphacan antibody incubation was carried out as a two step
reaction by first applying a goat anti-rabbit IgG antibody (Jackson Laboratories),
followed by washes and subsequent incubated with a donkey anti-goat Cy2™-
conjugated antibody (Amersham). The goat anti-rabbit antibody, the Cy2™ and
Cy3™ -conjugated antibodies and the Cy2™ -conjugated streptavidin were all applied
at dilutions of 1:100 for 2 hrs at room temp. After extensive washes sections were
dried on slides for 2 hrs at room temp, re-hydrated in double distilled water, dried for
thirty minutes and subsequently mounted in SlowFade™ (Molecular Probes),
coversliped and sealed using clear nail varnish. Controls were carried out in the
absence of the primary antibodies or the lectin. The slides were visualised under a
Zeiss Axiophot fluorescence microscope, photographed using a Spot camera™
(Diagnostic instruments, Inc.), imported into Adobe Photoshop 3.0.5 where minor
changes in brightness and contrast were performed and photographic plates were
printed on a Kodak DS 8650 PS Color printer.
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8.4 Results
Detailed analysis of phosphacan immunoreactivity in the adult rat cerebral
cortex revealed a pericellular staining resembling perineuronal net-like structures,
ensheathing the cell-body and major dendrites of non-pyramidal neurones. Neurones
surrounded by phosphacan immunoreactivity were found in all layers of the cortex,
except layer I, and were mainly distributed in the layers II, IV and VI. The
immunofluorescence intensity varied from a strong staining in the deeper layers
revealing both the contours of the cell body and dendrites, to an almost indistinct
staining of the perimeter of a subclass of neurones in layer II. A difference in the
density and intensity of positive neurones was also observed depending upon the
region of the cerebral cortex, but this was not further studied. In double-staining
experiments using both anti-phosphacan and anti-PV antibodies, it was shown that all
Figure 8.4.1  Co-localisation of phosphacan immunoreactivity within perineuronal nets around
parvalbumin expressing neurones in the cerebral cortex of adult rats. A and B show a double
stained section incubated with anti-PV (A) and anti-phosphacan (B) antibodies. Some of the
double stained cells in A and B are marked with arrow heads whereas the asterisks in B denote the
position of faintly stained neurones in A that are out of focus. C and D depict a double stained
section illustrating the lack of phosphacan immunoreactivity (curved arrow in D) around a PV-
expressing neurone (C). E and F show a double stained section incubated respectively with WFA
(E) and the anti-phosphacan antibody (F). Scale bars = 50 mm.
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phosphacan immunoreactive neurones in the cerebral cortex were also PV-positive
(Fig. 8.4.1 A, B). Very few PV-positive neurones were found without a phosphacan
net (Fig. 8.4.1 C, D), but the variation in intensity of the phosphacan
immunoreactivity made it difficult to distinguish negative from weakly stained cells.
When sections were incubated concomitantly with WFA, a marker for the
perineuronal net, and anti-phosphacan, we observed that phosphacan
immunoreactivity was localised around the same sub-population of neurones as the
perineuronal net (Fig. 8.4.1 E, F). In addition, there was a correlation between the
intensity of the phosphacan immunoreactivity and that of WFA in the deeper cortical
layers, but not in layer II where the phosphacan immunoreactivity was generally
weak. Similar results were obtained when the monoclonal anti-phosphacan antibody
3F8 (Rauch et al., 1991) was applied (not shown).
8.5 Discussion
 The amount of extracellular material detected in the brain is relatively low
(Ruoslahti, 1996) when compared to the ECM of many other tissues. In addition,
many if not all of the ECM components in the brain have restricted regional
distributions and in addition some also tend to accumulate around specific sub-
populations of neurones giving rise to net-like structures termed perineuronal nets (for
review see Celio and Blümcke, 1994; Celio et al., 1998). ECM compounds such as
hyaluronan (Bignami et al., 1992), neurocan (Matsui et al., 1998), tenascin-C (Celio
and Chiquet-Ehrismann, 1993) and tenascin-R (Celio and Blümcke, 1994) are seen to
accumulate around PV-expressing GABAergic interneurones (Hartig et al., 1992)
comprising a proportion of the neurones surrounded by perineuronal nets. The
distribution of PV-expressing neurones in the cerebral cortex (Celio, 1990) and their
co-localisation with WFA labelled perineuronal nets is well established in the
literature (Hartig et al., 1992; Brauer et al., 1993; Bruckner et al., 1994). CSPGs have
been shown to constitute part of the perineuronal nets around PV-positive neurones
(Hartig et al., 1994). Furthermore, using the monoclonal anti-phosphacan antibody
6B4, Maeda et al. (Maeda et al., 1995) have detected phosphacan immunoreactivity
around certain multipolar non-pyramidal neurones in the adult rat cerebral cortex. In
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this paper, we expand on these results by showing that phosphacan is one of the
CSPGs in perineuronal nets and that it surrounds only PV-positive neurones in the
cortex. The few PV-positive neurones we found not to be surrounded by phosphacan
immunoreactivity were localised in the cortical regions where the intensity of the
phosphacan immunoreactivity was generally weak. This made it difficult to determine
if phosphacan immunoreactivity truly was absent around the PV-positive neurones or
if the immunoreactivity was lower than could be detected. In the deeper layers of the
cortex, where the intensity of the phosphacan immunoreactivity appeared to be strong,
there was a perfect correlation between neurones surrounded by WFA and those
surrounded by phosphacan immunoreactivity. Nevertheless, certain regions of the
cortex had a low phosphacan immunoreactivity even though no apparent difference
could be observed in the WFA staining. Here we suggest that the proportion between
phosphacan and other CSPGs within perineuronal nets varies depending on region and
layer of the cortex. The appearance of phosphacan immunoreactivity in WFA labelled
perineuronal nets was not surprising as the former contains N-acetylgalactosamine
carbohydrates (GalNAc, Maeda et al., 1995) which are recognised by WFA.
Moreover, phosphacan is also known to bind to certain glycoproteins found in
perineuronal nets such as tenascin-C (Milev et al., 1997) and tenascin-R (Milev et al.,
1998). Therefore, the co-localisation of all three compounds in perineuronal nets
suggests a potential physiological relevance for their interactions.
Perineuronal nets are thus not only heterogeneous in composition (Celio and
Blümcke, 1994; Celio et al., 1998) but the proportion of their components vary
depending upon the localisation within the cerebral cortex. Such regional differences
in the composition of the ECM may reflect subdivisions of functionally defined areas.
So far, the functions and the exact composition of perineuronal nets are still far from
being determined (Celio and Blümcke, 1994) but the identification of phosphacan in
this structure adds a further component to this special form of extracellular matrix and
may enable us to better understand its role.
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9.1 Abstract
Recently identified chondroitin sulphate proteoglycans in perineuronal nets
include neurocan and phosphacan. However, the function and assembly of these
components has yet to be resolved. In this study, we show morphological alteration in
Wisteria floribunda labelled nets around cortical interneurones both in tenascin-R
knockout and tenascin-R/parvalbumin double knockout mice. This alteration reflects
the loss of phosphacan and neurocan from cortical nets in mice deficient in
tenascin-R. No effect on the membrane related cytoskeleton, as revealed by ankyrinR,
was observed in any of the mice. These results on mice lacking tenascin-R
substantiate previously reported in vitro interactions between tenascin-R and
phosphacan and neurocan.
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9.2 Introduction
A special feature of the brain extracellular matrix (ECM; Ruoslahti, 1996) is the
aggregation of certain components around specific sub-populations of neurones giving
rise to net-like structures termed perineuronal nets of extracellular matrix (PNEMs;
Celio et al., 1998). PNEMs are well characterised around cortical GABAergic
parvalbumin immunoreactive (PV-IR) interneurones (Hartig et al., 1999) and are
composed of hyaluronan, tenascin-C (Celio, 1993), -R (Celio and Blümcke, 1994) and
defined chondroitin sulphate proteoglycans (CSPGs) such as brevican (Hagihara et
al., 1999), neurocan (Matsui et al., 1998) and phosphacan (Haunso et al., 1999).
However, neither function (Hartig et al., 1999) nor process of assembly of PNEMs
has yet been determined (Celio et al., 1998). In vitro studies have shown binding
between tenascin-R (TN-R) and members of the CSPG family (Milev et al., 1998;
Hagihara et al., 1999) suggesting its involvement in the assembly and structure of
PNEMs. In addition, the intracellular organisation of the ankyrinR membrane-related
cytoskeleton (MRC) may also be involved in the formation of the lattice-like structure
of PNEMs, by controlling the position of integral membrane proteins (Wintergerst et
al., 1996) involved in forming the nets. In this report we show that TN-R is essential
for attracting and/or retaining neurocan and phosphacan in cortical PNEMs as no
pericellular staining was observed for these CSPGs when TN-R was lacking.
9.3 Material and methods
Mice lacking either TN-R (Weber et al., 1999) or PV (Schwaller et al., 1999)
were used and double knockout mice for both TN-R and PV were generated by cross-
breeding TN-R and PV single knockout mice. The genotype of TN-R, PV and
PV/TN-R deficient mice were determined by Southern blotting as previously
described (Schwaller et al., 1999; Weber et al., 1999). In total twelve adult mice ~
30g, comprising three of each genotype - wild type (WT), PV knockout (KO), TN-R
KO and PV/TN-R double KO - of either sex, were used in these experiments. Animals
were sacrificed, brains dissected out and processed for immunohistochemistry as
previously described (Haunso et al., 1999). Biotinylated Wisteria floribunda
92
agglutinin (WFA, Sigma) immunoreactivity (IR) was detected by applying the lectin
at a concentration of 20 µg/ml and TN-R-IR by applying a 1:500 dilution of mouse
anti-tenascin-R antibody (restrictin 23-14). Double-immunolabelling was performed
by incubating sections with a mouse monoclonal anti-PV antibody (PV235; Swant)
diluted 1:500 together with rabbit polyclonal antibodies against either phosphacan
(Milev et al., 1994), neurocan (Milev et al., 1996) or ankyrinR (Lambert and Bennett,
1993), all diluted 1:1,000. Sections incubated with the anti-PV antibody were
visualised with a fluoresceinisothiocyanate-conjugated (FITC; 1:200) anti-mouse
antibody (Molecular Probes) and biotinylated WFA was visualised by Texas Red-
conjugated streptavidine (Vector; 1:200). Detection of all rabbit polyclonal antibodies
or the monoclonal TN-R antibody was carried out as two step reactions by first
applying biotinylated goat anti-rabbit IgG antibodies (Vector; 1:200) or biotinylated
horse anti-mouse IgG antibody (Vector; 1:200), respectively, followed by washes and
subsequent incubation with Texas Red-conjugated streptavidine (1:200). Controls
were carried out in the absence of primary antibodies or the lectin. Slides were
analysed with a Bio-Rad 1024, argon/krypton confocal laser scanning fluorescence
microscope (LSCM; Bio-Rad Microsciences Division Ltd). Both green and blue-lines
of laser excitation were used and detected at 522nm for FITC and 680nm for Texas
Red-labelled structures. Using a x60 oil immersion objective and real time zoom
feature of the confocal program, captured optical sections of 0.2 mm thickness were
superimposed and images transferred to Adobe PhotoshopTM software where
photographic plates were prepared and printed using a Kodak dye sublimation printer
(DS 8650 PS).
9.4 Results
In both WT and TN-R KO animals, cortical PV-IR neurones had a normal
pattern of distribution and normal pericellular staining was observed in WT and PV
KO animals (not shown). Confocal analysis of individual WFA-labelled PNEMs
revealed a lattice-like staining around cell soma and dendritic arborisations in both
WT and PV KO animals (Fig. 9.4.1 A, B). However, in both TN-R KO and PV/TN-R
KO animals WFA-labelled PNEMs around the cell soma showed punctuated
immunolabelling (Fig. 9.4.1 C, D). Labelling along dendrites was also markedly
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Figure 9.4.1  Confocal images of WFA-labelled perineuronal nets in the cerebral cortex of WT (A),
PV KO (B ), TN-R KO (C) and PV/TN-R double KO (D). In both WT (A) and PV KO (B) mice the
nets have a normal lattice-like morphology around soma and extend along dendritic aborisations
(arrow heads). Nets were punctuated and disrupted around soma (asterisk) in TN-R KO (C) and to a
similar extent in PV/TN-R double KO (D) mice. Labelling of nets along dendrites was generally
absent in both genotypes. Scale bar = 20 mM.
reduced or absent (Fig. 9.4.1 C, D). Despite this, no apparent change in the overall
distribution or density of cells with WFA-labelled nets was observed in any of the
animals (as also shown by Weber et al. 1999). In WT and PV KO animals, double-
immunofluorescence labelling using neurocan or phosphacan combined with PV-IR
revealed a normal net-like staining pattern around cortical interneurones (Fig. 9.4.2 A,
B, D, E). In TN-R deficient mice we observed a massively reduced and more diffusely
distributed cortical neurocan-IR in mutant mice when compared to wild-type animals
(Fig. 9.4.2 C), whereas no pericellular phosphacan-IR (Fig. 9.4.2 F) could be detected
in any tenascin-R deficient mice. The ankyrinR-IR MRC (characteristic for cortical
PV-IR interneurones; Wintergerst et al., 1996) showed no morphological differences
in any of the mice studied, even in neurones lacking PV or those showing altered
neurocan and phosphacan PNEMs (Fig. 9.4.3).
9.5 Discussion
Many if not all ECM components in the brain show a restricted regional
distribution (Rauch et al., 1991; Lander et al., 1998) with some accumulating around
specific sub-populations of neurones giving rise to net-like structures termed PNEMs
(for review see Celio and Blümcke, 1994; Celio et al., 1998). Recently, interactions
between TN-R and defined CSPGs such as brevican (Aspberg et al., 1997),
phosphacan (Milev et al., 1998), neurocan (Milev et al., 1998) and versican (Aspberg
et al., 1995) have been shown in vitro. Furthermore, IR for brevican, phosphacan and
94
neurocan together with TN-R (Celio and Blümcke, 1994) has also been associated
with PNEMs (Matsui et al., 1998; Hagihara et al., 1999; Haunso et al., 1999),
conferring physiological importance to their previously described interactions in vitro.
In this paper, we report for the first time that the removal of a defined PNEM
molecule can alter the distribution and levels of other specific components in
perineuronal nets. We report that TN-R is needed for the correct assembly of PNEMs
and when absent, CSPGs such as phosphacan and neurocan are no longer present, or
in extremely low amounts, in cortical PNEMs, leading to a marked alteration in their
appearance. The lectin WFA, used in this investigation, recognises
N-acetylgalactosamine carbohydrates (Maeda et al., 1995) on both phosphacan and
Figure 9.4.2 Double confocal images of neurocan (A-C) and phosphacan (D-F) immunoreac-
tivity around cortical interneurones. (A) Neurocan-IR (red, arrows) around a PV-labelled
neurone (green) in WT. (B) Neurocan-IR (red) surrounding PV-negative (asterisk) neurone in
PV KO. (C) PV-labelled neurone (green) lacking neurocan-IR around cell soma in TN-R KO.
(D) Phosphacan-IR (red) around PV-labelled neurone (green) in WT. (E) Phosphacan-IR (red,
arrows) surrounding PV-negative (asterisk) neurone in PV KO. (F) PV-labelled neurone (green)
lacking phosphacan-IR around cell soma in TN-R KO. Scale bar = 20 mM.
Figure 9.4.3  Confocal images of ankyrinR membrane related cytoskeleton immunoreactivity in WT
(A), PV KO (B) and TN-R KO (C) mice. AnkyrinR-IR showed normal pattern of distribution and
morphology in cortical neurones of all genotypes. Scale bar = 20 mM.
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neurocan. The observed alteration in the WFA-labelled nets in mice lacking
tenascin-R (as also reported by Weber et al. 1999) therefore reflects a significant
reduction of the two investigated components and perhaps other CSPGs. It is
noteworthy that in areas such as the cerebellum, olfactory bulb and spinal cord some
neurocan-IR remained in tenascin-R deficient animals, but this was not investigated
further. In contrast phosphacan-IR nets were not detected anywhere else in the CNS in
these mice. This indicates that TN-R is not involved in determining which neurones
form PNEMs but may be involved in attracting and/or retaining phosphacan and
neurocan in cortical PNEMs. The MRC has been proposed as a prerequisite for the
organisation of PNEMs and also to be involved in defining the area of synaptic
contacts by keeping in register the overlaying PNEM (Celio and Rathjen, 1993;
Wintergerst et al., 1996). The results presented here indicate that the MRC is more
likely to be involved in determining the position of integral membrane proteins, rather
than retaining the lattice-like structure of the PNEM. Evidence for this comes from
the fact that the MRCs remain constant even though PNEMs have morphologically
degenerated into a punctuated structure.
The lack of both PV and the alteration in morphology of PNEMs seemed not to
have affected the distribution of individual cortical interneurones. It has been
proposed that perineuronal nets are required for fast-spiking behaviour of GABAergic
interneurones (Hartig et al., 1999). Modification of PNEMs could therefore influence
the fast-spiking properties of these neurones or the distribution of synapses contacting
their cell body, since the lattice-like structure of PNEMs defines the area of synaptic
contacts (Celio and Blümcke, 1994). Together with a changed calcium homeostasis,
this could modulate the inhibitory output from these GABAergic interneurones in
mice lacking both TN-R and PV.
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10. Distribution and quantification of GABAergic inhibitory
cortical interneurones in tenascin-R and parvalbumin single
and double knockout mice.
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10.1 Introduction
Parvalbumin (PV), calbindin-D28K and calretinin are calcium binding
proteins which define non-overlapping sub-populations of GABAergic inhibitory
interneurones in the cerebral cortex (Celio, 1986; Alcantara et al., 1996; Fujimaru and
Kosaka, 1996). The PV-expressing inhibitory interneurones are further characterised
by being surrounded by pericellular condensations of extracellular matrix (ECM)
components forming a fine meshwork within the local neuropil (for reviews see Celio
and Blümcke, 1994; Celio et al., 1998). These entities, termed perineuronal nets of
extracellular matrix (PNEMs), together with PV, have been suggested as essential for
sustaining the fast-spiking properties observed for these neurones (Hartig et al., 1999).
Mice lacking PV have been shown to be more prone to seizures than wild type mice
(Tandon et al., 1999). This change occurs although the ‘previously PV positive’
neurones still exist and can be observed using other markers for this sub-population of
neurones (Naegele et al., 1988; Kosaka and Heizmann, 1989; Kosaka et al., 1989;
Kosaka et al., 1990; Haunso et al., 2000). Another alteration impinging on this sub-
population of cortical interneurones is observed in tenascin-R (TN-R) knockout (KO)
mice. Here, morphological changes have been observed in PNEMs surrounding
PV-immunoreactive (IR) neurones (Weber et al., 1999; Haunso et al., 2000). As both
PV and PNEMs are thought to be critically involved in determining the properties of
these neurones, changes herein may influence and modulate the behaviour of these
animals. Any alteration in the GABAergic system may lead to change in neuronal
inhibition resulting in physiological, morphological and behavioural abnormalities.
Here, the distribution and number of GABAergic cortical interneurones in PV and
TN-R single KOs and PV/TN-R double KOs is examined and it is shown that the
overall inhibitory properties of these neurones remains intact in all animals.
10.2 Material and Methods
Mice lacking either PV (Schwaller et al., 1999) or TN-R (Weber et al., 1999)
were used and double KO mice deficient for both PV and TN-R were generated by
cross-breading PV and TN-R single KOs. The genotypes were determined as
previously described (Haunso et al., 2000). In this study, eight adult mice »30 g,
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comprising two of each genotype – wild type (WT), PV KO, TN-R KO and PV/TN-R
KO – of either sex, were used. Animals were sacrificed, brains dissected out and
processed for immunohistochemistry as previously described (Haunso et al., 1999).
Glutamic acid decarboxylase (GAD), the GABA synthesising enzyme, was visualised
as a marker for the whole GABAergic system (Kaufman et al., 1986). Double-
immunolabelling was performed by incubating 60 mM cryostat sections with a mouse
monoclonal anti-PV antibody (PV235; Swant) diluted 1:500 together with a rabbit
polyclonal anti-GAD antibody (Chemicon; 1:250). Incubation with primary antibodies
was performed over night at 4° C as floating sections in PBS (0.147 M NaCl, 2.68
mM KCl, 1.76 mM KH2PO4 and 10.14 mM Na2HPO4; pH7.4) containing 10% bovine
serum. All washes were performed for 3 times 10 min. in PBS and incubations with
secondary antibodies for 1 hr at room temp in PBS containing 10% bovine serum.
Sections incubated with anti-GAD antibodies were incubated with a biotinylated goat
anti-rabbit antibody (Vector; 1:200) followed by Texas Red-conjugated streptavidine
(Vector; 1:200). Anti-parvalbumin antibodies were visualised with a fluorescein
isothiocyanate-conjugated (FITC; 1:200) anti-mouse antibody (Molecular Probes).
Following the incubations, sections were washed, placed on slides and subsequently
left to dry at room temp. for 2 hrs. After drying, the sections were re-hydrated in
double distilled water, dried for an additional 30 minutes, coversliped in SlowFade
(Molecular Probes) and sealed using clear nail varnish. Staining in the sections was
analysed and images captured using a Bio-Rad 1024, argon/krypton confocal laser
scanning fluorescence microscope (LSCM; Bio-Rad Microsciences Division Ltd.).
Both green and blue-lines of laser excitation were used and detected at 522 nm for
FITC and 680 nm for Texas Red-labelled structures. Using x10 and x20 objective and
real-time zoom features of the confocal program, captured optical sections of 0.5 mm
thickness were superimposed and images transferred to Adobe PhotoshopÔ software
where photographic plates were prepared. GAD-immunoreactive (GAD-IR)
interneurones were quantified in cerebral cortices of WT, PV KO, TN-R KO and
PV/TN-R double KO mice. For each mouse, GAD-IR cell bodies were counted in two
or three sections with four fields per section. The quantification was performed in a
genotypic-blinded fashion and all immunostained cell bodies were counting
throughout the field using a x20 objective. Each field was chosen randomly within the
cerebral cortex and the average cell number per field used in statistical evaluations.
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10.3 Results
GAD-IR cortical interneurones showed a normal pattern of distribution and
intensity throughout all the CNS in the investigated animals (data not shown). GAD-
IR interneurones and their neuropil were present in all parts of the neocortex and
showed normal intensity, density and distribution in all KO animals when compared
to wild type mice (Fig. 10.3.1, A-D). The number of GAD-IR cortical interneurones
were quantified in all mice genotypes and as can be seen in table 10.3.1 and figure
10.3.2, no significant differences could be observed in either of the different
genotypes.
Figure 10.3.1  Confocal images of glutamic acid decarboxylase (GAD) labelled (A - D) and
combined parvalbumin (PV) and GAD labelled (E-H) cortical interneurones in WT (A & E), PV
KO (B & F), TN-R KO (C & G) and PV/TN-R double KO (D & H). Distribution and density of
GAD labelled interneurones (red) seem unchanged in all mice genotypes (A - D). Co-localisation of
GAD-IR and PV-IR is observed in some interneurones (E & G, arrows) whereas PV-IR is not
observed in mice lacking PV (F & H). Some interneurones expressed GAD but not PV (E and
asterisks in G). In some interneurones, the GAD-IR was so week that it appeared as if the neurones
only expressed PV. Scale bar in D = 100 mM (for images A - D). Scale bar in H = 50 mm (for
images E - H).
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Table 10.3.1 GAD-IR Av. # GAD-IR cells1 SD2 Sections Fields # Mice
WT 111 15.64 6 24 2
PV KO 134 25.89 6 24 2
TN-R KO 95 24.37 4 16 2
PV/TN-R KO 129 20.07 6 24 2
1Av; average, 2SD; standard deviation
Depending upon the cortical region, a varying degree of interneurones
expressing both GAD and PV were observed in the cortex of WT and TN-R single
KO animals whereas PV-IR was devoid in mice lacking PV (Fig. 10.3.1 F & H). As
expected, a number of GAD-IR interneurones not expressing PV were observed in
WT and TN-R KO animals (Fig. 10.3.1 E and asterisks in G), and also some
interneurones expressing GAD but not PV (Fig. 10.3.1 E & G).
Figure 10.3.2 Graph showing the average number of GAD-IR cortical
interneurones in wild type (WT), parvalbumin (PV) and tenascin-R (TN-
R) single knockouts (KO) and parvalbumin/tenascin-R double knockouts
(PV/TN-R-KO). Bars = standard deviations.
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10.4 Discussion
The output from the cerebral cortex, the cerebrofugal projections, arise from
cortical pyramidal cells with these projection neurones being tightly controlled by
nearby GABAergic interneurones associating with the pyramidal cells (Heimer,
1995). Calcium binding proteins are expressed in separate sub-populations of
GABAergic interneurones in the neocortex (Baimbridge et al., 1992), the area of
interest in this investigation. One large sub-population of cortical inhibitory
interneurones expresses PV (Baimbridge et al., 1992), and are also characterised by
having pronounced perineuronal nets of extracellular matrix (PNEMs; for review see
Celio and Blümcke, 1994). Recently, an alteration in the release of GABA from the
synaptic terminals of cortical interneurones has been observed in mice lacking
parvalbumin (Drs M. Vreugdenhil and B. Schwaller, personal communication). These
mice are also more susceptible to seizures, and it has been suggested that seizures
occur because the lack of PV influences the GABAergic output and thereby induces
the changes observed in these animals (Tandon et al., 1999). PNEMs have also been
postulated to play an essential role in the functional properties of this sub-population
of neurones and that modulations in these entities may influence the inhibitory
function of these neurones (Hartig et al., 1999). Here, it is shown that the overall
distribution and density of GABAergic cortical interneurones remain unchanged in
mice lacking either PV, TN-R or both. Significant differences in the overall intensity
of the GAD-IR in the genetically altered mice were also not observed, suggesting that
the total amount of GAD enzyme remained unchanged in these neurones. Because the
GAD-IR was quite weak in some cortical regions of WT and TN-R KO mice, the
impression that some PV expressing interneurones did not express GAD was
observed. Overall, no major changes in the cortical inhibitory system were observed
in any of the genetically modified mice. Synaptic contacts impinging on cortical
interneurones surrounded by PNEMs occur in the holes of the lattice-like net
structures (Celio and Blümcke, 1994) and the distribution of these contacts may be
altered in TN-R deficient mice as their PNEMs are markedly altered (Haunso et al.,
2000). Lack of PV leading to a change in calcium homeostasis in cortical GABAergic
interneurones, together with potential alterations in the distribution of synaptic
endings on them, may lead to synergistic effects in the double KO animals, resulting
in the modulation of the inhibitory output from these GABAergic interneurones.
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Analysing such effects and potential behavioural changes in these double KO animals
awaits further studies.
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11. General discussion and summary
In these studies, perineuronal nets of extracellular matrix (PNEMs) found
around GABAergic parvalbumin (PV) expressing interneurones have been further
characterised in respect to the components comprising these nets and the role of
tenascin-R (TN-R) in these entities. Although problems in affinity purification of
TN-R fragments and identification and biochemical characterisation of TN-R ligands
were encountered, novel findings with respect to PNEMs have been shown using
combined immunofluorescence and confocal microscopic techniques. The
morphological aspects of this study have given further insight into the possible
functional role of TN-R in PNEMs.
11.1 Expression of recombinant material in E. coli
TN-R is an extracellular matrix molecule expressed exclusively in the central
nervous system (Pesheva et al., 1989; Rathjen et al., 1991; Weber et al., 1999). A
special feature of TN-R, and some of its known ligands, is their accumulation around
certain sub-populations of neurones, forming PNEMs (Matsui et al., 1998;
Wintergerst et al., 1996; Hagihara et al., 1999; Haunso et al., 1999). TN-R has been
shown in vitro to promote neurite outgrowth and morphological polarisation of
various neurones (Lochter and Schachner, 1993; Lochter et al., 1994). TN-R is also a
repellent for growth cone advance (Pesheva et al., 1993; Taylor et al., 1993),
promotes adhesion and differentiation of oligodendrocytes and astrocytes (Pesheva et
al., 1989; Morganti et al., 1990; Pesheva et al., 1997) and has also been suggested as a
modulator of fasciculation (Xiao et al., 1998). Different recombinant TN-R domains
expressed in bacteria have been shown to mediate many of these properties and such
domains have also been used to identify specific ligands for TN-R (Aspberg et al.,
1997; Xiao et al., 1997).
Bacterial expression of the FG-knob from human tenascin-R led to the
formation of inclusion bodies under all tested conditions, concurring similar
observations in previous studies (Norenberg et al., 1995; Elefteriou et al., 1999),
thereby rendering it insoluble in native buffers. Affinity purification of the FG-knob
using hexahistidine tagged fusion proteins was nevertheless possible under denaturing
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conditions, but the purified FG-knob remained insoluble in standard native buffers
and only slightly soluble in buffers containing chaotropic salts. The general
insolubility of the FG-knob probably occurred because this domain needs either
additional TN-R domains or carbohydrates to fold correctly. Indeed, all members of
the tenascin multi-gene family are glycoproteins (Chiquet-Ehrismann, 1995) and it
has recently been shown that carbohydrates comprise 10 - 20% (w/w) of the observed
relative molecular size for mouse TN-R (Zamze et al., 1999). Analysis of the amino
acid sequence of the FG-knob from human TN-R revealed that it contains many
potential sites for N- and O-linked glycosylation, indicating that this domain may be
glycosylated in TN-R expressed in vivo. Fragments of phosphorylated or differently
modified proteins were purified from pig cortex using a TN-R affinity column
generated from the slight amounts of obtained soluble FG-knob. These proteins did
not contain sites similar to common matrix components such as elastin, collagen type
II or IV repeats or hyaluronic acid. Surprisingly, considering the many recent reports
of interactions between TN-R and CSPGs (Aspberg et al., 1995, 1997; Xiao et al.,
1997; Milev et al., 1998), these affinity purified protein fragments also did not belong
to the CSPG family, one of the major BECM families, suggesting that they may be
transmembrane proteins or secreted glycoproteins.
11.2 Expression of recombinant material in P. pastoris
Recombinant TN-R domains expressed in bacteria have frequently been used to
determine the overall function, and specific ligands for tenascin-R (Aspberg et al.,
1997; Xiao et al., 1996, 1997). The C-terminal domain of TN-R, the FG-knob, is
probably expressed in an insoluble form in bacteria (Norenberg et al., 1995; Elefteriou
et al., 1999) because other TN-R domains or carbohydrates are needed for the correct
folding.
Analysing heterologous expression of the FG-knob in the yeast P. pastoris
showed that the glycosylation pattern was different in the two strains, KM71 and
GS115, since secretion of FG fusion proteins in these strains gave rise to proteins of
different sizes. Moreover, the glycosylation pattern also changed during the induction
period, in the KM71 strains, resulting in secretion of two differently sized proteins. In
addition, it was observed that the majority of expressed protein was not secreted but
remained within the yeast cells. Very low amounts of secreted proteins were detected
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in conditioned medium from transfected yeast cells, and these quantities were
insufficient to be used for the generation of an affinity column.
11.3 Expression of recombinant material in Cos-1/M6 cells
Expression of the FG-knob from human TN-R, as a secreted protein, in a
mammalian cell line exposes the protein to the machinery in the endoplasmatic
reticulum and Golgi apparatus responsible for folding and post-translational
modifications (Creighton, 1993). Analysing heterologous expression of the FG-knob
in a Simian fibroblast cell line, termed Cos-1/M6, clearly showed two differently
glycosylated forms with a size difference of 40 kDa. Although TN-R is a
glycoprotein, differences in glycosylation pattern has never been reported for this
protein (Persheva et al., 1989; Zamze et al., 1999) and probably occurred here because
it was expressed in a cell line quite different from the brain cells normally expressing
TN-R (Bartsch et al., 1993; Wintergerst et al., 1993). The FG-knob was expressed as a
secreted protein in the Cos-1/M6 cell line. Nonetheless, it was undetectable in
conditioned medium because upon secretion homophilic interactions between
recombinant GST-FG molecules lead to a pericellular aggregation around the host
cells, thereby knitting them together and forming large cell aggregates. As homophilic
interactions between FG domains in native TN-R have never been described before in
the literature (see also section 7.3), it may be assumed that the cell aggregations
occurred because of a precipitation of non-soluble GST-FG at the surface of the host
cells and not because of a biological functional interaction.
11.4 Phosphacan, a member of the CSPG family, is a constituent of PNEMs
Perineuronal nets of extracellular matrix (PNEMs) are lattice-like accumulations
of brain extracellular matrix (BECM) components around GABAergic interneurones
expressing the calcium binding protein parvalbumin (PV). These nets are generally
believed to be composed of chondroitin sulphate proteoglycans (CSPGs; Margolis and
Margolis, 1993; Ruoslahti, 1996) and glycoproteins (Celio and Blümcke, 1994) and
recently, defined constituents belonging to these families have also been identified
(Wintergerst et al., 1996; Matsui et al., 1998; Hagihara et al., 1999).
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A specific member of the CSPG family, termed phosphacan, preferentially
associates with both cortical and non-cortical PNEMs and constitutes one among
several CSPGs making up these entities (Haunso et al., 1999). The identification of
phosphacan in PNEMs in vivo provides functional and biological importance to its
previously described interactions with other defined PNEM components in vitro
(Aspberg et al., 1995, 1997; Xiao et al., 1997). It is noteworthy that the proportion
phosphacan constituted of the CSPGs present in PNEMs varied depending upon
region and cortical layer (Haunso et al., 1999). Thus, not only are PNEMs
heterogeneous in composition (Celio et al., 1998) but the proportion of their
components varies depending upon the localisation within the cerebral cortex. Such
differences may reflect subdivisions of functionally defined areas and the
identification of phosphacan in PNEMs may further help us to understand the role of
these entities.
11.5 Loss of defined CSPG components in PNEMs of PV and TN-R single and
double KO mice
Lecticans, a family of CSPGs forming large aggregates with hyaluronic acid
(Aspberg et al., 1997), are the major components of BECM (Ruoslahti, 1996).
Defined members identified in the lectican family comprise aggrecan, versican,
brevican and neurocan and so far the two latter, together with a non-lectican CSPG,
i.e phosphacan, have been identified in PNEMs (Matsui et al., 1998; Hagihara et al.,
1999; Haunso et al., 1999). It has been shown in vitro, that all lecticans bind the
BECM glycoprotein TN-R either through carbohydrate-protein or protein-protein
interactions (Aspberg et al., 1995, 1997).
Investigation of PNEMs in parvalbumin (PV) and TN-R single and double
knockout (KO) mice revealed that they remained normal in mice lacking PV, whereas
TN-R deficient mice showed morphological alterations in these entities (Haunso et al.,
2000). Thus, TN-R is essential for the correct formation of PNEMs and when it is
absent, CSPGs such as phosphacan and neurocan were no longer present in cortical
PNEMs leading to morphological changes in these entities in mice deficient for TN-R.
Notable, in areas such as cerebellum, olfactory bulb and spinal cord some pericellular
neurocan immunoreactivity (IR) remained in TN-R deficient mice whereas
phosphacan-IR had completely disappeared (Haunso et al., 2000). This strongly
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indicates that TN-R is essential for the attraction and/or retention of certain CSPGs in
cortical PNEMs but that additional factors may also be present elsewhere in the CNS
that are able to compensate for the lack of TN-R-mediated attraction of neurocan.
PV-expressing cortical interneurones are characterised by the presence of a
membrane-related cytoskeleton (MRC) composed, among others, of ankyrinR and
spectrin (Wintergerst et al., 1996). MRCs assemble before the external PNEMs and it
has been suggested that they form a prerequisite for the organisation of these nets.
MRCs may function in defining the area in which synaptic contacts develop and
impinge on these interneurones by keeping in register the overlaying PNEM (Celio
and Rathjen, 1993; Wintergerst et al., 1996). As the MRC assembled normally in mice
lacking either PV, TN-R or both (Haunso et al., 2000), the MRC is more likely to be
involved in determining the position of integral membrane proteins and serve as focal
points for the PNEMs rather than merely forming a template for their lattice-like
structure.
11.6 GAD immunoreactive neurones in PV and TN-R single and double KO mice
Cortical interneurones are critically involved in modulating the corticofugal
projections arising from pyramidal cell in the neocortex (Heimer, 1995), with a large
sub-population of these cortical interneurones expressing PV (Baimbridge et al.,
1992). These interneurones are surrounded by PNEMs (Celio and Blümcke, 1994) and
it has been hypothesised that both expression of PV and the presence of PNEMs are
crucial for sustaining the fast-spiking properties of these GABAergic interneurones
(Celio and Blümcke, 1994; Hartig et al., 1999). Modulations in the properties of these
inhibitory interneurones may lead to alterations in their GABAergic output thereby
influencing the inhibitory cortical circuit.
Neither the lack of PV nor the alteration in morphology of PNEMs affected the
distribution or density of inhibitory cortical interneurones, indicating that the overall
inhibitory system remains intact in PV, TN-R and PV/TN-R KO mice. Nonetheless,
slight modulations such as alterations in the release of GABA from the synaptic
terminals of interneurones and an increased susceptibility to seizures has been
observed in mice lacking parvalbumin (Drs M. Vreugdenhil and B. Schwaller,
personal communication; Tandon et al., 1999; section 10.4). Probably, these changes
take place because of alterations in the calcium homeostasis and in the distribution of
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synaptic terminals impinging upon the cell bodies, and it is perceivable that
synergistic effects may occur in mice lacking both PV and TN-R, thereby further
modulating the output from the sub-population of cortical inhibitory interneurones in
these mice.
11.7 Conclusion
Taken together, these results indicate that the principal role for TN-R in relation
to the PNEMs may be to attract and/or retain other matrix components. The intimate
involvement of TN-R in the formation of the lattice-like structure of PNEMs is
probably effectuated via the multimerisation of TN-R molecules leading to the
formation of a scaffold onto which other PNEM components can assemble. TN-R is
however not envisaged to be involved in determining which population of neurones
form perineuronal nets of extracellular matrix, and is it self attracted to these neurones
either by other putative matrix molecules or by still unidentified transmembrane
receptors. The external PNEM and internal membrane-related cytoskeleton most
likely interact via transmembrane proteins but the structures of the internal and
external nets are formed independently.
It has been proposed that the intracellular cytoskeleton is involved in
determining the position of transmembrane receptors by anchoring them to the actin
filaments (Alberts et al., 1994; see also figure 11.7.1). The distribution of
transmembrane receptors in the cell membrane is determined by factors such as the
overall structure of the cytoskeleton and potential extracellular clues. Cytoskeleton
associated proteins (CAPs), comprising among others ankyrinR and spectrin, are
involved in determining the spatial formation of the cytoskeleton and are also
mediating the interactions between the actin filament and catenins interacting with the
cytosolic part of transmembrane receptors (Alberts et al., 1994). Here, it is proposed
that PNEMs assemble, as certain BECM components bind to putative transmembrane
proteins, specific for neurones forming PNEMs. Other BCEM components are then
drawn to these neurones and are themselves responsible for attracting additional
matrix molecules. The role of TN-R in the formation of PNEMs may be to form the
corners in the observed lattice-like structures of the PNEMs via its ability to form
dimers, trimers or multimers (see figure 11.7.1). Having multimerised, TN-R then
attracts proteoglycans such as phosphacan and neurocan to the PNEMs, and these in
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turn attract other BECM components, e.g. hyaluronic acid. Many matrix molecules
are modular proteins (Chiquet-Ehrismann, 1995; Bork and Koonin, 1996) and it can
be envisaged that each PNEM component is involved in the attraction of several other
components and that it is the synergistic effects of many constituents that ultimately
Figure 11.7.1  Schematic drawing of intra- and extracellular nets and their potential interactions.
The drawing has been simplified to only show two receptors and some of the molecules
interacting with them. Abbreviations: Cytoskeleton associated proteins (CAPs), receptor
interacting protein (RIP) and tenascin-R (TN-R). The general organisation of the cytoskeleton
was modified from Alberts et al., 1994 and the hypothesis was kindly put to paper by Dr. Rienk
Tuinhof.
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determines how strongly each component is bound within the nets. Nonetheless, here
it has been shown that TN-R is essential for the attraction and/or retention of
phosphacan and neurocan in cortical PNEMs, whereas other components may be able
to compensate for the lack of TN-R-mediated attraction of neurocan to non-cortical
PNEMs (Haunso et al., 2000). TN-R is most likely not the primary mediator of PNEM
assembly, as some immunoreactivity for PNEM components is still observed around
certain focal points on the cell membranes in TN-R deficient mice (Weber et al.,
1999; Haunso et al., 2000). Probably, the lack of TN-R, and subsequent loss of
phosphacan and neurocan, alters the strength with which several other components are
attracted to PNEMs, thereby leading to the observed alteration in the overall
morphology of these entities (see figure 11.7.1).
111
12. Appendix
Phosphate-buffered saline solution (PBS)
1 x PBS : 0.147 M NaCl; 2.68 mM KCl; 1.76 mM KH2PO4; 10.14 mM
Na2HPO4; pH7.4
Tris-buffered saline solutions (TBS)
1 x TBS : 25 mM Tris-HCl, pH7.4; 0.137 mM NaCl; 2.7 mM KCl
1 x TBS-T : 1 x TBS; 0.1% Tween-20
Tris-boric acid-EDTA buffer (TBE)
10 x TBE : 108 g Trizma base; 53 g boric acid; 9.8 g EDTA; ddH2O until
1L
Mini-preparation
solution I : 50 mM Tris-HCl, pH7.5; 10 mM EDTA; 100 mg/mL RNase A
solution II : 0.2 M NaOH; 1% SDS
solution III : 60 mL 5 M potassium acetate; 12 mL glacial acetic acid; 28
mL ddH2O
Preparation of chemical competent bacteria
Solutions
TB solution : 10 mM Pipes; 15 mM CaCl2; 250 mM KCl; adjust to pH6.7
with 5 M KOH; add 55 mM MnCl; filter and store at 4°C
Procedure
Streak XL-1 blue bacteria (from a glycerol stock) on a LB plate and place it
over night at 37°C. Pick 10 to 12 clones with a sterile tooth pick or an inoculation
loop and place in 100 mL LB-medium (without antibiotics). Grow medium at 37°C in
an orbital shaking incubator until OD600 has reached approximately 0.45. Prior to
centrifuging 10 min. at 2500 g, place the medium for 10 min. on ice. Resuspend the
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pellet in 40 mL TB solution, incubate for 10 min. on ice and centrifuge at 2,500 g for
ten minutes. Resuspend pellet in 10 mL TB containing 7% DMSOv (9.7 mL TB and
0.7 mL DMSO) and place on ice for 10 minutes. Gently tap the tube to resuspend the
bacteria, make 300 mL aliquots in Eppendorf tubes and place them in liquid N2. Store
chemical competent bacteria at -70°C.
Lennox L Broth base and agar (LB-medium / LB-agar)
1 x LB-agar : 32 g Lennox L agar; ddH2O until 1 L
1 x LB-medium : 20 g LB-broth base; ddH2O until 1 L
Dulbecco’s Modified Eagle’s Medium (DMEM)
1 x DMEM, serum-free: 10 g DMEM w/1000 mg glucose; 3.7 g NaHCO3; 5
mL 100 x glutamine (200 mM); 5 mL 100 x penicillin
plus streptomycin (10,000 U; 10,000 mg/mL); pH7.4,
ddH2O until 1 L
1 x DMEM w/10% FCS: 100 mL foetal calf serum; 10 g DMEM w/1000 mg
glucose; 3.7 g NaHCO3; 5 mL 100 x glutamine (200
mM); 5 mL 100 x penicillin plus streptomycin (10,000
U; 10,000 mg/mL); pH7.4; ddH2O until 1 L
Solution for propagation of yeast cells
10 x YNB : 134 g yeast nitrogen base w/ ammonium sulphate w/o
amino acid; ddH2O until 1 L
1 x BMGH : 690 mL autoclaved ddH2O; 100 mL 1 M potassium
phosphate, pH6.0; 100 mL 10 x YNB; 2 mL 0.02% biotin; 100
mL 10% glycerol
1 x BMMH : 690 mL autoclaved ddH2O; 100 mL 1 M potassium
phosphate, pH6.0; 100 mL 10 x YNB; 2 mL 0.02% biotin; 100
mL 0.5% methanol
MDH-plates : 800 mL autoclaved ddH2O; 100 mL 10 x YNB, 2 mL
0.02% biotin; 100 mL dextrose; 15 g agar
                                                                
v Dimethyl sulfoxide
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MHH-plates : 800 mL autoclaved ddH2O; 100 mL 10 x YNB; 2 mL
0.02%; 100 mL 5% methanol; 15 g agar
1 x YPAD : 1% yeast extract; 2% peptone; 2% D-glucose
YPDS-plates : 1% yeast extract; 2% peptone; 2% D-glucose; 1 M
sorbitol; 2% agar
Tissue homogenisation buffers
hom. buffer A : 0.4 M NaCl; 10 mM Tris-HCl, pH7.5; 1 mM EDTA;
1 mM EGTA; 0.02% NaN3
hom. buffer B : 10 mM Tris-HCl, pH7.5; 2% Triton-X 100; 0.02% NaN3
hom. buffer C : 10 mM Tris-HCl, pH7.5; 3 mM CaCl2; 0.02% NaN3
hom. buffer D : 1 M NaCl, 10 mM Tris-HCl, pH7.5; 1 mM EDTA; 1 mM
EGTA; 0.02% NaN3
hom. buffer E : 0.1 M diethanolamin, pH11; 0.1 M NaCl; 1 mM EGTA;
1 mM EGTA
Buffers for purification of recombinant material
Native buffers
GST lysis buffer : 1 x PBS
GST washing buffer: 1 x PBS; 0.1% Triton-X
GST elution buffer: 50 mM Tris-HCl, pH8.0; 5 mM reduced glutathione;
100 mM NaCl
nHis lysis buffer : 20 mM sodium phosphate, pH7.8; 500 mM NaCl
nHis washing buffer: 20 mM sodium phosphate, pH6.0; 500 mM NaCl
nHis elution buffer: 20 mM sodium phosphate, pH6.0; 0.2 M imidazole
Denaturing buffers
dHis lysis buffer : 8 M urea; 20 mM sodium phosphate, pH7.8; 500 mM NaCl;
5 mM imidazole
dHis washing buffer: 6 M urea; 20 mM sodium phosphate, pH6.0; 500 mM NaCl
dHis elution buffer: 6 M urea; 20 mM sodium phosphate, pH6.0; 0.2 M imidazole
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Sodium dodecylsulphate polyacrylamide gel electrophoresis gels (SDS-PAGE)
Small SDS-PAGE gels (for two gels)
stacking gel    5%     3%
30% acrylamide/bis (29:1) 810 mL 480 mL
0.5 M Tris-HCl, pH6.8 625 mL 625 mL
SDS (10%)         50 mL  50 mL
APS (10%)       25 mL  25 mL
TEMED                 10 mL  10 mL
ddH2O               3.5 mL 3.8 mL
     ____________________________________________________
VTOTAL     5 mL    5 mL
separation gel    15%       12%       10%     8% 6%        3%
30% acrylamide/Bis (29:1)    5 mL       4 mL   3.33 mL    2.66 mL     2 mL      1 mL
1.5 M Tris-HCl, pH9.2         3.75 mL  3.75 mL   3.75 mL   3.75 mL 3.75 mL 3.75 mL
SDS (10%)           100 mL    100 mL    100 mL     100 mL   100 mL   100 mL
APS (10%)    50 mL      50 mL      50 mL       50 mL     50 mL     50 mL
TEMED                20 mL      20 mL      20 mL       20 mL     20 mL     20 mL
ddH2O                       1 mL       2 mL   2.66 mL   3.33 mL      4 mL      5 mL
_____________________________________________________________________
VTOTAL             10 mL    10 mL      10 mL      10 mL      10 mL   10 mL
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Large SDS-PAGE gels (per gel)
stacking gel : 3% gels, made as described above
separation gel   16%    4%
30% acrylamide/Bis (29:1) 6.9 mL 1.7 mL
1.5 M Tris-HCl, pH9.2 4.7 mL 4.7 mL
SDS (10%) 126 mL 126 mL
APS (10%)   33 mL   33 mL
TEMED     5 mL     5 mL
ddH2O  1.2 mL 6.4 mL
      ________________________________________
VTOTAL   13 mL 13 mL
Large SDS-PAGE gel for 2D-PAGE (per gel)
separation gel  16%      4%
30 % acrylamide/PSAw (29:1) 9.9 mL  2.5 mL
1.5 M Tris-HCl, pH9.2 4.6 mL  4,6 mL
SDS (10%) 200 mL  200 mL
APS (10%)    55 mL    55 mL
TEMED   4.6 mL   4.6 mL
Na2S2O3 (20 g/L)   4.6 mL   4.6 mL
ddH2O / glycerolx 3.9 mL 11.3 mL
_________________________________________________
VTOTAL    19 mL       19 mL
SDS-PAGE solutions
Coomassie Brilliant : 0.1 g Coomassie blue; 45 mL methanol; 10 mL glacial
Blue R250 acetic acid, ddH2O until 1 L
destainer (1L) : 100 mL methanol; 100 mL glacial acetic acid; ddH2O
until 1 L
                                                                
w Piperazine diacrylamide (BioRad)
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drying solution : 5% glycerol; 10% ethanol
6 x Laemmli loading: 7 mL 0.5 M Tris-HCl, pH6.8; 3 mL glycerol; 1 g
buffer SDS, few grains of bromphenol blue
running buffer, 1 x: 0.025 M Tris-HCl; 0.192 M glycine; 0.01% SDS
Western blotting : 800 mL 1 x SDS-PAGE running buffer; 200 mL
buffer methanol
                                                                                                                                                                                         
x Distilled water for the 4% and 87% glycerol for the 16% acrylamide solution
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13. Abbreviations
AD Alzheimer’s disease
APS ammonium peroxodisulfate
BMGH buffered minimal glycerol medium containing histidine
BMMH buffered minimal methanol medium containing histidine
cDNA complementary DNA
CHAPS 3-[(3-cholamidopropyl)dimethyl-ammonio]-1-propanesulfonate
COS cells Simian fibroblasts transformed by SV40
CJD Creutzfeldt-Jacob disease
CNS central nervous system
ddH2O double distilled water
dHis denaturing hexahistidine
DMEM Dulbecco’s modified Eagle’s medium
DMSO dimethyl sulfoxide
DNA deoxyribonucleic acid
DTE 1,4-dithioerythiol
DTT 1,4-dithiothreitol
ECL enhanced chemiluminescence
E. coli Escherichia coli
EDTA ethylenediaminetetraacetic acid
EGF epidermal growth factor
EGTA Bis[2-aminoethylethene]-N,N,N’,N’ tetracacetic acid
ER endoplasmatic reticulum
FG fibrinogen like knob
FITC fluorescinisothiocyanate
FN fibronectin
GABA g-aminobutyric acid
GAD glutamic acid decarboxylase
GalNAc N-acetylgalactosamine
GST glutathion-S-transferase
h hexahistidine
hFG hexahistidine fibrinogen like knob
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His buffers buffers used for purification of hexahistidine fusion proteins
HIV human immunodeficiency virus
hom. homogenisation
IPG Immobiline DryStrip gels
IPTG isopropyl b-D-thiogalactopyranoside
IR immunoreactivity
kDA kilodalton
KO knockout
LB Lennox L broth
MDH minimal dextrose with histidine
MHH minimal methanol with histidine
MRC membrane related cytoskeleton
MS multiple sclerosis
nHis native hexahistidine
NTA nickel-nitrotriacetic acid
PAGE polyacrylamide gel electrophoresis
PBS phosphate-buffered saline solution
PNEM perineuronal net of extracellular matrix
PNS peripheral nervous system
P. pastoris Pichia pastoris
PV parvalbumin
S. cerevisiae Saccharomyces cerevisiae
SDS sodium dodecylsulphate
TBS Tris-buffered saline solution
TBS-T Tris-buffered saline solution containing Triton-X 100
TCA trichloroacetic acid
TEMED N,N,N’,N’ tetramethylethylenediamine
TN-R tenascin-R
Tris tris[hydroxymethyl]aminomethane hydrochloride
TSE transmissible spongiform encephalopathie
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YNB yeast nitrogen base
YPD yeast extract peptone dextrose
YPDS yeast extract peptone dextrose
X-Gal 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside
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Abstract
A special feature of the extracellular matrix in adult brains of various species is the concentration of certain components around
different sub-populations of neurones, giving rise to net-like structures termed perineuronal nets. Recently, some of these components
have been identified but the function of these nets has yet to be resolved. Using immunofluorescence microscopy, we report here that
phosphacan, a chondroitin sulphate proteoglycan, is an additional component of Wisteria floribunda labelled perineuronal nets
surrounding parvalbumin-expressing neurones in rat cerebral cortex. Glycoproteins such as tenascin-C and -R have been identified in
perineuronal nets and the present detection of phosphacan immunoreactivity in the same entity is of potential physiological importance
because of their previously described interactions. q 1999 Elsevier Science B.V. All rights reserved.
Keywords: Chondroitin sulphate proteoglycan; Extracellular matrix; Parvalbumin; Perineuronal net; Phosphacan; Rat cerebral cortex; WFA
It is generally recognised that brain extracellular matrix
 .B-ECM plays an important role in the development and
maintenance of the central nervous system. B-ECM, which
mainly consists of hyaluronan, glycoproteins and proteo-
glycans can influence the nervous system by binding
growth factors and cell receptors, and by modulating cell
 w x.adhesion and signalling for review, see Ref. 19 . A large
part of potential signalling molecules in the B-ECM be-
longs to the chondroitin sulphate proteoglycan family
 .CSPGs , whose members tend to have distinct distribution
w x patterns in the brain 10,18 . Phosphacan reviewed in Ref.
w x.12 , comprising the extracellular region of the receptor
 .protein tyrosine phosphatase zrb RPTP zrb , belongs to
this family of CSPGs. Phosphacan is synthesised by astro-
w xcytes 17 and its localisation, carbohydrate and sulphate
compositions are developmentally regulated in the nervous
w xtissue 14 . In embryonic and early postnatal rat brain,
phosphacan immunoreactivity is distributed in the neuropil
of the cerebral cortex and in the adult rat brain is localised
w xmainly around multipolar non-pyramidal neurones 11 .
) Corresponding author. Fax: q41-26-300-9732; E-mail:
pierre-alain.menoud@unifr.ch
CSPGs have been shown to be present in the perineuronal
w xnet 5 surrounding GABAergic interneurones expressing
 . w x the calcium-binding protein parvalbumin PV 8 for an
w x.overview of PV distribution in the brain, see Ref. 4 . In
this report, we show that phosphacan immunoreactivity is
present in the perineuronal net surrounding PV-positive
GABAergic interneurones in the adult rat cerebral cortex.
Eight adult Wistar rats of either sex weighing ;300 g
were euthanised with carbon dioxide and perfused via the
 .left ventricle with 150 ml of 4% wrv paraformaldehyde
in PBS 0.147 M NaCl, 2.68 mM KCl, 1.76 mM KH PO2 4
.and 10.14 mM Na HPO ; pHs7.4 . Brains were re-2 4
moved and placed for a further 1 h in 4% paraformal-
dehyde, then transferred for an additional 1 h in PBS and
 .subsequently incubated overnight at 48C in 18% wrv
sucrose in PBS. Brains were frozen and cut, using a
cryostat, into 40 mm thick horizontal sections. Prior to
applying the primary antibodies the sections were washed
in PBS for 5 min, post-fixed for 1 min in 4% paraformal-
dehyde and subsequently washed again in PBS for 2 min.
Double-immunolabelling was performed by incubating the
sections with a rabbit polyclonal anti-phosphacan antibody
w x  .17 dilution 1:1000 and either with the biotinylated
 .lectin Wisteria floribunda agglutinin WFA, Sigma at a
0006-8993r99r$ - see front matter q 1999 Elsevier Science B.V. All rights reserved.
 .PII: S0006-8993 99 01596-6
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concentration of 20 mgrml or with a mouse monoclonal
 .anti-PV antibody PV235, Swant diluted 1:1000. Free-
floating sections were incubated overnight at 48C in PBS
 .containing 10% vrv bovine serum. Sections were rinsed
three times 10 min in PBS. All the following incubations
were carried out at room temperature in PBS containing
 .10% vrv bovine serum and all washes for three times 10
min in PBS. Sections incubated with the anti-PV antibody
were revealed with an anti-mouse Cy3e-conjugated anti-
 .body Jackson Laboratories . Sections incubated with bio-
tinylated WFA were revealed by a Cy2e-conjugated
 .streptavidin Jackson Laboratories . The anti-phosphacan
antibody incubation was carried out as a two step reaction
by first applying a goat anti-rabbit IgG antibody Jackson
.Laboratories , followed by washes and subsequent incu-
bated with a donkey anti-goat Cy2e-conjugated antibody
 .Amersham . The goat anti-rabbit antibody, the Cy2e- and
Cy3e-conjugated antibodies and the Cy2e-conjugated
streptavidin were all applied at dilutions of 1:100 for 2 h at
room temperature. After extensive washes, sections were
air dried on slides for 2 h at room temperature, rehydrated
in double distilled water, dried for 30 min and subse-
 .quently mounted in SlowFadee Molecular Probes , cov-
erslipped and sealed using clear nail varnish. Controls
were carried out in the absence of the primary antibodies
or the lectin. Slides were visualised under a Zeiss Axio-
phot fluorescence microscope, photographed using a Spot
 .camerae Diagnostic instruments , imported into Adobe
Photoshop 3.0.5 where minor changes in brightness and
contrast were performed and photographic plates were
printed on a Kodak DS 8650 PS Color printer.
Detailed analysis of phosphacan immunoreactivity in
the adult rat cerebral cortex revealed a pericellular staining
resembling perineuronal net-like structures, ensheathing
the cell-body and major dendrites of non-pyramidal neu-
rones. Neurones surrounded by phosphacan immuno-
reactivity were found in all layers of the cortex, except
layer I, and were mainly distributed in layers II, IV and VI.
The immunofluorescence intensity varied from a strong
staining in the deeper layers revealing both the contours of
the cell body and dendrites, to an almost indistinct staining
of the perimeter of a subclass of neurones in layer II.
Moreover, a difference in the density and intensity of
positive neurones was also observed depending upon the
region of the cerebral cortex, but this was not further
studied. In double-staining experiments using both anti-
phosphacan and anti-PV antibodies, it was shown that all
phosphacan immunoreactive neurones in the cerebral cor-
 .tex were also PV-positive Fig. 1A,B . Very few PV-posi-
tive neurones were found without a phosphacan net Fig.
.1C,D , but the variation in intensity of the phosphacan
immunoreactivity made it difficult to distinguish negative
from weakly stained cells. When sections were incubated
concomitantly with WFA, a marker for the perineuronal
Fig. 1. Co-localisation of phosphacan immunoreactivity within perineuronal nets around parvalbumin expressing neurones in the cerebral cortex of adult
 .  .rats. A and B show a double stained section incubated with anti-PV A and anti-phosphacan B antibodies. Some of the double stained cells in A and B
are marked with arrow heads whereas the asterisks in B denote the position of faintly stained neurones in A that are out of focus. C and D depict a double
 .  .stained section illustrating the lack of phosphacan immunoreactivity curved arrow in D around a PV-expressing neurone C, curved arrow . E and F show
 .  .a double stained section incubated respectively with WFA E and the anti-phosphacan antibody F . Scale barss50 mm.
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net, and anti-phosphacan, we observed that phosphacan
immunoreactivity was localised around the same sub-popu-
 .lation of neurones as the perineuronal net Fig. 1E,F . In
addition, there was a correlation between the intensity of
the phosphacan immunoreactivity and that of WFA in the
deeper cortical layers, but not in layer II where the phos-
phacan immunoreactivity was generally weak. Similar re-
sults were obtained when the monoclonal anti-phosphacan
w x  .antibody 3F8 18 was applied not shown .
The amount of extracellular material detected in the
w xbrain is relatively low 19 when compared to the ECM of
many other tissues. Moreover, many if not all of the ECM
components in the brain have restricted regional distribu-
tions and in addition some also tend to accumulate around
specific sub-populations of neurones giving rise to net-like
structures termed perineuronal nets for review, see Refs.
w x. w x5,7 . ECM compounds such as hyaluronan 1 , neurocan
w x w x w x13 , tenascin-C 6 and tenascin-R 5 are seen to accumu-
w xlate around PV-expressing GABAergic interneurones 9
comprising a proportion of the neurones surrounded by
perineuronal nets. The distribution of PV-expressing neu-
w xrones in the cerebral cortex 4 and their co-localisation
with WFA labelled perineuronal nets is well established in
w xthe literature 2,3,9 . Moreover, it has also been shown that
CSPGs constitute part of the perineuronal nets around
w xPV-positive neurones 8 . Furthermore, using the mono-
w xclonal anti-phosphacan antibody 6B4, Maeda et al. 11
have detected phosphacan immunoreactivity around certain
multipolar non-pyramidal neurones in the adult rat cerebral
cortex. In this paper, we expand on these results by
showing that phosphacan is one of the CSPGs in perineu-
ronal nets and that it surrounds only PV-positive neurones
in the cortex. The few PV-positive neurones we found not
to be surrounded by phosphacan immunoreactivity were
localised in the cortical regions where the intensity of the
phosphacan immunoreactivity was generally weak. This
made it difficult to determine if phosphacan immuno-
reactivity truly was absent around the PV-positive neu-
rones or if the immunoreactivity was lower than could be
detected. In the deeper layers of the cortex, where the
intensity of the phosphacan immunoreactivity appeared to
be strong, there was a perfect correlation between neurones
surrounded by WFA and those surrounded by phosphacan
immunoreactivity. However, certain regions of the cortex
had a low phosphacan immunoreactivity even though no
apparent difference could be observed in the WFA stain-
ing. Here we suggest that the proportion between phospha-
can and other CSPGs within perineuronal nets varies de-
pending on region and layer of the cortex. The appearance
of phosphacan immunoreactivity in WFA labelled perineu-
ronal nets was not surprising as the former contains N-
 . w xacetylgalactosamine carbohydrates GalNAc 11 which
are recognised by WFA. Moreover, phosphacan is also
known to bind to certain glycoproteins found in perineu-
w x w xronal nets such as tenascin-C 16 and tenascin-R 15 .
Therefore, the co-localisation of all three compounds in
perineuronal nets suggests a potential physiological rele-
vance for their interactions.
Perineuronal nets are thus not only heterogeneous in
w xcomposition 5,7 but the proportion of their components
vary depending upon the localisation within the cerebral
cortex. Such regional differences in the composition of the
ECM may reflect subdivisions of functionally defined
areas. So far, the functions and the exact composition of
w xperineuronal nets are still far from being determined 5
but the identification of phosphacan in this structure adds a
further component to this special form of extracellular
matrix and may enable us to better understand its role.
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Abstract
Recently identified chondroitin sulphate proteoglycans in perineuronal nets include neurocan and phosphacan. However, the function
and assembly of these components has yet to be resolved. In this study we show morphological alteration in Wisteria floribunda labelled
nets around cortical interneurones both in tenascin-R knockout and tenascin-R/parvalbumin double knockout mice. This alteration reflects
the loss of phosphacan and neurocan from cortical nets in mice deficient in tenascin-R. No effect on the membrane related cytoskeleton,
as revealed by ankyrin , was observed in any of the mice. These results on mice lacking tenascin-R substantiate previously reported inR
vitro interactions between tenascin-R and phosphacan and neurocan. Ó 2000 Elsevier Science B.V. All rights reserved.
Themes: Cellular and molecular biology
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A special feature of the brain extracellular matrix PNEMs, by controlling the position of integral membrane
(ECM) [18] is the aggregation of certain components proteins [21] involved in forming the nets. In this report
around specific sub-populations of neurones giving rise to we show that TN-R is essential for attracting and/or
net-like structures termed perineuronal nets of extracellular retaining neurocan and phosphacan in cortical PNEMs as
matrix (PNEMs) [6]. PNEMs are well characterised around no pericellular staining was observed for these CSPGs
cortical GABAergic parvalbumin immunoreactive (PV-IR) when TN-R was lacking.
interneurones [8] and are composed of hyaluronan, tenas- Mice lacking either TN-R [20] or PV [19] were used
cin-C [4], -R [3] and defined chondroitin sulphate proteo- and double knockout mice for both TN-R and PV were
glycans (CSPGs) such as brevican [7], neurocan [13] and generated by cross-breeding TN-R and PV single knockout
phosphacan [9]. However, neither function [8] nor process mice. The genotype of TN-R, PV and PV/TN-R deficient
of assembly of PNEMs has yet been determined [6]. In mice were determined by Southern blotting as previously
vitro studies have shown binding between tenascin-R (TN- described [19,20]. In total twelve adult mice |30 g,
R) and members of the CSPG family [7,14] suggesting its comprising three of each genotype — wild type (WT), PV
involvement in the assembly and structure of PNEMs. In knockout (KO), TN-R KO and PV/TN-R double KO — of
addition, the intracellular organisation of the ankyrin either sex, were used in these experiments. Animals wereR
membrane-related cytoskeleton (MRC) may also be in- sacrificed, brains dissected out and processed for immuno-
volved in the formation of the lattice-like structure of histochemistry as previously described [9]. Biotinylated
Wisteria floribunda agglutinin (WFA, Sigma) immuno-
reactivity (IR) was detected by applying the lectin at a
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23–14). Double-immunolabelling was performed by in-
cubating sections with a mouse monoclonal anti-PV anti-
body (PV235, Swant) diluted 1:500 together with rabbit
polyclonal antibodies against either phosphacan [15],
neurocan [16] or ankyrin [10], all diluted 1:1000. Sec-R
tions incubated with the anti-PV antibody were visualised
with a fluorescein isothiocyanate-conjugated (FITC, 1:200)
anti-mouse antibody (Molecular Probes) and biotinylated
WFA was visualised by Texas Red-conjugated strep-
tavidine (Vector, 1:200). Detection of all rabbit polyclonal
antibodies or the monoclonal TN-R antibody was carried Fig. 2. Double confocal images of neurocan (A–C) and phosphacan
out as two step reactions by first applying biotinylated goat (D–F) immunoreactivity around cortical interneurones. (A) Neurocan-IR
anti-rabbit IgG antibodies (Vector, 1:200) or biotinylated (red, arrows) around a PV-labelled neurone (green) in WT. (B) Neurocan-
IR (red) surrounding PV-negative (asterisk) neurone in PV KO. (C)horse anti-mouse IgG antibody (Vector, 1:200), respective-
PV-labelled neurone (green) lacking neurocan-IR around cell soma inly, followed by washes and subsequent incubation with
TN-R KO. (D) Phosphacan-IR (red, arrows) around PV-labelled neuroneTexas Red-conjugated streptavidine(1:200). Controls were (green) in WT. (E) Phosphacan-IR (red) surrounding PV-negative (aster-
carried out in the absence of primary antibodies or the isk) neurone in PV KO. (F) PV-labelled neurone (green) lacking
lectin. Slides were analysed with a Bio-Rad 1024, argon/ phosphacan-IR around cell soma in TN-R KO. Scale bar520 mm.
krypton confocal laser scanning fluorescence microscope
(LSCM, Bio-Rad Microsciences Division Ltd). Both green
and blue-lines of laser excitation were used and detected at reduced or absent (Fig. 1C,D). Despite this, no apparent
522 nm for FITC and 680 nm for Texas Red-labelled change in the overall distribution or density of cells with
structures. Using 360 oil immersion objective and real- WFA-labelled nets was observed in any of the animals, as
time zoom feature of the confocal program, captured also shown by Weber et al. [20]. In WT and PV KO
optical sections of 0.2-mm thickness were superimposed animals, double-immunofluorescence labelling using
and images transferred to Adobe PhotoshopE software neurocan or phosphacan combined with PV-IR revealed a
where photographic plates were prepared and printed using normal net-like staining pattern around cortical inter-
a Kodak dye sublimation printer (DS 8650 PS) neurones (Fig. 2A,B,D,E). In TN-R deficient mice we
In both WT and TN-R KO animals cortical PV-IR observed a massively reduced and more diffusely distribut-
neurones had a normal pattern of distribution and normal ed cortical neurocan-IR in mutant mice when compared to
pericellular staining was observed in WT and PV KO wild-type animals (Fig. 2C), whereas no pericellular
animals (not shown). Confocal analysis of individual phosphacan-IR (Fig. 2F) could be detected in any tenascin-
WFA-labelled PNEMs revealed a lattice-like staining R deficient mice. The ankyrin -IR MRC (characteristic forR
around cell soma and dendritic aborisations in both WT cortical PV-IR interneurones [21]) showed no morphologi-
and PV KO animals (Fig. 1A,B). However, in both TN-R cal differences in any of the mice studied, even in neurones
KO and PV/TN-R KO animals WFA-labelled PNEMs lacking PV or those showing altered neurocan and phos-
around the cell soma showed punctuated immunolabelling phacan PNEMs (Fig. 3).
(Fig. 1C,D). Labelling along dendrites was also markedly Many if not all ECM components in the brain show a
Fig. 1. Confocal images of WFA-labelled perineuronal nets in the cerebral cortex of WT (A), PV KO (B), TN-R KO (C) and PV/TN-R double KO (D). In
both WT (A) and PV KO (B) mice the nets have a normal lattice-like morphology around soma and extend along dendritic aborisations (arrow heads). Nets
were punctuated and disrupted around soma (asterisk) in TN-R KO (C) and to a similar extent in PV/TN-R double KO (D) mice. Labelling of nets along
dendrites was generally absent in both genotypes. Scale bar520 mm.
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perineuronal nets are required for fast-spiking behaviour of
GABAergic interneurones [8]. Modification of PNEMs
could therefore influence the fast-spiking properties of
these neurones or the distribution of synapses contacting
their cell body, since the lattice-like structure of PNEMs
defines the area of synaptic contacts [3]. Together with a
Fig. 3. Confocal images of ankyrin membrane-related cytoskeletonR changed calcium homeostasis this could modulate the
immunoreactivity in WT (A), PV KO (B) and TN-R KO (C) mice. inhibitory output from these GABAergic interneurones inAnkyrin -IR showed normal pattern of distribution and morphology inR
mice lacking both TN-R and PV.cortical neurones of all genotypes. Scale bar520 mm.
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